Techniques for deployment of a prosthetic valve
A method includes percutaneously advancing an implant to a native heart valve of a subject, the implant being housed in a compressed state within a delivery tool. Next, the method includes unhousing a longitudinally-intermediate portion of the implant, the longitudinally-intermediate portion being longitudinally between a longitudinally-proximal portion of the implant and a longitudinally distal portion of the implant. Subsequently, the longitudinally-proximal portion of the implant is unhoused. Subsequently, the longitudinally-distal portion of the implant is unhoused. By unhousing flanges of the implant, the flanges automatically expand. Upon the flanges expanding, a proximal end of each flange extends radially outward from a central longitudinal axis of the implant and longitudinally in a proximal direction. Other applications are also described.
Latest CARDIOVALVE LTD. Patents:
This application is a Continuation application of U.S. patent application Ser. No. 15/668,659, filed Aug. 3, 2017, entitled, “Techniques for deployment of a prosthetic valve,” which issued as U.S. Pat. No. 10,918,481 and which:
-
- (1) is a Continuation-In-Part of PCT application IL2016/050125, filed Feb. 3, 2016, entitled “Prosthetic valve with axially-sliding frames,” which published as WO 2016/125160, and which claims priority from U.S. Provisional Patent Application 62/112,343 to Hariton et al., filed Feb. 5, 2015, and entitled “Prosthetic valve with axially-sliding frames”; and
- (2) is a Continuation-In-Part of U.S. patent application Ser. No. 15/541,783, entitled “Prosthetic valve with axially-sliding frames,” which issued as U.S. Pat. No. 9,974,651, and which is the US National Phase of PCT application IL2016/050125, filed Feb. 3, 2016, entitled “Prosthetic valve with axially-sliding frames,” which published as WO 2016/125160, and which claims priority from U.S. Provisional Patent Application 62/112,343 to Hariton et al., filed Feb. 5, 2015, and entitled “Prosthetic valve with axially-sliding frames.”
All of the above applications are incorporated herein by reference.
FIELD OF THE INVENTIONSome applications of the present invention relate in general to valve replacement. More specifically, some applications of the present invention relate to prosthetic valves for replacement of a cardiac valve.
BACKGROUNDIschemic heart disease causes regurgitation of a heart valve by the combination of ischemic dysfunction of the papillary muscles, and the dilatation of the ventricle that is present in ischemic heart disease, with the subsequent displacement of the papillary muscles and the dilatation of the valve annulus.
Dilation of the annulus of the valve prevents the valve leaflets from fully coapting when the valve is closed. Regurgitation of blood from the ventricle into the atrium results in increased total stroke volume and decreased cardiac output, and ultimate weakening of the ventricle secondary to a volume overload and a pressure overload of the atrium.
SUMMARY OF THE INVENTIONFor some applications, an implant is provided having a tubular portion, an upstream support portion and one or more flanges. The implant is percutaneously deliverable to a native heart valve in a compressed state, and is expandable at the native valve. The implant and its delivery system facilitate causing the upstream support portion and the flanges to protrude radially outward from the tubular portion without expanding the tubular portion. Expansion of the tubular portion brings the upstream support portion and the flanges closer together, for securing the implant at the native valve by sandwiching tissue of the native valve between the upstream support portion and the flanges.
For some applications, a delivery tool is provided, including a delivery capsule, disposed at a distal portion of the tool. The delivery capsule includes a proximal capsule-portion dimensioned to house a first part of an implant, and a distal capsule-portion dimensioned to house a second part of the implant; and an extracorporeal control portion, disposed at a proximal portion of the tool, the control portion including one or more controllers and one or more locks. The controllers are operatively coupled to the proximal and distal capsule-portions such that the proximal and distal capsule-portions are movable with respect to the implant via actuation of the controllers. The tool has sequential states in which movement of the proximal and distal capsule-portions is variously inhibited or facilitated. For some applications, in response to a movement of a capsule-portion that is facilitated in a given state, the tool unlocks the subsequent state.
There is therefore provided, in accordance with an application of the present invention, apparatus including an implant and a delivery tool, the tool including:
a delivery capsule, disposed at a distal portion of the tool, the delivery capsule including a proximal capsule-portion dimensioned to house a first part of the implant, and a distal capsule-portion dimensioned to house a second part of the implant; and
an extracorporeal control portion, disposed at a proximal portion of the tool, the control portion including one or more controllers and one or more locks, the controllers being operatively coupled to the proximal and distal capsule-portions such that the proximal and distal capsule-portions are movable with respect to the implant via actuation of the controllers,
and the controllers and the locks are mechanically cooperative such that:
-
- in a state A of the tool:
- a first distal movement of the distal capsule-portion up to a first distance distally with respect to the implant is facilitated,
- a second distal movement of the distal capsule-portion further distally with respect to the implant is inhibited, and
- a proximal movement of the proximal capsule-portion proximally with respect to the implant is facilitated; and
- in a state B of the tool:
- the second distal movement of the distal capsule-portion is facilitated.
- in a state A of the tool:
In an application, in the state A, a lock of the one or more locks is locked, and unlocking of the lock transitions the tool into the state B.
In an application, the lock is not unlockable until the distal capsule-portion has been moved the first distance distally with respect to the implant.
In an application, the lock is not unlockable until the proximal capsule-portion has been moved proximally with respect to the implant.
In an application:
the one or more controllers include a first controller and a second controller, and
in the state A, actuation of the first controller causes the first distal movement of the distal capsule-portion, and actuation of the second controller causes the proximal movement of the proximal capsule-portion.
In an application, in the state B, further actuation of the first controller causes the second distal movement of the distal capsule-portion.
In an application, the one or more controllers further include a third controller, and, in the state B, actuation of the third controller causes the second distal movement of the distal capsule-portion.
In an application, the implant is for use at a native mitral valve of a subject, and:
the first part of the implant includes an upstream support portion, configured to be placed against an upstream surface of the native mitral valve,
the second part of the implant includes a downstream end of the implant, and a plurality of flanges (i) disposed longitudinally between the upstream support portion and the downstream end, and (ii) configured to engage leaflets of the native mitral valve; and
the implant is housed by the delivery capsule such that the first distal movement of the distal capsule-portion unhouses, from the distal capsule-portion, the plurality of flanges, but not the downstream end of the implant.
In an application, the implant is housed by the delivery capsule such that the second distal movement of the distal capsule-portion unhouses, from the distal capsule-portion, the downstream end of the implant.
In an application, the implant is housed by the delivery capsule such that the proximal movement of the proximal capsule-portion unhouses, from the proximal capsule-portion, the upstream support portion.
In an application, the implant includes:
a valve frame that includes:
-
- a tubular portion shaped to define a lumen therethrough, and
- the upstream support portion, extending from an upstream end of the tubular portion;
an outer frame that circumscribes the tubular portion, and includes the plurality of flanges; and
a plurality of prosthetic leaflets, coupled to the tubular portion within the lumen.
In an application, the second part of the implant includes at least part of the tubular portion.
There is further provided, in accordance with an application of the present invention, apparatus including an implant and a delivery tool, the tool including:
a delivery capsule, disposed at a distal portion of the tool, the delivery capsule including a proximal capsule-portion dimensioned to house a first part of the implant, and a distal capsule-portion dimensioned to house a second part of the implant; and
an extracorporeal control portion, disposed at a proximal portion of the tool, the control portion including one or more controllers and one or more locks, the controllers being operatively coupled to the proximal and distal capsule-portions such that the proximal and distal capsule-portions are movable with respect to the implant via actuation of the controllers, and the controllers and the locks are mechanically cooperative such that:
-
- in a first state of the tool:
- a first distal movement of the distal capsule-portion up to a first distance distally with respect to the implant is facilitated,
- a second distal movement of the distal capsule-portion further distally with respect to the implant is inhibited,
- a proximal movement of the proximal capsule-portion proximally with respect to the implant is inhibited, and
- responsively to movement of the distal capsule-portion distally, the tool automatically unlocks a second state of the tool;
- in the second state of the tool:
- the proximal movement of the proximal capsule-portion is facilitated,
- the second distal movement of the distal capsule-portion remains inhibited, and
- responsively to movement of the proximal capsule-portion proximally, the tool automatically unlocks a third state of the tool; and
- in the third state of the tool:
- the second distal movement of the distal capsule-portion is facilitated.
- in a first state of the tool:
In an application, the tool automatically unlocks the second state responsively to the distal capsule-portion having moved the first distance.
In an application:
the one or more locks include a first lock and a second lock,
the one or more controllers include a first controller and a second controller,
in the first state of the tool, actuation of the first controller causes the first distal movement of the distal capsule-portion,
the tool automatically unlocks the second state by automatically making the first lock unlockable,
in the second state of the tool, actuation of the second controller causes the proximal movement of the proximal capsule-portion, and
the tool automatically unlocks the third state by automatically making the second lock unlockable.
In an application, in the third state of the tool, further actuation of the first controller causes the second distal movement of the distal capsule-portion.
In an application, the one or more controllers further include a third controller, and, in the third state of the tool, actuation of the third controller causes the second distal movement of the distal capsule-portion.
In an application, the implant is for use at a native mitral valve of a subject, and:
the first part of the implant includes an upstream support portion, configured to be placed against an upstream surface of the native mitral valve,
the second part of the implant includes a downstream end of the implant, and a plurality of flanges (i) disposed longitudinally between the upstream support portion and the downstream end, and (ii) configured to engage leaflets of the native mitral valve; and
the implant is housed by the delivery capsule such that the first distal movement of the distal capsule-portion unhouses, from the distal capsule-portion, the plurality of flanges, but not the downstream end of the implant.
In an application, the implant is housed by the delivery capsule such that the second distal movement of the distal capsule-portion unhouses, from the distal capsule-portion, the downstream end of the implant.
In an application, the implant is housed by the delivery capsule such that the proximal movement of the proximal capsule-portion unhouses, from the proximal capsule-portion, the upstream support portion.
In an application, the implant includes:
a valve frame that includes:
-
- a tubular portion shaped to define a lumen therethrough, and
- the upstream support portion, extending from an upstream end of the tubular portion;
an outer frame that circumscribes the tubular portion, and includes the plurality of flanges; and
a plurality of prosthetic leaflets, coupled to the tubular portion within the lumen.
In an application, the second part of the implant includes at least part of the tubular portion.
There is further provided, in accordance with an application of the present invention, a method, including:
percutaneously advancing an implant to a native heart valve of a subject, the implant housed in a compressed state within a delivery tool;
unhousing a longitudinally-intermediate portion of the implant, the longitudinally-intermediate portion being longitudinally between a longitudinally-proximal portion of the implant and a longitudinally distal portion of the implant;
subsequently, unhousing the longitudinally-proximal portion of the implant; and
subsequently, unhousing the longitudinally-distal portion of the implant.
In an application:
unhousing the longitudinally-intermediate portion of the implant includes unhousing flanges of the implant such that the flanges automatically expand;
unhousing the longitudinally-proximal portion of the implant includes unhousing an upstream support portion of the implant such that the upstream support portion automatically expands; and
unhousing the longitudinally-distal portion of the implant includes unhousing the longitudinally-distal portion of the implant such that the longitudinally-distal portion of the implant automatically expands.
In an application, the longitudinally-distal portion includes a tubular portion within which a valve member is disposed, and unhousing the longitudinally-distal portion of the implant includes unhousing the longitudinally-distal portion of the implant such that the tubular portion expands to form a lumen and the valve member regulates one-way flow of blood through the lumen.
In an application, unhousing the longitudinally-distal portion of the implant includes facilitating expansion of the implant such that the tubular portion expands and the flanges become longitudinally closer to the upstream support portion.
There is further provided, in accordance with an application of the present invention, apparatus for use with a native valve that is disposed between an atrium and a ventricle of a heart of a subject, the apparatus including:
a valve frame, including:
-
- a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis, the tubular portion defining a plurality of valve-frame coupling elements disposed circumferentially around the longitudinal axis; and
- a plurality of arms, extending radially outward from an upstream portion of the tubular portion to define an arm span, and configured to engage tissue in the atrium;
a plurality of prosthetic leaflets, coupled to the frame, disposed within the lumen, and arranged to provide unidirectional flow of blood from an upstream end of the lumen to a downstream end of the lumen; and
an outer frame:
-
- coupled to the valve frame, and
- including a ring that circumscribes the tubular portion, and a plurality of flanges that extend radially outward from the ring to define a flange span, and are configured to engage tissue of the ventricle,
and:
each arm of the plurality of arms defines a rigid portion and a flexible portion that is disposed radially outward from the rigid portion, and is more flexible than the rigid portion, and the majority of the flexible portion is disposed further radially outward than the flange span.
In an application, the implant is configured such that the rigid portion provides resistance against axial movement of the implant, while the flexible portion facilitates conformation of the arm to anatomy of the atrium and/or lateral movement of the implant within the native valve.
In an application, each arm of the plurality of arms defines a serpentine shape in the flexible portion.
In an application, each arm of the plurality of arms defines a plurality of holes in the flexible portion.
In an application, less than 90 percent of the flexible portion is disposed further radially outward than the flange span.
In an application, more than 60 percent of the flexible portion is disposed further radially outward than the flange span.
In an application, for each arm of the plurality of arms, the flexible portion covers an overall surface area including (i) the area occupied by material from which the arm is formed, and (ii) spaces, and the material from which the arm is formed occupies less than 80 percent of the overall surface area.
In an application, the material from which the arm is formed occupies more than 20 percent of the overall surface area.
In an application, the material from which the arm is formed occupies less than 70 percent of the overall surface area.
There is further provided, in accordance with an application of the present invention, apparatus for use with a native valve that is disposed between an atrium and a ventricle of a heart of a subject, the apparatus including:
a valve frame, including a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis, the tubular portion defining a plurality of valve-frame coupling elements disposed circumferentially around the longitudinal axis;
a plurality of prosthetic leaflets, coupled to the frame, disposed within the lumen, and arranged to provide unidirectional flow of blood from an upstream end of the lumen to a downstream end of the lumen;
an outer frame:
-
- including a ring defined by a pattern of alternating peaks and troughs, the peaks being longitudinally closer to the upstream end than to the downstream end, and the troughs being longitudinally closer to the downstream end than to the upstream end, and the pattern of the ring having an amplitude longitudinally between the peaks and the troughs,
- including a plurality of legs, each of the legs coupled to the ring at a respective trough, and
- shaped to define a plurality of outer-frame coupling elements, each of the outer-frame coupling elements (i) coupled to the ring at a respective peak, and (ii) fixed with respect to a respective valve-frame coupling element,
and:
the tubular portion has (i) a compressed state in which the tubular portion has a compressed diameter, and (ii) an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and
the fixation of the outer-frame coupling elements to the valve-frame coupling elements is such that compression of the tubular portion from the expanded state toward the compressed state such that the valve-frame coupling elements pull the outer-frame coupling elements radially inward: (i) reduces a circumferential distance between each of the outer-frame coupling elements and its adjacent outer-frame coupling elements, and (ii) increases the amplitude of the pattern of the ring.
In an application, the ring circumscribes the tubular portion.
In an application, the valve-frame coupling elements are disposed circumferentially around the longitudinal axis between the upstream end and the downstream end but not at the upstream end nor at the downstream end.
In an application, the upstream support portion includes one or more fabric pockets disposed circumferentially, each pocket of the one or more pockets having an opening that faces a downstream direction.
In an application, the outer frame is coupled to the valve frame only via the fixation of the outer-frame coupling elements to the respective valve-frame coupling elements.
In an application, the apparatus further includes an upstream support portion that includes a plurality of arms that extend radially from the tubular portion, and:
the upstream support portion has (i) a constrained-arm state, and (ii) a released-arm state in which the arms extend radially outward from the tubular portion,
each leg has a tissue-engaging flange that has (i) a constrained-flange state, and (ii) a released-flange state in which the flange extends radially outward from the tubular portion, and
the apparatus has an intermediate state in which (i) the tubular portion is in its compressed state, (ii) the upstream support portion is in its released-arm state, and (iii) the legs are in their released-flange state.
In an application:
the apparatus includes an implant that includes the valve frame, the leaflets, and the outer frame, and
the apparatus further includes a tool:
-
- including a delivery capsule dimensioned (i) to house and retain the implant in a compressed state of the implant in which (a) the tubular portion is in its compressed state, (b) the upstream support portion is in its constrained-arm state, and (c) the legs are in their constrained-flange state, and (ii) to be advanced percutaneously to the heart of the subject while the implant is housed and in its compressed state, and
- operable from outside the subject to:
- transition the implant from its compressed state into the intermediate state while retaining the tubular portion in its compressed state, and
- subsequently, expand the tubular portion toward its expanded state.
In an application, the tool is operable from outside the subject to transition the implant from its compressed state into the intermediate state by (i) releasing the legs into their released-flange state, while retaining the tubular portion in its compressed state, and (ii) subsequently, releasing the upstream support portion into its released-arm state, while retaining the tubular portion in its compressed state.
In an application, the tool is operable from outside the subject to transition the implant from its compressed state into the intermediate state by (i) releasing the upstream support portion into its released-arm state, while retaining the tubular portion in its compressed state, and (ii) subsequently, releasing the legs into their released-flange state, while retaining the tubular portion in its compressed state.
In an application, the fixation of the outer-frame coupling elements to the valve-frame coupling elements is such that, when the apparatus is in its intermediate state, expansion of the tubular portion from its compressed state toward its expanded state moves the flanges longitudinally away from the valve-frame coupling elements.
In an application, the fixation of the outer-frame coupling elements to the valve-frame coupling elements is such that, when the apparatus is in its intermediate state, expansion of the tubular portion from its compressed state toward its expanded state reduces the amplitude of the pattern of the ring and passes the flanges between the arms.
In an application, the upstream support portion further includes a covering that covers the arms to form an annular shape in the released-arm state, and, when the apparatus is in its intermediate state, expansion of the tubular portion from its compressed state toward its expanded state presses the flanges onto the covering.
In an application, in the compressed state of the tubular portion, a downstream end of each leg is longitudinally closer than the valve-frame coupling elements to the downstream end, and the flange of each leg is disposed longitudinally closer than the valve-frame coupling elements to the upstream end.
In an application, in the expanded state of the tubular portion, the downstream end of each leg is longitudinally closer than the valve-frame coupling elements to the downstream end, and the flange of each leg is disposed longitudinally closer than the valve-frame coupling elements to the upstream end.
There is further provided, in accordance with an application of the present invention, apparatus for use with a native valve of a heart of a subject, the apparatus including an implant that includes:
a valve frame that includes a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis, the tubular portion having an upstream end, a downstream end, a longitudinal length therebetween, and a diameter transverse to the longitudinal axis;
a valve member, coupled to the tubular portion, disposed within the lumen, and arranged to provide unidirectional upstream-to-downstream flow of blood through the lumen;
an upstream support portion, coupled to the tubular portion; and
an outer frame, coupled to the tubular portion, and including a tissue-engaging flange,
and:
the implant has a first state and a second state,
in both the first state and the second state, (i) the upstream support portion extends radially outward from the tubular portion, and (ii) the tissue-engaging flange extends radially outward from the tubular portion, and
the tubular portion, the upstream support portion, and the outer frame are arranged such that transitioning of the implant from the first state toward the second state:
-
- increases the diameter of the tubular portion by a diameter-increase amount,
- decreases the length of the tubular portion by a length-decrease amount, and
- moves the flange a longitudinal distance toward or toward-and-beyond the upstream support portion, the distance being greater than the length-decrease amount.
In an application, the tubular portion, the upstream support portion, and the outer frame are arranged such that the longitudinal distance is more than 20 percent greater than the length-decrease amount.
In an application, the tubular portion, the upstream support portion, and the outer frame are arranged such that the longitudinal distance is more than 30 percent greater than the length-decrease amount.
In an application, the tubular portion, the upstream support portion, and the outer frame are arranged such that the longitudinal distance is more than 40 percent greater than the length-decrease amount.
There is further provided, in accordance with an application of the present invention, apparatus for use with a native valve that is disposed between an atrium and a ventricle of a heart of a subject, the apparatus including:
a valve frame, including a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis;
a plurality of prosthetic leaflets, coupled to the frame, disposed within the lumen, and arranged to provide unidirectional flow of blood from an upstream end of the lumen to a downstream end of the lumen;
an outer frame, including:
-
- a ring defined by a pattern of alternating peaks and troughs:
- the peaks being longitudinally closer than the troughs to the upstream end,
- the peaks being fixed to respective sites of the tubular portion at respective coupling points disposed circumferentially around the longitudinal axis, and
- the pattern of the ring having an amplitude longitudinally between the peaks and the troughs; and
- a plurality of legs, each of the legs coupled to the ring at a respective trough,
and:
- a ring defined by a pattern of alternating peaks and troughs:
the tubular portion has (i) a compressed state in which the tubular portion has a compressed diameter, and (ii) an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and
the fixation of the peaks to the respective sites of the tubular portion is such that compression of the tubular portion from the expanded state toward the compressed state such that the respective sites of the tubular portion pull the peaks radially inward via radially-inward tension on the coupling points: (i) reduces a circumferential distance between each of the coupling points and its adjacent coupling points, and (ii) increases the amplitude of the pattern of the ring.
In an application, the outer frame is coupled to the valve frame only via the fixation of the peaks to the respective sites of the tubular portion at the respective coupling points.
There is further provided, in accordance with an application of the present invention, apparatus for use with a native valve that is disposed between an atrium and a ventricle of a heart of a subject, the apparatus including:
a valve frame, including a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis, the valve frame defining a plurality of valve-frame coupling elements disposed circumferentially around the longitudinal axis;
a plurality of prosthetic leaflets, coupled to the frame, disposed within the lumen, and arranged to provide unidirectional flow of blood from an upstream end of the lumen to a downstream end of the lumen;
an outer frame:
-
- including a ring defined by a pattern of alternating peaks and troughs, the peaks being longitudinally closer to the upstream end than to the downstream end, and the troughs being longitudinally closer to the downstream end than to the upstream end, and the pattern of the ring having an amplitude longitudinally between the peaks and the troughs,
- including a plurality of legs, each of the legs coupled to the ring at a respective trough, and
- shaped to define a plurality of outer-frame coupling elements, each of the outer-frame coupling elements (i) coupled to the ring at a respective peak, and (ii) fixed with respect to a respective valve-frame coupling element,
and:
the tubular portion has (i) a compressed state in which the tubular portion has a compressed diameter, and (ii) an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and
the fixation of the outer-frame coupling elements with respect to the valve-frame coupling elements is such that compression of the tubular portion from the expanded state toward the compressed state (i) pulls the outer-frame coupling elements radially inward via radially-inward pulling of the valve-frame coupling elements on the outer-frame coupling elements, (ii) reduces a circumferential distance between each of the outer-frame coupling elements and its adjacent outer-frame coupling elements, and (iii) increases the amplitude of the pattern of the ring, without increasing a radial gap between the valve frame and the ring by more than 1.5 mm.
In an application, the outer frame is coupled to the valve frame only via the fixation of the outer-frame coupling elements to the respective valve-frame coupling elements.
There is further provided, in accordance with an application of the present invention, apparatus for use with a native valve that is disposed between an atrium and a ventricle of a heart of a subject, the apparatus including:
a valve frame, including a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis;
a plurality of prosthetic leaflets, coupled to the frame, disposed within the lumen, and arranged to provide unidirectional flow of blood from an upstream end of the lumen to a downstream end of the lumen;
an outer frame, including:
-
- a ring defined by a pattern of alternating peaks and troughs:
- the peaks being longitudinally closer than the troughs to the upstream end,
- the peaks being fixed to respective sites of the tubular portion at respective coupling points disposed circumferentially around the longitudinal axis, and
- the pattern of the ring having an amplitude longitudinally between the peaks and the troughs; and
- a plurality of legs, each of the legs coupled to the ring at a respective trough,
and:
- a ring defined by a pattern of alternating peaks and troughs:
the tubular portion has (i) a compressed state in which the tubular portion has a compressed diameter, and (ii) an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and
the fixation of the peaks to the respective sites of the tubular portion is such that compression of the tubular portion from the expanded state toward the compressed state (i) pulls the peaks radially inward via radially-inward pulling of the respective sites of the tubular portion on the peaks, (ii) reduces a circumferential distance between each of the coupling points and its adjacent coupling points, and (iii) increases the amplitude of the pattern of the ring, without increasing a radial gap between the valve frame and the ring by more than 1.5 mm.
In an application, the outer frame is coupled to the valve frame only via the fixation of the peaks to the respective sites of the tubular portion at the respective coupling points.
There is further provided, in accordance with an application of the present invention, apparatus for use with a native valve disposed between an atrium and a ventricle of a heart of a subject, the apparatus including:
a valve frame, including a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis, the tubular portion having an upstream end, a downstream end, and defining a plurality of valve-frame coupling elements disposed circumferentially around the longitudinal axis between the upstream end and the downstream end but not at the upstream end nor at the downstream end;
a plurality of prosthetic leaflets, disposed within the lumen, and arranged to provide unidirectional flow of blood through the lumen;
an outer frame:
-
- including a ring defined by a pattern of alternating peaks and troughs, the peaks being longitudinally closer to the upstream end than to the downstream end, and the troughs being longitudinally closer to the downstream end than to the upstream end,
- including a plurality of legs, each of the legs coupled to the ring at a respective trough, and
- shaped to define a plurality of outer-frame coupling elements, each of the outer-frame coupling elements (i) coupled to the ring at a respective peak, and (ii) fixed with respect to a respective valve-frame coupling element at a respective coupling point,
and:
the tubular portion has (i) a compressed state in which the tubular portion has a compressed diameter, and (ii) an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and
expansion of the tubular portion from the compressed state toward the expanded state (i) increases a circumferential distance between each of the outer-frame coupling elements and its adjacent outer-frame coupling elements, and (ii) moves the plurality of legs in a longitudinally upstream direction with respect to the tubular portion.
In an application, the outer frame is coupled to the valve frame only via the fixation of the outer-frame coupling elements to the respective valve-frame coupling elements.
There is further provided, in accordance with an application of the present invention, apparatus for use with a native valve disposed between an atrium and a ventricle of a heart of a subject, the apparatus including:
a valve frame, including a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis, the tubular portion having an upstream end and a downstream end;
a plurality of prosthetic leaflets, disposed within the lumen, and arranged to provide unidirectional flow of blood through the lumen;
an outer frame, including:
-
- a ring defined by a pattern of alternating peaks and troughs:
- the peaks being longitudinally closer than the troughs to the upstream end,
- the peaks being fixed to respective sites of the tubular portion at respective coupling points disposed circumferentially around the longitudinal axis between the upstream end and the downstream end but not at the upstream end nor the downstream end; and
- a plurality of legs, each of the legs coupled to the ring at a respective trough,
and:
- a ring defined by a pattern of alternating peaks and troughs:
the tubular portion has (i) a compressed state in which the tubular portion has a compressed diameter, and (ii) an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and
expansion of the tubular portion from the compressed state toward the expanded state (i) increases a circumferential distance between each of the coupling points and its adjacent coupling points, and (ii) moves the plurality of legs in a longitudinally upstream direction with respect to the tubular portion.
In an application, the outer frame is coupled to the valve frame only via the fixation of the peaks to the respective sites of the tubular portion at the respective coupling points.
There is further provided, in accordance with an application of the present invention, apparatus for use with a native valve of a heart of a subject, the apparatus including:
a frame assembly, having an upstream end and a downstream end, and a central longitudinal axis therebetween, and including:
-
- a valve frame, including:
- a tubular portion having an upstream end and a downstream end, and shaped to define a lumen therebetween, and
- an upstream support portion, extending from the upstream end of the tubular portion; and
- at least one leg, coupled to the valve frame at a coupling point, and having a tissue-engaging flange; and
- a valve frame, including:
a valve member disposed within the lumen, and configured to facilitate one-way liquid flow through the lumen from the upstream end of the tubular portion to the downstream end of the tubular portion,
and the frame assembly:
has a compressed state, for percutaneous delivery to the heart, in which the tubular portion has a compressed diameter,
is biased to assume an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and
is configured such that increasing the diameter of the tubular portion toward the expanded diameter causes longitudinal movement:
-
- of the upstream support portion toward the coupling point, and
- of the tissue-engaging flange away from the coupling point.
In an application:
the apparatus includes an implant that includes the frame assembly and the valve member, and
the apparatus further includes a tool:
-
- including a delivery capsule dimensioned (i) to house and retain the implant in the compressed state, and (ii) to be advanced percutaneously to the heart of the subject while the implant is housed and in the compressed state, and
- operable from outside the subject to facilitate an increase of the diameter of the tubular portion from the compressed diameter toward the expanded diameter such that the increase of the diameter actuates longitudinal movement:
- of the upstream support portion toward the coupling point, and
- of the tissue-engaging flange away from the coupling point.
In an application, the frame assembly is configured such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state causes longitudinal movement of the upstream end of the tubular portion toward the coupling point.
In an application, the coupling point is disposed closer to the downstream end of the frame assembly than are either the tissue-engaging flange or the upstream support portion.
In an application, in the expanded state of the frame assembly, the leg extends away from the central longitudinal axis.
In an application:
the expanded state of the frame assembly is a fully-expanded state of the frame assembly,
the leg is expandable into an expanded state of the leg, independently of increasing the diameter of the tubular portion, and
in the expanded state of the leg, the leg extends away from the central longitudinal axis.
In an application:
in the expanded state of the frame assembly, the leg extends away from the central longitudinal axis, and
in the compressed state of the frame assembly, the leg is generally parallel with the central longitudinal axis.
In an application, the frame assembly is configured such that the longitudinal movement of the tissue-engaging flange away from the coupling point is a translational movement of the tissue-engaging flange that does not include rotation of the tissue-engaging flange.
In an application, the frame assembly is configured such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state causes 1-20 mm of longitudinal movement of the tissue-engaging flange away from the coupling point.
In an application, the frame assembly is configured such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state causes 1-20 mm of longitudinal movement of the upstream support portion toward the coupling point.
In an application, the frame assembly is configured such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state reduces a distance between the upstream support portion and the tissue-engaging flange by 5-30 mm.
In an application, the frame assembly is configured such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state moves the tissue-engaging flange longitudinally past the upstream support portion.
In an application:
the tubular portion is defined by a plurality of cells of the valve frame, and
increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state:
-
- includes (i) increasing a width, orthogonal to the longitudinal axis of the frame assembly, of each cell, and (ii) reducing a height, parallel with the longitudinal axis of the frame assembly, of each cell, and
- causes longitudinal movement of the upstream support portion toward the coupling point by reducing a height, parallel with the longitudinal axis of the frame assembly, of the tubular portion, by reducing the height of each cell.
In an application, the leg is disposed on an outside of the tubular portion.
In an application:
the at least one leg includes a plurality of legs,
the coupling point includes a plurality of coupling points, and
the frame assembly includes a leg frame that circumscribes the tubular portion, includes the plurality of legs, and is coupled to the valve frame at the plurality of coupling points, such that the plurality of legs is distributed circumferentially around the tubular portion.
In an application, the plurality of coupling points is disposed circumferentially around the frame assembly on a transverse plane that is orthogonal to the longitudinal axis of the frame assembly.
In an application, the plurality of legs is coupled to the valve frame via a plurality of struts, each strut:
having a first end that is coupled to a leg of the plurality of legs, and a second end that is coupled to a coupling point of the plurality of coupling points,
in the compressed state of the frame assembly, being disposed at a first angle in which the first end is disposed closer to the downstream end of the frame assembly than is the second end, and
being deflectable with respect to the coupling point of the plurality of coupling points, such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state causes the strut to deflect to a second angle in which the first end is disposed further from the downstream end of the frame assembly than is the first end in the compressed state of the frame assembly.
In an application, the leg frame is structured such that each leg of the plurality of legs is coupled to two struts of the plurality of struts, and two struts of the plurality of struts are coupled to each coupling point of the plurality of coupling points.
In an application, the leg is coupled to the valve frame via a strut, the strut:
having a first end that is coupled to the leg, and a second end that is coupled to the coupling point,
in the compressed state of the frame assembly, being disposed at a first angle in which the first end is disposed closer to the downstream end of the frame assembly than is the second end, and
being deflectable with respect to the coupling point, such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state causes the strut to deflect to a second angle in which the first end is disposed further from the downstream end of the frame assembly than is the first end in the compressed state of the frame assembly.
In an application, the at least one leg includes at least a first leg and a second leg.
In an application, the first leg and the second leg are both coupled to the valve frame at the coupling point.
In an application, the first leg is coupled to the coupling point via a respective first strut, and the second leg is coupled to the coupling point via a respective second strut.
In an application, the first and second legs, the first and second struts, and the coupling point are arranged such that, in the expanded state of the frame assembly:
the coupling point is disposed, circumferentially with respect to the tubular portion, between the first strut and the second strut,
the first strut is disposed, circumferentially with respect to the tubular portion, between the coupling point and the first leg, and
the second strut is disposed, circumferentially with respect to the tubular portion, between the coupling point and the second leg.
In an application, the coupling point includes at least a first coupling point and a second coupling point.
In an application, the leg is coupled to the valve frame at the first coupling point and at the second coupling point.
In an application, the leg is coupled to the first coupling point via a respective first strut, and to the second coupling point via a respective second strut.
In an application, the first and second legs, the first and second struts, and the coupling point are arranged such that, in the expanded state of the frame assembly:
the leg is disposed, circumferentially with respect to the tubular portion, between the first strut and the second strut,
the first strut is disposed, circumferentially with respect to the tubular portion, between the leg and the first coupling point, and
the second strut is disposed, circumferentially with respect to the tubular portion, between the leg and the second coupling point.
In an application, in the expanded state of the frame assembly, the upstream support portion extends radially outward from the tubular portion.
In an application:
the expanded state of the frame assembly is a fully-expanded state of the frame assembly,
the upstream support portion is expandable into an expanded state of the upstream support portion, independently of increasing the diameter of the tubular portion, and
in the expanded state of the upstream support portion, the upstream support portion extends radially outward from the tubular portion.
In an application, in the compressed state of the frame assembly, the upstream support portion is generally tubular, collinear with the tubular portion, and disposed around the central longitudinal axis.
In an application, in the expanded state of the frame assembly, an inner region of the upstream support portion extends radially outward from the tubular portion at a first angle with respect to the tubular portion, and an outer region of the upstream support portion extends, from the inner region of the upstream support portion, further radially outward from the tubular portion at a second angle with respect to the tubular portion, the second angle being smaller than the first angle.
There is further provided, in accordance with an application of the present invention, apparatus for use with a native valve of a heart of a subject, the apparatus including:
a frame assembly, having an upstream end and a downstream end, and a central longitudinal axis therebetween, and including:
-
- a valve frame, including:
- a tubular portion having an upstream end and a downstream end, and shaped to define a lumen therebetween, and
- an upstream support portion, extending from the upstream end of the tubular portion; and
- at least one leg, coupled to the valve frame at a coupling point, and having a tissue-engaging flange; and
- a valve frame, including:
a valve member disposed within the lumen, and configured to facilitate one-way liquid flow through the lumen from the upstream end of the tubular portion to the downstream end of the tubular portion,
and the frame assembly:
has a compressed state, for percutaneous delivery to the heart, in which the tubular portion has a compressed diameter,
is biased to assume an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and
is configured such that reducing the diameter of the tubular portion toward the compressed diameter causes longitudinal movement:
-
- of the upstream support portion away from the coupling point, and
- of the tissue-engaging flange toward the coupling point.
There is further provided, in accordance with an application of the present invention, apparatus for use with a native valve of a heart of a subject, the apparatus including:
a frame assembly, having an upstream end and a downstream end, and a central longitudinal axis therebetween, including:
-
- a valve frame, including:
- a tubular portion having an upstream end and a downstream end, and shaped to define a lumen therebetween, and
- an upstream support portion, extending from the upstream end of the tubular portion; and
- at least one leg, coupled to the valve frame at a coupling point, and having a tissue-engaging flange; and
- a valve frame, including:
a valve member disposed within the lumen, and configured to facilitate one-way liquid flow through the lumen from the upstream end of the tubular portion to the downstream end of the tubular portion,
and the frame assembly:
has a compressed state, for percutaneous delivery to the heart,
is intracorporeally expandable into an expanded state in which a diameter of the tubular portion is greater than in the compressed state, and
is configured such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state causes longitudinal movement of the tissue-engaging flange away from the coupling point.
There is further provided, in accordance with an application of the present invention, apparatus for use with a native valve of a heart of a subject, the apparatus including:
a frame assembly, having an upstream end and a downstream end, and a central longitudinal axis therebetween, and including:
-
- an inner frame including an inner-frame tubular portion that circumscribes the central longitudinal axis, has an upstream end and a downstream end, and defines a channel therebetween, the inner frame defining a plurality of inner-frame couplings disposed circumferentially at a longitudinal location of the inner frame,
- an outer frame including an outer-frame tubular portion that coaxially circumscribes at least a portion of the inner-frame tubular portion, the outer frame defining a plurality of outer-frame couplings disposed circumferentially at a longitudinal location of the outer frame, and
- a plurality of connectors, each connector connecting a respective inner-frame coupling to a respective outer-frame coupling;
a liner, disposed over at least part of the inner-frame tubular portion; and
a plurality of prosthetic leaflets, coupled to the inner-frame tubular portion and disposed within the channel,
and:
the frame assembly: (i) is compressible by a radially-compressive force into a compressed state in which the inner frame is in a compressed state thereof and the outer frame is in a compressed state thereof, (ii) is configured, upon removal of the radially-compressive force, to automatically expand into an expanded state thereof in which the inner frame is in an expanded state thereof and the outer frame is in an expanded state thereof,
in the expanded state of the frame assembly, the prosthetic leaflets are configured to facilitate one-way fluid flow, in a downstream direction, through the channel, and
the connection of the inner-frame couplings to the respective outer-frame couplings is such that expansion of the frame assembly from the compressed state to the expanded state causes the inner-frame tubular portion to slide longitudinally in a downstream direction with respect to the outer-frame tubular portion.
There is further provided, in accordance with an application of the present invention, apparatus for use with a native valve disposed between an atrium and a ventricle of a heart of a subject, the apparatus including:
a tubular portion, having an upstream portion that includes an upstream end, and a downstream portion that includes a downstream end, and shaped to define a lumen between the upstream portion and the downstream portion;
a plurality of prosthetic leaflets, disposed within the lumen, and arranged to provide unidirectional flow of blood from the upstream portion to the downstream portion;
an annular upstream support portion:
-
- having an inner portion that extends radially outward from the upstream portion, and
- including one or more fabric pockets disposed circumferentially around the inner portion, each pocket of the one or more pockets having an opening that faces a downstream direction.
In an application:
the upstream support portion includes (i) a plurality of arms that extend radially outward from the tubular portion, and (ii) a covering, disposed over the plurality of arms,
each arm has (i) a radially-inner part at the inner portion of the upstream support portion, and (ii) a radially-outer part at the outer portion of the upstream support portion,
at the inner portion of the upstream support portion, the covering is closely-fitted between the radially-inner parts of the arms, and
at the outer portion of the upstream support portion, the pockets are formed by the covering being loosely-fitted between the radially-outer parts of the arms.
In an application:
the upstream support portion includes (i) a plurality of arms that extend radially outward from the tubular portion, and (ii) a covering, disposed over the plurality of arms,
each arm has (i) a radially-inner part at the inner portion of the upstream support portion, and (ii) a radially-outer part at the outer portion of the upstream support portion, the radially-outer part being more flexible than the radially-inner part.
In an application:
the upstream support portion includes (i) a plurality of arms that extend radially outward from the tubular portion, and (ii) a covering, disposed over the plurality of arms,
each arm has (i) a radially-inner part at the inner portion of the upstream support portion, and (ii) a radially-outer part at the outer portion of the upstream support portion,
at the outer portion of the upstream support portion, the pockets are formed by each arm curving to form a hook shape.
In an application, each pocket is shaped and arranged to billow in response to perivalvular flow of blood in an upstream direction.
In an application, the apparatus is configured to be transluminally delivered to the heart, and implanted at the native valve by expansion of the apparatus, such that the upstream support portion is disposed in the atrium and the tubular portion extends from the upstream support portion into the ventricle, and each pocket is shaped and arranged such that perivalvular flow of blood in an upstream direction presses the pocket against tissue of the atrium.
There is further provided, in accordance with an application of the present invention, apparatus including:
a plurality of prosthetic valve leaflets; and
a frame assembly, including:
-
- a tubular portion defined by a repeating pattern of cells, the tubular portion extending circumferentially around a longitudinal axis so as to define a longitudinal lumen, the prosthetic valve leaflets coupled to the inner frame and disposed within the lumen;
- an outer frame, including a plurality of legs, distributed circumferentially around the tubular portion, each leg having a tissue-engaging flange;
- an upstream support portion that includes a plurality of arms that extend radially outward from the tubular portion; and
- a plurality of appendages, each having a first end that defines a coupling element via which the tubular portion is coupled to the outer frame, and a second end;
and the frame assembly defines a plurality of hubs, distributed circumferentially around the longitudinal axis on a plane that is transverse to the longitudinal axis, each hub defined by convergence and connection of, (i) two adjacent cells of the tubular portion, (ii) an arm of the plurality of arms, and (iii) an appendage of the plurality of appendages.
In an application, each hub has six radiating spokes, two of the six spokes being part of a first cell of the two adjacent cells, two of the six spokes being part of a second cell of the two adjacent cells, one of the six spokes being the arm, and one of the six spokes being the second end of the appendage.
In an application, the appendages are in-plane with the tubular portion.
In an application, the appendages are in-plane with the outer frame.
There is further provided, in accordance with an application of the present invention, a method for use with a native valve of a heart of a subject, the method including:
percutaneously advancing to heart, an implant:
-
- including a valve frame, a valve member disposed within a lumen defined by the valve frame, and at least one leg, coupled to the valve frame at a coupling point, and
- having an upstream end, a downstream end, and a central longitudinal axis therebetween;
positioning the implant within the heart such that a tissue-engaging flange of the leg is disposed downstream of the valve, and thereafter causing the flange to protrude radially outward from the axis;
subsequently, while an upstream support portion of the valve frame is disposed upstream of the valve, causing the upstream support portion to protrude radially outward from the axis, such that tissue of the valve is disposed between the upstream support portion and the flange; and
subsequently, sandwiching the tissue between the upstream support portion and the flange by reducing a distance between the upstream support portion and the flange by causing longitudinal movement (i) of the upstream support portion toward the coupling point, and (ii) of the tissue-engaging flange away from the coupling point.
In an application, causing the longitudinal movement (i) of the upstream support portion toward the coupling point, and (ii) of the tissue-engaging flange away from the coupling point, includes causing the longitudinal movement by increasing a diameter of the lumen.
There is further provided, in accordance with an application of the present invention, a method for use with a native valve of a heart of a subject, the method including:
percutaneously advancing to heart, an implant:
-
- including a valve frame, a valve member disposed within a lumen defined by the valve frame, and at least one leg, coupled to the valve frame at a coupling point, and
- having an upstream end, a downstream end, and a central longitudinal axis therebetween;
positioning the implant within the heart such that an upstream support portion of the valve frame is disposed upstream of the valve, and thereafter causing the upstream support portion to protrude radially outward from the axis;
subsequently, while a tissue-engaging flange of the leg is disposed downstream of the valve, causing the tissue-engaging flange to protrude radially outward from the axis, such that tissue of the valve is disposed between the upstream support portion and the flange; and
subsequently, sandwiching the tissue between the upstream support portion and the flange by reducing a distance between the upstream support portion and the flange by causing longitudinal movement (i) of the upstream support portion toward the coupling point, and (ii) of the tissue-engaging flange away from the coupling point.
In an application, causing the longitudinal movement (i) of the upstream support portion toward the coupling point, and (ii) of the tissue-engaging flange away from the coupling point, includes causing the longitudinal movement by increasing a diameter of the lumen.
There is further provided, in accordance with an application of the present invention, a method for use with a native valve of a heart of a subject, the method including:
percutaneously advancing an implant to the heart, the implant:
-
- having an upstream end, a downstream end, and a central longitudinal axis therebetween, and
- including a tubular portion, an upstream support portion, and a plurality of tissue-engaging flanges;
positioning the implant within the heart such that the upstream support portion is disposed upstream of the valve,
positioning the implant within the heart such that the tissue-engaging flanges are disposed downstream of the valve,
without increasing a diameter of the tubular portion:
-
- causing the upstream support portion to extend radially outward from the axis so as to have a first support-portion span, and
- causing the flanges to extend radially outward from the axis so as to have a first flange span; and
subsequently, causing the upstream support portion and the flanges move toward each other by at least 5 mm by increasing a diameter of the tubular portion such that:
-
- the upstream support portion extends radially outward so as to have a second support-portion span, the first support-portion span being at least 40 percent as great as the second support-portion span, and
- the flanges extend radially outward so as to have a second flange span, the first flange span being at least 30 percent as great as the second flange span.
There is further provided, in accordance with an application of the present invention, a method for use with a native valve of a heart of a subject, the method including:
percutaneously advancing an implant to the heart, the implant:
-
- having an upstream end, a downstream end, and a central longitudinal axis therebetween, and
- including a tubular portion, an upstream support portion, and a plurality of tissue-engaging flanges;
positioning the implant within the heart such that the upstream support portion is disposed upstream of the valve,
positioning the implant within the heart such that the tissue-engaging flanges are disposed downstream of the valve,
without increasing a diameter of the tubular portion:
-
- causing the upstream support portion to extend radially outward from the axis, and
- causing the flanges to extend radially outward from the axis so as to have a first flange span; and
subsequently, by increasing a diameter of the tubular portion:
-
- causing the upstream support portion and the flanges move toward each other by at least 5 mm,
- causing the upstream support portion to move further radially outward from the axis, and
- causing each flange of the plurality of flanges to translate radially outward so as to have a second flange span that is greater than the first flange span.
The present invention will be more fully understood from the following detailed description of applications thereof, taken together with the drawings, in which:
Reference is made to
Typically, and as described hereinbelow, leg 50 is part of an outer frame (or “leg frame”) 60, and frames 30 and 60 define respective coupling elements 31 and 61, which are fixed with respect to each other at coupling points 52. Typically, frames 30 and 60 are coupled to each other only at coupling points 52 (e.g., only via the fixation of coupling elements 31 and 61 with respect to each other).
Implant 20 further comprises a valve member 58 (e.g., one or more prosthetic leaflets) disposed within lumen 38, and configured to facilitate one-way liquid flow through the lumen from upstream end 34 to downstream end 36 (e.g., thereby defining the orientation of the upstream and downstream ends of tubular portion 32).
In the compressed state of frame assembly 22, tubular portion 32 has a diameter d1, and in the expanded state, the tubular portion has a diameter d2 that is greater that diameter d1. For some applications, diameter d1 is 4-15 mm, (e.g., 5-11 mm) and diameter d2 is 20-50 mm, (e.g., 23-33 mm). Frame assembly 22 is configured such that increasing the diameter of tubular portion 32 (e.g., from d1 to d2) causes longitudinal movement of flange 54 away from coupling point 52. In the same way, reducing the diameter of tubular portion 32 (e.g., from d2 to d1) causes longitudinal movement of flange 54 toward coupling point 52. It is to be noted that the term “longitudinal movement” (including the specification and the claims) means movement parallel with central longitudinal axis ax1. Therefore, longitudinal movement of flange 54 away from coupling point 52 means increasing a distance, measured parallel with longitudinal axis ax1, between flange 54 and coupling point 52. An example of such a configuration is described in more detail with respect to
Thus, expansion of tubular portion 32 from its compressed state toward its expanded state (i) increases a circumferential distance between each of coupling points 52 and its adjacent coupling points (e.g., between each of outer-frame coupling elements 61 and its adjacent outer-frame coupling elements) (e.g., from d8 to d9), and (ii) moves legs 50 in a longitudinally upstream direction with respect to the tubular portion.
Typically, frame assembly 22 is configured such that increasing the diameter of tubular portion 32 also causes longitudinal movement of upstream support portion 40 toward coupling point 52, e.g., as described in more detail with respect to
For some applications, upstream support portion 40 comprises a plurality of arms 46 that each extends radially outward from tubular portion 32 (e.g., from upstream end 34 of the tubular portion). Arms 46 are typically flexible. For some such applications, arms 46 are coupled to tubular portion 32 such that each arm may deflect independently of adjacent arms during implantation (e.g., due to anatomical topography).
For some applications, upstream support portion 40 comprises a plurality of barbs 48 that extend out of a downstream surface of the upstream support portion. For example, each arm 46 may comprise one or more of barbs 48. Barbs 48 press into tissue upstream of the native valve (e.g., into the valve annulus), thereby inhibiting downstream movement of implant 20 (in addition to inhibition of downstream movement provided by the geometry of upstream support portion 40).
One or more surfaces of frame assembly 22 are covered with a covering 23, which typically comprises a flexible sheet, such as a fabric, e.g., comprising polyester. Typically, covering 23 covers at least part of tubular portion 32, typically lining an inner surface of the tubular portion, and thereby defining lumen 38.
Further typically, upstream support portion 40 is covered with covering 23, e.g., extending between arms 46 to form an annular shape. It is hypothesized that this reduces a likelihood of paravalvular leakage. For such applications, excess covering 23 may be provided between arms 46 of upstream support portion 40, so as to facilitate their independent movement. Although
Alternatively, each arm 46 may be individually covered in a sleeve of covering 23, thereby facilitating independent movement of the arms.
For some applications, at least part of legs 50 (e.g., flanges thereof) is covered with covering 23.
Typically, frame assembly 22 comprises a plurality of legs 50 (e.g., two or more legs, e.g., 2-16 legs, such as 4-12 legs, such as 6-12 legs), arranged circumferentially around valve frame 30 (e.g., around the outside of tubular portion 32). Typically, frame assembly 22 comprises a plurality of coupling points 52 at which the legs are coupled to valve frame 30.
As described in more detail hereinbelow (e.g., with reference to
For some applications, a plurality of (e.g., two) legs are coupled to each coupling point 52 via a respective plurality of (e.g., two) struts 70. For some such applications, frame assembly 22 is arranged such that, in the expanded state of the frame assembly, coupling point 52 is disposed, circumferentially with respect to tubular portion 32, between two struts 70, and each of the two struts are disposed, circumferentially with respect to the tubular portion, between the coupling point and a respective leg 50.
For some applications, frame assembly 22 comprises an outer frame (e.g., a leg frame) 60 that circumscribes tubular portion 32, comprises (or defines) the plurality of legs 50 and the plurality of struts 70, and is coupled to valve frame 30 at the plurality of coupling points 52, such that the plurality of legs is distributed circumferentially around the tubular portion. For such applications, outer frame 60 comprises a ring 66 that is defined by a pattern of alternating peaks 64 and troughs 62, and that typically circumscribes tubular portion 32. For example, the ring may comprise struts 70, extending between the peaks and troughs. Peaks 64 are longitudinally closer to upstream end 34 of tubular portion 32 than to downstream end 36, and troughs 62 are longitudinally closer to the downstream end than to the upstream end. (It is to be noted that throughout this patent application, including the specification and the claims, the term “longitudinally” means with respect to longitudinal axis ax1. For example, “longitudinally closer” means closer along axis ax1 (whether positioned on axis ax1 or lateral to axis ax1), and “longitudinal movement” means a change in position along axis ax1 (which may be in additional to movement toward or away from axis ax1).) Therefore, peaks 64 are closer than troughs 62 to upstream end 34, and troughs 62 are closer than peaks 64 to downstream end 36. For applications in which frame 60 comprises ring 66, each leg 50 is coupled to the ring (or defined by frame 60) at a respective trough 62.
In the embodiment shown, the peaks and troughs are defined by ring 66 having a generally zig-zag shape. However, the scope of the invention includes ring 66 having another shape that defines peaks and troughs, such as a serpentine or sinusoid shape.
For applications in which frame assembly 22 has a plurality of coupling points 52, the coupling points (and therefore coupling elements 31 and 61) are disposed circumferentially around the frame assembly (e.g., around axis ax1), typically on a transverse plane that is orthogonal to axis ax1. This transverse plane is illustrated by the position of section A-A in
Typically, coupling points 52 (and therefore coupling elements 31 and 61) are disposed longitudinally between upstream end 24 and downstream end 26 of frame assembly 22, but not at either of these ends. Further typically, coupling points 52 are disposed longitudinally between upstream end 34 and downstream end 36 of tubular portion 32, but not at either of these ends. For example, the coupling points may be more than 3 mm (e.g., 4-10 mm) both from end 34 and from end 36. It is hypothesized that this advantageously positions the coupling points at a part of tubular portion 32 that is more rigid than end 34 or end 36.
It is to be noted that leg 50 is typically expandable into its expanded state (e.g., a released-flange state) such that flange 54 extends away from axis ax1, independently of increasing the diameter of tubular portion 32 (e.g., as shown in
For some applications, while tubular portion 32 remains in its compressed state, flange 54 can extend away from axis ax1 over 40 percent (e.g., 40-80 percent, such as 40-70 percent) of the distance that it extends from the axis subsequent to the expansion of the tubular portion. For example, for applications in which implant 20 comprises a flange on opposing sides of the implant, a span d15 of the flanges while tubular portion 32 is in its compressed state may be at least 40 percent (e.g., 40-80 percent, such as 40-70 percent) as great as a span d16 of the flanges subsequent to the expansion of the tubular portion. For some applications, span d15 is greater than 15 mm and/or less than 50 mm (e.g., 20-30 mm). For some applications, span d16 is greater than 30 mm and/or less than 60 mm (e.g., 40-50 mm). It is to be noted that flange 54 is effectively fully expanded, with respect to other portions of leg 50 and/or with respect to tubular portion 32, before and after the expansion of the tubular portion.
Similarly, for some applications, while tubular portion 32 remains in its compressed state, upstream support portion 40 (e.g., arms 46) can extend away from axis ax1 over 30 percent (e.g., 30-70 percent) of the distance that it extends from the axis subsequent to the expansion of the tubular portion. That is, for some applications, a span d17 of the upstream support portion while tubular portion 32 is in its compressed state may be at least 30 percent (e.g., 30-70 percent) as great as a span d18 of the upstream support portion subsequent to the expansion of the tubular portion. For some applications, span d17 is greater than 16 mm (e.g., greater than 20 mm) and/or less than 50 mm (e.g., 30-40 mm). For some applications, span d18 is greater than 40 mm and/or less than 65 mm (e.g., 45-56 mm, such as 45-50 mm). It is to be noted that upstream support portion 40 is effectively fully expanded, with respect to tubular portion 32, before and after the expansion of the tubular portion.
It is to be noted that when tubular portion 32 is expanded, flanges 54 typically translate radially outward from span d15 to span d16 (e.g., without deflecting). Typically, upstream support portion 40 behaves similarly (e.g., arms 46 translated radially outward from span d17 to span d18, e.g., without deflecting). That is, an orientation of each flange 54 and/or each arm 46 with respect to tubular portion 32 and/or axis ax1 is typically the same in the state shown in
For some applications, increasing the diameter of tubular portion 32 from d1 to d2 causes greater than 1 mm and/or less than 20 mm (e.g., 1-20 mm, such as 1-10 mm or 5-20 mm) of longitudinal movement of flange 54 away from coupling point 52. For some applications, increasing the diameter of tubular portion 32 from d1 to d2 causes greater than 1 mm and/or less than 20 mm (e.g., 1-20 mm, such as 1-10 mm or 5-20 mm) of longitudinal movement of upstream support portion 40 toward coupling point 52. For some applications, distance d3 is 7-30 mm. For some applications, distance d4 is 0-15 mm (e.g., 2-15 mm). For some applications, increasing the diameter of tubular portion 32 from d1 to d2 reduces the distance between the upstream support portion and flanges 54 by more than 5 mm and/or less than 30 mm, such as 5-30 mm (e.g., 10-30 mm, such as 10-20 mm or 20-30 mm). For some applications, the difference between d3 and d4 is generally equal to the difference between d1 and d2. For some applications, the difference between d3 and d4 is more than 1.2 and/or less than 3 times (e.g., 1.5-2.5 times, such as about 2 times) greater than the difference between d1 and d2.
For some applications, flanges 54 curve such that a tip of each flange is disposed at a shallower angle with respect to inner region 42 of upstream support portion 40, than are portions of leg 50 that are closer to downstream end 26 of frame assembly 22. For some such applications, a tip of each flange may be generally parallel with inner region 42. For some such applications, while tubular portion 32 is in its expanded state, a tip portion 55 of each flange 54 that extends from the tip of the flange at least 2 mm along the flange, is disposed within 2 mm of upstream support portion 40. Thus, for some applications, while tubular portion 32 is in its expanded state, for at least 5 percent (e.g., 5-8 percent, or at least 8 percent) of span 18 of upstream support portion 40, the upstream support portion is disposed within 2 mm of a flange 54.
For some applications, in the absence of any obstruction (such as tissue of the valve or covering 23) between flange 54 and upstream support portion 40, increasing the diameter of tubular portion 32 from d1 to d2 causes the flange and the upstream support portion to move past each other (e.g., the flange may move between arms 46 of the upstream support portion), such that the flange is closer to the upstream end of implant 20 than is the upstream support portion, e.g., as shown hereinbelow for frame assemblies 122 and 222, mutatis mutandis. (For applications in which upstream support portion 40 is covered by covering 23, flanges 54 typically don't pass the covering. For example, in the absence of any obstruction, flanges 54 may pass between arms 46, and press directly against covering 23.) It is hypothesized that for some applications this configuration applies greater force to the valve tissue being sandwiched, and thereby further facilitates anchoring of the implant. That is, for some applications, distance d3 is smaller than the sum of distance d5 and a distance d14 (described with reference to
For some applications, in the expanded state of frame assembly 22, upstream support portion 40 has an inner region (e.g., an inner ring) 42 that extends radially outward at a first angle with respect to axis ax1 (and typically with respect to tubular portion 32), and an outer region (e.g., an outer ring) 44 that extends, from the inner region, further radially outward from the tubular portion at a second angle with respect to the tubular portion, the second angle being smaller than the first angle. For example, for some applications inner region 42 extends radially outward at an angle alpha_1 of 60-120 degrees (e.g., 70-110 degrees) with respect to axis ax1, and outer region 44 extends radially outward at an angle alpha_2 of 5-70 degrees (e.g., 10-60 degrees) with respect to axis ax1.
It is to be noted that angles alpha_1 and alpha_2 are measured between the respective region support portion 40, and the portion of axis ax1 that extends in an upstream direction from the level of frame assembly 22 at which the respective region begins to extend radially outward.
For some applications in which implant 20 is configured to be placed at an atrioventricular valve (e.g., a mitral valve or a tricuspid valve) of the subject, region 42 is configured to be placed against the upstream surface of the annulus of the atrioventricular valve, and region 44 is configured to be placed against the walls of the atrium upstream of the valve.
For some applications, each arm 46 defines a rigid portion 43 and a flexible portion 45 that is disposed radially outward from the rigid portion, and is more flexible than the rigid portion. Typically, at least part of flexible portion 45 is disposed in outer region 44, and at least part of rigid portion 43 is disposed in inner region 42. Therefore, typically overall, outer region 44 is more flexible than inner region 42. To achieve this differential flexibility, each arm 46 may have a different structure in portion 45 and/or region 44, than it has in portion 43 and/or region 42.
Therefore, as shown for arms 46a and 46b, flexible portion 45 covers an overall surface area including (i) the area in which the material from which the arm is formed occupies, and (ii) spaces, such as holes, or gaps between turns. For some applications, the material from which the arm is formed occupies less than 80 percent and/or more than 20 percent of the overall surface area (e.g., 20-80 percent, e.g., 40-80 percent, e.g., 40-70 percent of the overall surface area).
It is hypothesized that the relative rigidity of portion 43 and/or region 42 provides resistance against axial movement (e.g., ventricular migration) of implant 20, while the relative flexibility of portion 45 and/or region 44 facilitates conformation of upstream support portion 40 to the atrial anatomy and/or lateral movement of the implant within the native valve.
For some applications, and as shown (e.g., in
For some applications, two or more of arms 46 are connected by a connector (not shown), reducing the flexibility, and/or the independence of movement of the connected arms relative to each other. For some applications, arms 46 are connected in particular sectors of upstream support portion 40, thereby making these sectors more rigid than sectors in which the arms are not connected. For example, a relatively rigid sector may be provided to be placed against the posterior portion of the mitral annulus, and a relatively flexible sector may be provided to be placed against the anterior side of the mitral annulus, so as to reduce forces applied by upstream support portion 40 on the aortic sinus.
For some applications, and as shown, coupling points 52 are disposed closer to downstream end 26 of frame assembly 22 than are flanges 54, or is upstream support portion 40.
As described in more detail with respect to
Typically, in the compressed state of tubular portion 32, a downstream end of each leg 50 is longitudinally closer than valve-frame coupling elements 31 to downstream end 36, and flange 54 of each leg is disposed longitudinally closer than the valve-frame coupling elements to upstream end 34. Typically, this is also the case in the expanded state of tubular portion 32.
In the compressed state of frame assembly 22 (and in particular of tubular portion 32), each strut 70 is disposed at a first angle in which first end 72 is disposed closer than second end 74 to the downstream end of the frame assembly. Expansion of frame assembly 22 (and in particular of tubular portion 32) toward its expanded state causes strut 70 to deflect to a second angle. This deflection moves first end 72 away from the downstream end of frame assembly 22. That is, in the expanded state of frame assembly 22, first end 72 is further from the downstream end of the frame assembly than it is when the frame assembly is in its compressed state. This movement is shown as a distance d5 between the position of end 72 in state (A) and its position in state (B). This movement causes the above-described movement of flanges 54 away from coupling points 52. As shown, flanges 54 typically move the same distance d5 in response to expansion of frame assembly 22.
For applications in which outer frame 60 comprises ring 66, the pattern of alternating peaks and troughs may be described as having an amplitude longitudinally between the peaks and troughs, i.e., measured parallel with central longitudinal axis ax1 of frame assembly 22, and the transition between the compressed and expanded states may be described as follows: In the compressed state of frame assembly 22 (and in particular of tubular portion 32), the pattern of ring 66 has an amplitude d20. In the expanded state frame assembly 22 (and in particular of tubular portion 32), the pattern of ring 66 has an amplitude d21 that is lower than amplitude d20. Because (i) it is at peaks 64 that ring 66 is coupled to valve frame 30 at coupling points 52, and (ii) it is at troughs 62 that ring 66 is coupled to legs 50, this reduction in the amplitude of the pattern of ring 66 moves legs 50 (e.g., flanges 54 thereof) longitudinally further from the downstream end of the frame assembly. The magnitude of this longitudinal movement (e.g., the difference between magnitudes d20 and d21) is equal to d5.
Typically, distance d5 is the same distance as the distance that flange 54 moves away from coupling point 52 during expansion of the frame assembly. That is, a distance between flange 54 and the portion of leg 50 that is coupled to strut 70, typically remains constant during expansion of the frame assembly. For some applications, the longitudinal movement of flange 54 away from coupling point 52 is a translational movement (e.g., a movement that does not include rotation or deflection of the flange).
For some applications, a distance d6, measured parallel to axis ax1 of frame assembly 22, between coupling point 52 and first end 72 of strut 70 while assembly 22 is in its compressed state, is 3-15 mm. For some applications, a distance d7, measured parallel to axis ax1, between coupling point 52 and first end 72 of strut 70 while assembly 22 is in its expanded state, is 1-5 mm (e.g., 1-4 mm).
For some applications, amplitude d20 is 2-10 mm (e.g., 4-7 mm). For some applications, amplitude d21 is 4-9 mm (e.g., 5-7 mm).
For some applications, and as shown, in the expanded state, first end 72 of strut 70 is disposed closer to the downstream end of frame assembly 22 than is coupling point 52. For some applications, in the expanded state, first end 72 of strut 70 is disposed further from the downstream end of frame assembly 22 than is coupling point 52.
For applications in which frame assembly 22 comprises a plurality of legs 50 and a plurality of coupling points 52 (e.g., for applications in which the frame assembly comprises outer frame 60) expansion of the frame assembly increases a circumferential distance between adjacent coupling points 52, and an increase in a circumferential distance between adjacent legs 50.
For some applications, in addition to being coupled via ring 66 (e.g., struts 70 thereof) legs 50 are also connected to each other via connectors 78. Connectors 78 allow the described movement of legs 50 during expansion of frame assembly 22, but typically stabilize legs 50 relative to each other while the frame assembly is in its expanded state. For example, connectors 78 may bend and/or deflect during expansion of the frame assembly.
Due to the configurations described herein, the distance by which flanges 54 move with respect to (e.g., toward, or toward-and-beyond) upstream support portion 40 (e.g., arms 46 thereof), is typically greater than the reduction in the overall height of tubular portion 32 (e.g., more than 20 percent greater, such as more than 30 percent greater, such as more than 40 percent greater). That is, implant 20 comprises:
-
- a valve frame (30) that comprises a tubular portion (32) that circumscribes a longitudinal axis (ax1) of the valve frame so as to define a lumen (38) along the axis, the tubular portion having an upstream end (34), a downstream end (36), a longitudinal length therebetween, and a diameter (e.g., d1 or d2) transverse to the longitudinal axis;
- a valve member (58), coupled to the tubular portion, disposed within the lumen, and arranged to provide unidirectional upstream-to-downstream flow of blood through the lumen;
- an upstream support portion (40), coupled to the tubular portion; and
- an outer frame (60), coupled to the tubular portion, and comprising a tissue-engaging flange (54),
wherein:
-
- the implant has a first state (e.g., as shown in
FIG. 2D andFIG. 4D ) and a second state (e.g., as shown inFIG. 2E andFIG. 4E ), - in both the first state and the second state, (i) the upstream support portion extends radially outward from the tubular portion, and (ii) the tissue-engaging flange extends radially outward from the tubular portion, and
- the tubular portion, the upstream support portion, and the outer frame are arranged such that transitioning of the implant from the first state toward the second state:
- increases the diameter of the tubular portion by a diameter-increase amount (e.g., the difference between d1 and d2),
- decreases the length of the tubular portion by a length-decrease amount (e.g., the difference between d22 and d23), and
- moves the flange a longitudinal distance with respect to (e.g., toward or toward-and-beyond) the upstream support portion (e.g., the difference between d3 and d4), this distance being greater than the length-decrease amount.
- the implant has a first state (e.g., as shown in
As shown in the figures, valve frame 30 is typically coupled to outer frame 60 by coupling between (i) a valve-frame coupling element 31 defined by valve frame 30, and (ii) an outer-frame coupling element 61 defined by outer frame 60 (e.g., an outer-frame coupling element is coupled to end 74 of each strut). Typically, elements 31 and 61 are fixed with respect to each other. Each coupling point 52 is thereby typically defined as the point at which a valve-frame coupling element and a corresponding outer-frame coupling element 61 are coupled (e.g., are fixed with respect to each other). For some applications, and as shown, elements 31 and 61 are eyelets configured to be coupled together by a connector, such as a pin or suture. Alternatively or additionally, elements 31 and 61 are soldered or welded together. For example, elements 31 and 61 may be coupled together by a pin that passes through the eyelets, and is welded in place.
Typically, and as shown, valve-frame coupling elements 31 are defined by tubular portion 32, and are disposed circumferentially around central longitudinal axis ax1. Outer-frame coupling elements 61 are coupled to ring 66 (or defined by frame 60, such as by ring 66) at respective peaks 64.
As shown (e.g., in
The structural changes to frame assembly 22 (e.g., to outer frame 60 thereof) are described hereinabove as they occur during (e.g., as a result of) expansion of the frame assembly (in particular tubular portion 32 thereof). This is the natural way to describe these changes because, as described hereinbelow with respect to
For some applications, the fixation of peaks 64 to respective sites of tubular portion 32 is such that compression of the tubular portion from its expanded state toward its compressed state such that the respective sites of the tubular portion pull the peaks radially inward via radially-inward tension on coupling points 52: (i) reduces a circumferential distance between each of the coupling points and its adjacent coupling points (e.g., from d9 to d8), and (ii) increases the amplitude of the pattern of ring 66 (e.g., from d21 to d20).
For some applications, the fixation of outer-frame coupling elements 61 to valve-frame coupling elements 31 is such that compression of tubular portion 32 from its expanded state toward its compressed state such that the valve-frame coupling elements pull the outer-frame coupling elements radially inward: (i) reduces a circumferential distance between each of the outer-frame coupling elements and its adjacent outer-frame coupling elements (e.g., from d9 to d8), and (ii) increases the amplitude of the pattern of ring 66 (e.g., from d21 to d20).
For some applications, the fixation of peaks 64 to the respective sites of tubular portion 32 is such that compression of the tubular portion from its expanded state toward its compressed state (i) pulls the peaks radially inward via radially-inward pulling of the respective sites of the tubular portion on the peaks, (ii) reduces a circumferential distance between each of coupling points 52 and its adjacent coupling points (e.g., from d9 to d8), and (iii) increases the amplitude of the pattern of ring 66 (e.g., from d21 to d20), without increasing radial gap d19 between valve frame 30 (e.g., tubular portion 32 thereof) and the ring by more than 1.5 mm.
For some applications, the fixation of outer-frame coupling elements 61 with respect to valve-frame coupling elements 31 is such that compression of tubular portion 32 from its expanded state toward its compressed state (i) pulls outer-frame coupling elements 61 radially inward via radially-inward pulling of valve-frame coupling elements 31 on outer-frame coupling elements 61, (ii) reduces a circumferential distance between each of the outer-frame coupling elements and its adjacent outer-frame coupling elements (e.g., from d9 to d8), and (iii) increases the amplitude of the pattern of ring 66 (e.g., from d21 to d20), without increasing radial gap d19 between valve frame 30 (e.g., tubular portion 32 thereof) and the ring by more than 1.5 mm.
Reference is made to
Implant 20 is delivered, in its compressed state, to native valve 10 using a delivery tool 89 that is operable from outside the subject (
Subsequently, flanges 54 are allowed to protrude radially outward, as described hereinabove, e.g., by releasing them from capsule 90 (
Subsequently, implant 20 is moved upstream, such that upstream support portion 40, in its compressed state, is disposed upstream of leaflets 12 (i.e., within atrium 6). For some applications, the upstream movement of implant 20 causes flanges 54 to engage leaflets 12. However, because of the relatively large distance d3 provided by implant 20 (described hereinabove), for some applications it is not necessary to move the implant so far upstream that flanges 54 tightly engage leaflets 12 and/or pull the leaflets upstream of the valve annulus. Upstream support portion 40 is then allowed to expand such that it protrudes radially outward, as described hereinabove, e.g., by releasing it from capsule 90 (
Typically, expansion of frame assembly 22 is inhibited by distal capsule-portion 92, e.g., by inhibiting expansion of tubular portion 32. For example, a downstream region 33 of frame assembly 22, downstream of flanges 54, may remain compressed within distal capsule-portion 92. Alternatively or additionally, the expansion may be inhibited by another portion of delivery tool 89 (e.g., a portion of the delivery tool that is disposed within lumen 38).
Subsequently, implant 20 is allowed to expand toward its expanded state, such that tubular portion 32 widens to diameter d2, and the distance between upstream support portion 40 and flanges 54 reduces to distance d4 (
As described hereinabove, implant 20 is configured such that when tubular portion 32 is expanded, flanges 54 and upstream support portion 40 move a relatively large distance toward each other. This enables distance d3 to be relatively large, while distance d4 is sufficiently small to provide effective anchoring. As also described hereinabove, implant 20 is configured such that flanges 54 and upstream support portion 40 can extend radially outward a relatively large distance while tubular portion 32 remains compressed. It is hypothesized that for some applications, these configurations (independently and/or together) facilitate effective anchoring of implant 20, by facilitating placement of a relatively large proportion of valve tissue (e.g., leaflets 12) between the flanges and the upstream support portion prior to expanding tubular portion 32 and sandwiching the valve tissue.
It is further hypothesized that the relatively great radially-outward extension of flanges 54 and upstream support portion 40 prior to expansion of tubular portion 32, further facilitates the anchoring/sandwiching step by reducing radially-outward pushing of the valve tissue (e.g., leaflets 12) during the expansion of the tubular portion, and thereby increasing the amount of valve tissue that is sandwiched.
It is yet further hypothesized that this configuration of implant 20 facilitates identifying correct positioning of the implant (i.e., with upstream support portion 40 upstream of leaflets 12 and flanges 54 downstream of the leaflets) prior to expanding tubular portion 32 and sandwiching the valve tissue.
It is to be noted that the deployment of implant 20 is therefore achieved by:
-
- unhousing a longitudinally-intermediate portion of the implant (to allow flanges 54 to expand), the longitudinally-intermediate portion being longitudinally between a longitudinally-proximal portion of the implant and a longitudinally distal portion of the implant;
- subsequently, unhousing the longitudinally-proximal portion of the implant (to allow upstream support portion 40 to expand); and
- subsequently, unhousing the longitudinally-distal portion of the implant (to allow the longitudinally-distal portion of the implant, typically including the tubular portion within which valve member 58 is disposed, to expand).
It is to be further noted that the deployment of implant 20 may be described with respect to delivery tool 89. For example:
-
- distal capsule-portion 92 is moved distally with respect to the implant (to allow flanges 54 to expand);
- subsequently, proximal capsule-portion 94 is moved proximally with respect to the implant (to allow upstream support portion 40 to expand); and
- subsequently, distal capsule-portion 92 is again moved distally with respect to the implant (to allow the longitudinally distal portion of the implant, typically including the tubular portion within which valve member 58 is disposed, to expand).
For some applications, delivery tool 89 (e.g., an extracorporeal control portion 110 thereof, disposed at a proximal portion of the delivery tool) is configured to ensure that the operator follows the particular sequence of movement of capsule-portions 92 and 94 described. For example, control portion 110 may comprise a series of locks 114, each lock becoming unlockable only after the previous step in the sequence has been completed, the unlocking of the lock allowing the subsequent step in the sequence to be performed. For some such applications, control portion 110 may further comprise a series of controllers 112, via which the operator causes the movement of a respective capsule-portion for each respective step. An example of how control portion 110 may be used, in accordance with some applications of the invention, is as follows:
-
- (1) Operator moves distal capsule-portion 92 distally with respect to implant 20 by actuating a first controller 112a. Once capsule-portion 92 has been moved a given distance, a first lock 114a automatically becomes unlockable (and typically capsule-portion 92 is prevented from moving further than the given distance).
- (2) Operator unlocks lock 114a, and then moves proximal capsule-portion 94 proximally with respect to implant 20 by actuating a second controller 112b. Once capsule-portion 94 has been moved a given distance, a second lock 114b automatically becomes unlockable.
- (3) Operator unlocks lock 114b, and then moves distal capsule-portion 92 further distally with respect to implant 20 by again actuating first controller 112a. Alternatively, control portion 110 may comprise a third controller (not shown) for this second movement of distal capsule-portion 92.
It is to be noted that throughout this patent application (including in the specification and in the claims) the term “unlockable” means able to be unlocked (rather than meaning not lockable).
Therefore, apparatus is provided, in accordance with some applications of the invention, the apparatus comprising an implant (e.g., implant 20) and a delivery tool (e.g., tool 89), the tool comprising:
(1) a delivery capsule, disposed at a distal portion of the tool, the delivery capsule comprising a proximal capsule-portion 94 dimensioned to house a first part of the implant, and a distal capsule-portion 92 dimensioned to house a second part of the implant; and
(2) an extracorporeal control portion 110, disposed at a proximal portion of the tool, the control portion comprising one or more controllers 112 and one or more locks 114, the controllers being operatively coupled to the proximal and distal capsule-portions such that the proximal and distal capsule-portions are movable with respect to the housed implant via actuation of the controllers,
wherein the controllers and the locks are mechanically cooperative such that:
-
- in a first state of the tool:
- a first distal movement of the distal capsule-portion up to a first distance distally with respect to the implant is facilitated,
- a second distal movement of the distal capsule-portion further distally with respect to the implant is inhibited,
- a proximal movement of the proximal capsule-portion proximally with respect to the implant is inhibited, and
- responsively to movement of the distal capsule-portion distally, the tool automatically unlocks a second state of the tool;
- in the second state of the tool:
- the proximal movement of the proximal capsule-portion is facilitated,
- the second distal movement of the distal capsule-portion remains inhibited, and
- responsively to movement of the proximal capsule-portion proximally, the tool automatically unlocks a third state of the tool; and
- in the third state of the tool:
- the second distal movement of the distal capsule-portion is facilitated.
- in a first state of the tool:
For some applications, rather than having three states, tool 89 has two states. For clarity, these will be referred to as state A and state B. However, state A may be similar to the second state described hereinabove, mutatis mutandis. (State A may alternatively be called a primary state, and state B may alternatively be called a secondary state.) For applications in which tool 89 has two states, the tool typically has only one lock 114, the unlocking of which transitions the tool from state A to state B.
In state, A, it is possible to move distal capsule-portion 92 up to the first distance distally with respect to implant 20 (e.g., by actuating controller 112a), and to move proximal capsule-portion 94 proximally with respect to the implant (e.g., by actuating controller 112b), but it is not possible to move the distal capsule-portion further distally, which would deploy downstream region 33. Typically, in state A, it is also possible to return proximal capsule-portion 94 distally and distal capsule-portion 92 proximally. In state B, it is possible to move distal capsule-portion 92 further distally, thereby deploying downstream region 33. For some applications, lock 114 is not unlockable until distal capsule-portion 92 has been moved the first distance distally, and/or until proximal capsule-portion 94 has been moved proximally.
Therefore, apparatus is provided, in accordance with some applications of the invention, the apparatus comprising an implant and a delivery tool, the tool comprising:
-
- a delivery capsule, disposed at a distal portion of the tool, the delivery capsule comprising a proximal capsule-portion dimensioned to house a first part of the implant, and a distal capsule-portion dimensioned to house a second part of the implant; and
- an extracorporeal control portion, disposed at a proximal portion of the tool, the control portion comprising one or more controllers and one or more locks, the controllers being operatively coupled to the proximal and distal capsule-portions such that the proximal and distal capsule-portions are movable with respect to the implant via actuation of the controllers,
wherein the controllers and the locks are mechanically cooperative such that:
-
- in a state A of the tool: (i) a first distal movement of the distal capsule-portion up to a first distance distally with respect to the implant is facilitated, (ii) a second distal movement of the distal capsule-portion further distally with respect to the implant is inhibited, and (iii) a proximal movement of the proximal capsule-portion proximally with respect to the implant is facilitated; and
- in a state B of the tool, the second distal movement of the distal capsule-portion is facilitated.
As shown in
Reference is now made to
Reference is again made to
It is to be noted that for some applications, downstream delivery of implant 20 may be performed by expanding flanges 54 first (e.g., as shown in
Reference is now made to
Reference is made to
Frame assembly 122 comprises (i) a valve frame 130 that comprises a tubular portion 132 and an upstream support portion 140 that typically comprises a plurality of arms 146, and (ii) an outer frame (e.g., a leg frame) 160 that circumscribes the valve frame, and comprises a plurality of legs 150 that each comprise a tissue-engaging flange 154. Typically, outer frame 160 comprises a ring 166 to which legs 150 are coupled. Ring 166 is defined by a pattern of alternating peaks and troughs, the peaks being fixed to frame 130 at respective coupling points 152, e.g., as described hereinabove for frame assembly 22, mutatis mutandis.
Frame assembly 222 comprises (i) a valve frame 230 that comprises a tubular portion 232 and an upstream support portion 240 that typically comprises a plurality of arms 246, and (ii) an outer frame (e.g., a leg frame) 260 that circumscribes the valve frame, and comprises a plurality of legs 250 that each comprise a tissue-engaging flange 254. Typically, outer frame 260 comprises a ring 266 to which legs 250 are coupled. Ring 266 is defined by a pattern of alternating peaks and troughs, the peaks being fixed to frame 230 at respective coupling points 252, e.g., as described hereinabove for frame assembly 22, mutatis mutandis.
Whereas arms 46 of frame assembly 22 are shown as extending from upstream end 34 of tubular portion 32, arms 146 and 246 of frame assemblies 122 and 222, respectively, extend from sites further downstream. (This difference may also be made to frame assembly 22, mutatis mutandis.) Tubular portions 32, 132 and 232 are each defined by a repeating pattern of cells that extends around the central longitudinal axis. Typically, and as shown, tubular portions 32, 132 and 232 are each defined by two stacked, tessellating rows of cells. In the expanded state of each tubular portion, these cells are typically narrower at their upstream and downstream extremities than midway between these extremities. For example, and as shown, the cells may be roughly diamond or astroid in shape. In frame assembly 22, each arm 46 is attached to and extends from a site 35 that is at the upstream extremity of cells of the upstream row. In contrast, in frame assemblies 122 and 222, each arm 146 or 246 is attached to and extends from a site 135 (assembly 122) or 235 (assembly 222) that is at the connection between two adjacent cells of the upstream row (alternatively described as being at the upstream extremity of cells of the downstream row).
It is hypothesized by the inventors that this lower position of the arms, while maintaining the length of the lumen of the tubular portion, advantageously reduces the distance that the tubular portion (i.e., the downstream end thereof) extends into the ventricle of the subject, and thereby reduces a likelihood of inhibiting blood flow out of the ventricle through the left ventricular outflow tract. It is further hypothesized that this position of the arms reduces radial compression of the tubular portion by movement of the heart, due to greater rigidity of the tubular portion at sites 135 and 235 (which is supported by two adjacent cells) than at site 35 (which is supported by only one cell).
As shown, in the expanded state of frame assemblies 22, 122 and 222, the legs (50, 150 and 250, respectively) are circumferentially staggered with the arms of the upstream support portion (46, 146 and 246, respectively). This allows the legs to move in an upstream direction between the arms during expansion of the tubular portion (32, 132 and 232, respectively), facilitating application of greater sandwiching force on tissue of the native valve. The lower position of the arms of assemblies 122 and 222 includes circumferentially shifting the position of the arms by the width of half a cell. In order to maintain the circumferential staggering of the arms and legs, rings 166 and 266 (and thereby legs 150 and 250) are circumferentially shifted correspondingly. As a result, whereas the peaks of ring 66 generally align with connections between adjacent cells of the downstream row of cells of tubular portion 32 (and are fixed to these sites), the peaks of rings 166 and 266 are generally aligned midway between these sites (i.e., at spaces of the cellular structure of the tubular portion). Appendages 168 (for assembly 122) or 268 (for assembly 222) facilitate fixing of the peak with respect to the tubular structure.
For assembly 122, appendages 168 are defined by valve frame 130 (e.g., by tubular portion 132 thereof) and extend (in a downstream direction) to the peaks of ring 166, to which they are fixed. For example, each appendage 168 may define a valve-frame coupling element 131 that is fixed to a respective outer-frame coupling element 161 defined by outer frame 260. Typically, appendages 168 extend from sites 135. Typically, appendages 168 are integral with tubular portion 132 and/or in-plane with the tubular portion (e.g., are part of its tubular shape).
For assembly 222, appendages 268 are defined by outer frame 260, and extend (e.g., in an upstream direction) from the peaks of ring 266. Typically, appendages 268 extend to sites 235, to which they are fixed. For example, each appendage 268 may define an outer-frame coupling element 261 that is fixed to a respective valve-frame coupling element 231 defined by valve frame 230 (e.g., by tubular portion 232 thereof). Typically, appendages 268 are integral with outer frame 260 and/or in-plane with adjacent portions of outer frame 260, such as ring 266.
Therefore, frame assembly 122 defines a hub at site 135, and frame assembly 222 defines a hub at site 235. For some applications, apparatus therefore comprises:
-
- a plurality of prosthetic valve leaflets; and
- a frame assembly, comprising:
- a tubular portion (132 or 232) defined by a repeating pattern of cells, the tubular portion extending circumferentially around longitudinal axis ax1 so as to define a longitudinal lumen, the prosthetic valve leaflets coupled to the inner frame and disposed within the lumen;
- an outer frame (160 or 260), comprising a plurality of legs (150 or 250), distributed circumferentially around the tubular portion, each leg having a tissue-engaging flange (154 or 254);
- an upstream support portion (140 or 240) that comprises a plurality of arms (146 or 246) that extend radially outward from the tubular portion; and
- a plurality of appendages (168 or 268), each having a first end that defines a coupling element (161 or 261) via which the tubular portion is coupled to the outer frame, and a second end;
wherein the frame assembly defines a plurality of hubs (135 or 235), distributed circumferentially around the longitudinal axis on a plane that is transverse to longitudinal axis ax1, each hub defined by convergence and connection of, (i) two adjacent cells of the tubular portion, (ii) an arm of the plurality of arms, and (iii) an appendage of the plurality of appendages.
Reference is made to
Frame assembly 122 comprises (i) a valve frame 330 that comprises a tubular portion 332 and an upstream support portion 340 that typically comprises a plurality of arms 346, and (ii) an outer frame (e.g., a leg frame) 360 that circumscribes the valve frame, and comprises a plurality of legs 350 that each comprise a tissue-engaging flange 354. Typically, outer frame 360 comprises a ring 366 to which legs 350 are coupled. Ring 366 is defined by a pattern of alternating peaks and troughs, the peaks being fixed to frame 330 at respective coupling points 352, e.g., as described hereinabove for frame assembly 22 and/or frame assembly 122, mutatis mutandis.
Frame assembly 322 comprises an annular upstream support portion 340 that has an inner portion 342 that extends radially outward from the upstream portion (e.g., the upstream end) of tubular portion 332. Upstream support portion 340 further comprises one or more fabric pockets 344 disposed circumferentially around inner portion 342, each pocket of the one or more pockets having an opening that faces a downstream direction (i.e., generally toward the downstream end of implant 320). In the figures, upstream support portion 340 has a single toroidal pocket 344 that extends circumferentially around inner portion 342.
Typically, a covering 323 (e.g., similar to covering 23, described hereinabove, mutatis mutandis) is disposed over arms 346, thereby forming pocket 344. Further typically, arms 346 are shaped to form pocket 344 from covering 323. For example, and as shown, arms 346 may curve to form a hook-shape.
For some applications, portion 340 has a plurality of separate pockets 344, e.g., separated at arms 346. For some such applications, covering 323 is loosely-fitted (e.g., baggy) between radially-outward parts of arms 346, e.g., compared to inner portion 342, in which the covering is more closely-fitted between radially-inward parts of the arms.
Pocket(s) 344 may be used in combination with any of the implants described herein, mutatis mutandis.
Reference is again made to
It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.
Claims
1. A method, comprising: wherein:
- percutaneously advancing an implant to a native heart valve of a subject, the implant housed in a compressed state within a delivery tool;
- unhousing a longitudinally-intermediate portion of the implant, the longitudinally-intermediate portion being longitudinally between a longitudinally-proximal portion of the implant and a longitudinally distal portion of the implant;
- subsequently, unhousing the longitudinally-proximal portion of the implant; and
- subsequently, unhousing the longitudinally-distal portion of the implant,
- unhousing the longitudinally-intermediate portion of the implant comprises unhousing flanges of the implant such that the flanges automatically expand, and such that upon the flanges expanding a proximal end of each flange extends radially outward from a central longitudinal axis of the implant and longitudinally in a proximal direction.
2. The method according to claim 1, wherein:
- unhousing the longitudinally-proximal portion of the implant comprises unhousing an upstream support portion of the implant such that the upstream support portion automatically expands; and
- unhousing the longitudinally-distal portion of the implant comprises unhousing the longitudinally-distal portion of the implant such that the longitudinally-distal portion of the implant automatically expands.
3. The method according to claim 2, wherein the longitudinally-distal portion includes a tubular portion within which a valve member is disposed, and wherein unhousing the longitudinally-distal portion of the implant comprises unhousing the longitudinally-distal portion of the implant such that the tubular portion expands to form a lumen and the valve member regulates one-way flow of blood through the lumen.
4. The method according to claim 3, wherein unhousing the longitudinally-distal portion of the implant comprises facilitating expansion of the implant such that the tubular portion expands and the flanges become longitudinally closer to the upstream support portion.
5. The method according to claim 4, wherein facilitating expansion of the implant comprises sandwiching leaflets of the native heart valve between the flanges and the upstream support portion.
6. The method according to claim 1, wherein:
- percutaneously advancing the implant to the native heart valve comprises advancing the implant housed within a capsule of the delivery tool, the capsule having a distal capsule-portion and a proximal capsule-portion,
- unhousing the longitudinally-intermediate portion of the implant comprises unhousing the longitudinally-intermediate portion from within the distal capsule-portion by moving the distal capsule-portion distally with respect to the implant,
- unhousing the longitudinally-proximal portion comprises unhousing the longitudinally-proximal portion from within the proximal capsule-portion by moving the proximal capsule-portion proximally with respect to the implant, and
- unhousing the longitudinally-distal portion of the implant comprises deploying the longitudinally-distal portion of the implant from the distal capsule-portion.
7. The method according to claim 6, wherein deploying the longitudinally-distal portion of the implant from the distal capsule-portion comprises additionally moving the distal capsule-portion distally with respect to the implant.
8. Apparatus, comprising:
- an implant for implantation at a native valve of a heart of a subject, the implant comprising a valve frame assembly comprising: a tubular portion having an upstream end and a downstream end that defines, in part, a longitudinally-distal portion of the implant; an upstream support portion, extending from the upstream end of the tubular portion, the upstream portion defining a longitudinally-proximal portion of the implant; and a plurality of tissue-engaging flanges coupled to the tubular portion at respective coupling points, the plurality of flanges defining a longitudinally-intermediate portion of the implant; and
- a delivery tool: comprising a delivery capsule dimensioned (i) to house and retain the implant in a compressed state of the implant in which (a) the tubular portion is in a constrained-tubular-portion state, (b) the upstream support portion is in a constrained-upstream-support-portion state, and (c) the plurality of flanges are in a constrained-flange state, and (ii) to be advanced percutaneously to the heart of the subject while the implant is housed and in the compressed state, and operable from outside the subject to: transition the implant from the compressed state into an intermediate state of the implant by (1) unhousing the longitudinally-intermediate portion, while retaining the tubular portion in the constrained-tubular-portion state, and (2) subsequently, unhousing the longitudinally-proximal portion of the implant, while retaining at least the longitudinally-distal portion of the implant in a constrained state, and subsequently, unhouse the longitudinally-distal portion of the implant such that the implant assumes an expanded state, such that in the expanded state a proximal end of each flange extends radially outward from a central longitudinal axis of the implant and longitudinally in a proximal direction.
9. The apparatus according to claim 8, wherein:
- the upstream support portion is configured such that, upon the implant entering the intermediate state, the upstream support portion is expanded into a released-upstream-support-portion state.
10. The apparatus according to claim 8, wherein the tubular portion is configured such that, upon the implant transitioning from the intermediate state to the expanded state, the tubular portion expands and thereby moves the plurality of flanges longitudinally closer to the upstream support portion.
11. The apparatus according to claim 8, wherein the tubular member comprises a valve member, and wherein, in the expanded state of the implant, the tubular portion defines a lumen therethrough, and the valve member is configured to regulate one-way flow of blood through the lumen.
12. The apparatus according to claim 8, wherein the capsule of the delivery tool comprises a distal capsule-portion and a proximal capsule-portion, and wherein the capsule is configured such that:
- upon the implant entering the intermediate state, (i) the distal capsule-portion is moved distally with respect to the implant to unhouse the longitudinally-intermediate portion of the implant, while still surrounding the longitudinally-distal portion of the implant, and (ii) the proximal capsule-portion is moved proximally with respect to the implant to unhouse the longitudinally-proximal portion, and
- upon the implant entering the expanded state, the distal capsule-portion is moved further distally with respect to the implant to unhouse the longitudinally-distal portion of the implant.
13. A method, comprising: wherein:
- percutaneously advancing an implant to a native heart valve of a subject, the implant housed in a compressed state within a delivery tool;
- unhousing a longitudinally-intermediate portion of the implant, the longitudinally-intermediate portion being longitudinally between a longitudinally-proximal portion of the implant and a longitudinally distal portion of the implant;
- subsequently, unhousing the longitudinally-proximal portion of the implant; and
- subsequently, unhousing the longitudinally-distal portion of the implant,
- unhousing the longitudinally-intermediate portion of the implant comprises unhousing flanges of the implant such that the flanges automatically expand;
- unhousing the longitudinally-proximal portion of the implant comprises unhousing an upstream support portion of the implant such that the upstream support portion automatically expands; and
- unhousing the longitudinally-distal portion of the implant comprises unhousing the longitudinally-distal portion of the implant such that the longitudinally-distal portion of the implant automatically expands,
- wherein the longitudinally-distal portion includes a tubular portion within which a valve member is disposed, and wherein unhousing the longitudinally-distal portion of the implant comprises unhousing the longitudinally-distal portion of the implant such that the tubular portion expands to form a lumen and the valve member regulates one-way flow of blood through the lumen, and
- wherein unhousing the longitudinally-distal portion of the implant comprises facilitating expansion of the implant such that the tubular portion expands and the flanges become longitudinally closer to the upstream support portion.
14. A method, comprising: wherein:
- percutaneously advancing an implant to a native heart valve of a subject, the implant housed in a compressed state within a delivery tool;
- unhousing a longitudinally-intermediate portion of the implant, the longitudinally-intermediate portion being longitudinally between a longitudinally-proximal portion of the implant and a longitudinally distal portion of the implant;
- subsequently, unhousing the longitudinally-proximal portion of the implant; and
- subsequently, unhousing the longitudinally-distal portion of the implant,
- percutaneously advancing the implant to the native heart valve comprises advancing the implant housed within a capsule of the delivery tool, the capsule having a distal capsule-portion and a proximal capsule-portion,
- unhousing the longitudinally-intermediate portion of the implant comprises unhousing the longitudinally-intermediate portion from within the distal capsule-portion by moving the distal capsule-portion distally with respect to the implant,
- unhousing the longitudinally-proximal portion comprises unhousing the longitudinally-proximal portion from within the proximal capsule-portion by moving the proximal capsule-portion proximally with respect to the implant, and
- unhousing the longitudinally-distal portion of the implant comprises deploying the longitudinally-distal portion of the implant from the distal capsule-portion.
15. The method according to claim 14, wherein deploying the longitudinally-distal portion of the implant from the distal capsule-portion comprises additionally moving the distal capsule-portion distally with respect to the implant.
16. Apparatus, comprising:
- an implant for implantation at a native valve of a heart of a subject, the implant comprising a valve frame assembly comprising: a tubular portion having an upstream end and a downstream end that defines, in part, a longitudinally-distal portion of the implant; an upstream support portion, extending from the upstream end of the tubular portion, the upstream portion defining a longitudinally-proximal portion of the implant; and a plurality of tissue-engaging flanges coupled to the tubular portion at respective coupling points, the plurality of flanges defining a longitudinally-intermediate portion of the implant; and
- a delivery tool: comprising a delivery capsule dimensioned (i) to house and retain the implant in a compressed state of the implant in which (a) the tubular portion is in a constrained-tubular-portion state, (b) the upstream support portion is in a constrained-upstream-support-portion state, and (c) the plurality of flanges are in a constrained-flange state, and (ii) to be advanced percutaneously to the heart of the subject while the implant is housed and in the compressed state, and operable from outside the subject to: transition the implant from the compressed state into an intermediate state of the implant by (1) unhousing the longitudinally-intermediate portion, while retaining the tubular portion in the constrained-tubular-portion state, and (2) subsequently, unhousing the longitudinally-proximal portion of the implant, while retaining at least the longitudinally-distal portion of the implant in a constrained state, and subsequently, unhouse the longitudinally-distal portion of the implant such that the implant assumes an expanded state,
- wherein the tubular portion is configured such that, upon the implant transitioning from the intermediate state to the expanded state, the tubular portion expands and thereby moves the plurality of flanges longitudinally closer to the upstream support portion.
17. Apparatus, comprising:
- an implant for implantation at a native valve of a heart of a subject, the implant comprising a valve frame assembly comprising: a tubular portion having an upstream end and a downstream end that defines, in part, a longitudinally-distal portion of the implant; an upstream support portion, extending from the upstream end of the tubular portion, the upstream portion defining a longitudinally-proximal portion of the implant; and a plurality of tissue-engaging flanges coupled to the tubular portion at respective coupling points, the plurality of flanges defining a longitudinally-intermediate portion of the implant; and
- a delivery tool: comprising a delivery capsule dimensioned (i) to house and retain the implant in a compressed state of the implant in which (a) the tubular portion is in a constrained-tubular-portion state, (b) the upstream support portion is in a constrained-upstream-support-portion state, and (c) the plurality of flanges are in a constrained-flange state, and (ii) to be advanced percutaneously to the heart of the subject while the implant is housed and in the compressed state, and operable from outside the subject to: transition the implant from the compressed state into an intermediate state of the implant by (1) unhousing the longitudinally-intermediate portion, while retaining the tubular portion in the constrained-tubular-portion state, and (2) subsequently, unhousing the longitudinally-proximal portion of the implant, while retaining at least the longitudinally-distal portion of the implant in a constrained state, and subsequently, unhouse the longitudinally-distal portion of the implant such that the implant assumes an expanded state,
- wherein the capsule of the delivery tool comprises a distal capsule-portion and a proximal capsule-portion, and wherein the capsule is configured such that:
- upon the implant entering the intermediate state, (i) the distal capsule-portion is moved distally with respect to the implant to unhouse the longitudinally-intermediate portion of the implant, while still surrounding the longitudinally-distal portion of the implant, and (ii) the proximal capsule-portion is moved proximally with respect to the implant to unhouse the longitudinally-proximal portion, and
- upon the implant entering the expanded state, the distal capsule-portion is moved further distally with respect to the implant to unhouse the longitudinally-distal portion of the implant.
3604488 | September 1971 | Wishart et al. |
3656185 | April 1972 | Carpentier |
3840018 | October 1974 | Heifetz |
3874388 | April 1975 | King et al. |
3898701 | August 1975 | La Russa |
4042979 | August 23, 1977 | Angell |
4118805 | October 10, 1978 | Reimels |
4214349 | July 29, 1980 | Munch |
4222126 | September 16, 1980 | Boretos et al. |
4261342 | April 14, 1981 | Aranguren |
4275469 | June 30, 1981 | Gabbay |
4340091 | July 20, 1982 | Skelton et al. |
4423525 | January 3, 1984 | Vallana et al. |
4434828 | March 6, 1984 | Trincia |
4473928 | October 2, 1984 | Johnson |
4602911 | July 29, 1986 | Ahmadi et al. |
4625727 | December 2, 1986 | Leiboff |
4712549 | December 15, 1987 | Peters et al. |
4778468 | October 18, 1988 | Hunt et al. |
4853986 | August 8, 1989 | Allen |
4892541 | January 9, 1990 | Alonso |
4917698 | April 17, 1990 | Carpenter et al. |
4961738 | October 9, 1990 | Mackin |
4972494 | November 20, 1990 | White et al. |
4994077 | February 19, 1991 | Dobben |
5061277 | October 29, 1991 | Carpentier et al. |
5078739 | January 7, 1992 | Martin |
5104407 | April 14, 1992 | Lam et al. |
5108420 | April 28, 1992 | Marks |
5201757 | April 13, 1993 | Heyn et al. |
5201880 | April 13, 1993 | Wright |
5258008 | November 2, 1993 | Wilk |
5300034 | April 5, 1994 | Behnke |
5306296 | April 26, 1994 | Wright et al. |
5314473 | May 24, 1994 | Godin |
5325845 | July 5, 1994 | Adair |
5332402 | July 26, 1994 | Teitelbaum |
5397351 | March 14, 1995 | Pavenik et al. |
5405378 | April 11, 1995 | Strecker |
5443500 | August 22, 1995 | Sigwart |
5450860 | September 19, 1995 | O'Connor |
5473812 | December 12, 1995 | Morris et al. |
5477856 | December 26, 1995 | Lundquist |
5601572 | February 11, 1997 | Middleman et al. |
5607444 | March 4, 1997 | Lam |
5607470 | March 4, 1997 | Milo |
5626609 | May 6, 1997 | Zvenyatsky et al. |
5647857 | July 15, 1997 | Anderson et al. |
5669919 | September 23, 1997 | Sanders et al. |
5674279 | October 7, 1997 | Wright et al. |
5683402 | November 4, 1997 | Cosgrove et al. |
5702397 | December 30, 1997 | Goble et al. |
5702398 | December 30, 1997 | Tarabishy |
5709695 | January 20, 1998 | Northrup, III |
5713948 | February 3, 1998 | Uflacker |
5716370 | February 10, 1998 | Williamson et al. |
5716397 | February 10, 1998 | Myers |
5716417 | February 10, 1998 | Girard et al. |
5728116 | March 17, 1998 | Rosenman |
5730150 | March 24, 1998 | Peppel et al. |
5741297 | April 21, 1998 | Simon |
5749371 | May 12, 1998 | Zadini et al. |
5765682 | June 16, 1998 | Bley et al. |
5776140 | July 7, 1998 | Cottone |
5810882 | September 22, 1998 | Bolduc |
5824066 | October 20, 1998 | Gross |
5830221 | November 3, 1998 | Stein et al. |
5843120 | December 1, 1998 | Israel et al. |
5855614 | January 5, 1999 | Stevens et al. |
5868777 | February 9, 1999 | Lam |
5873906 | February 23, 1999 | Lau et al. |
5876373 | March 2, 1999 | Giba et al. |
5935098 | August 10, 1999 | Blaisdell et al. |
5954766 | September 21, 1999 | Zadno-Azizi et al. |
5957949 | September 28, 1999 | Leonhardt et al. |
5957953 | September 28, 1999 | DiPoto et al. |
5961440 | October 5, 1999 | Schweich et al. |
5961539 | October 5, 1999 | Northrup, III et al. |
5980565 | November 9, 1999 | Jayaraman |
5984959 | November 16, 1999 | Robertson |
6010530 | January 4, 2000 | Goicoechea |
6019787 | February 1, 2000 | Richard et al. |
6042554 | March 28, 2000 | Rosenman |
6042607 | March 28, 2000 | Williamson, IV |
6045497 | April 4, 2000 | Schweich et al. |
6050936 | April 18, 2000 | Schweich et al. |
6059715 | May 9, 2000 | Schweich et al. |
6059827 | May 9, 2000 | Fenton |
6074401 | June 13, 2000 | Gardiner et al. |
6074417 | June 13, 2000 | Peredo |
6102945 | August 15, 2000 | Campbell |
6106550 | August 22, 2000 | Magovern |
6110200 | August 29, 2000 | Hinnenkamp |
6113612 | September 5, 2000 | Swanson et al. |
6120534 | September 19, 2000 | Ruiz |
6126686 | October 3, 2000 | Badylak et al. |
6143024 | November 7, 2000 | Campbell et al. |
6152937 | November 28, 2000 | Peterson et al. |
6159240 | December 12, 2000 | Sparer |
6165119 | December 26, 2000 | Schweich et al. |
6165183 | December 26, 2000 | Kuehn et al. |
6165210 | December 26, 2000 | Lau et al. |
6174332 | January 16, 2001 | Loch |
6183411 | February 6, 2001 | Mortier et al. |
6187020 | February 13, 2001 | Zegdi et al. |
6187040 | February 13, 2001 | Wright |
6193686 | February 27, 2001 | Estrada et al. |
6193745 | February 27, 2001 | Fogarty et al. |
6315784 | November 13, 2001 | Djurovic |
6217610 | April 17, 2001 | Carpentier et al. |
6231602 | May 15, 2001 | Carpentier et al. |
6251092 | June 26, 2001 | Qin et al. |
6254609 | July 3, 2001 | Vrba et al. |
6264700 | July 24, 2001 | Kilcoyne et al. |
6287339 | September 11, 2001 | Vasquez et al. |
6296656 | October 2, 2001 | Bodluc et al. |
6312465 | November 6, 2001 | Griffin et al. |
6319281 | November 20, 2001 | Patel |
6332893 | December 25, 2001 | Mortier et al. |
6334873 | January 1, 2002 | Lane et al. |
6346074 | February 12, 2002 | Roth |
6350278 | February 26, 2002 | Lenker et al. |
6352561 | March 5, 2002 | Leopold et al. |
6391036 | May 21, 2002 | Berg et al. |
6402780 | June 11, 2002 | Williamson, IV |
6406420 | June 18, 2002 | McCarthy et al. |
6406493 | June 18, 2002 | Tu et al. |
6409755 | June 25, 2002 | Vrba |
6419696 | July 16, 2002 | Ortiz et al. |
6428550 | August 6, 2002 | Vargas et al. |
6440164 | August 27, 2002 | Dimatteo et al. |
6451054 | September 17, 2002 | Stevens |
6454799 | September 24, 2002 | Schreck |
6458153 | October 1, 2002 | Bailey et al. |
6461366 | October 8, 2002 | Seguin |
6470892 | October 29, 2002 | Forsell |
6478807 | November 12, 2002 | Foreman et al. |
6482228 | November 19, 2002 | Norred |
6491711 | December 10, 2002 | Durcan |
6503274 | January 7, 2003 | Howanec et al. |
6511491 | January 28, 2003 | Grudem et al. |
6524338 | February 25, 2003 | Gundry |
6530952 | March 11, 2003 | Vesely |
6533772 | March 18, 2003 | Sherts et al. |
6537314 | March 25, 2003 | Langberg et al. |
6540782 | April 1, 2003 | Snyders |
6547801 | April 15, 2003 | Dargent et al. |
6551350 | April 22, 2003 | Thornton et al. |
6554845 | April 29, 2003 | Fleenor et al. |
6558396 | May 6, 2003 | Inoue |
6558418 | May 6, 2003 | Carpentier et al. |
6564805 | May 20, 2003 | Garrison et al. |
6565603 | May 20, 2003 | Cox |
6569196 | May 27, 2003 | Vesely |
6569198 | May 27, 2003 | Wilson et al. |
6579297 | June 17, 2003 | Bicek et al. |
6582464 | June 24, 2003 | Gabbay |
6589160 | July 8, 2003 | Schweich et al. |
6602263 | August 5, 2003 | Swanson et al. |
6602288 | August 5, 2003 | Cosgrove et al. |
6602289 | August 5, 2003 | Colvin et al. |
6613078 | September 2, 2003 | Barone |
6613079 | September 2, 2003 | Wolinsky et al. |
6616675 | September 9, 2003 | Evard et al. |
6619291 | September 16, 2003 | Hlavka et al. |
6626899 | September 30, 2003 | Houser et al. |
6626917 | September 30, 2003 | Craig |
6626930 | September 30, 2003 | Allen et al. |
6629534 | October 7, 2003 | St. Goar et al. |
6629921 | October 7, 2003 | Schweich et al. |
6651671 | November 25, 2003 | Donlon et al. |
6652556 | November 25, 2003 | VanTassel et al. |
6669724 | December 30, 2003 | Park et al. |
6682558 | January 27, 2004 | Tu et al. |
6689125 | February 10, 2004 | Keith et al. |
6689164 | February 10, 2004 | Seguin |
6695866 | February 24, 2004 | Kuehn et al. |
6699256 | March 2, 2004 | Logan et al. |
6702826 | March 9, 2004 | Liddicoat et al. |
6702846 | March 9, 2004 | Mikus et al. |
6706065 | March 16, 2004 | Langberg et al. |
6709456 | March 23, 2004 | Langberg et al. |
6711444 | March 23, 2004 | Koblish |
6716244 | April 6, 2004 | Klaco |
6718985 | April 13, 2004 | Hlavka et al. |
6719781 | April 13, 2004 | Kim |
6719786 | April 13, 2004 | Ryan et al. |
6719788 | April 13, 2004 | Cox |
6723038 | April 20, 2004 | Schroeder et al. |
6726716 | April 27, 2004 | Marquez |
6726717 | April 27, 2004 | Alfieri et al. |
6730118 | May 4, 2004 | Spenser et al. |
6730121 | May 4, 2004 | Ortiz et al. |
6733525 | May 11, 2004 | Yang et al. |
6749630 | June 15, 2004 | McCarthy et al. |
6752813 | June 22, 2004 | Goldfarb et al. |
6764310 | July 20, 2004 | Ichihashi et al. |
6764510 | July 20, 2004 | Vidlund et al. |
6764514 | July 20, 2004 | Li et al. |
6764518 | July 20, 2004 | Godin |
6767362 | July 27, 2004 | Schreck |
6770083 | August 3, 2004 | Seguin |
6786924 | September 7, 2004 | Ryan et al. |
6786925 | September 7, 2004 | Schoon et al. |
6790231 | September 14, 2004 | Liddicoat et al. |
6797001 | September 28, 2004 | Mathis et al. |
6797002 | September 28, 2004 | Spence et al. |
6802319 | October 12, 2004 | Stevens et al. |
6805710 | October 19, 2004 | Bolling et al. |
6805711 | October 19, 2004 | Quijano et al. |
6821297 | November 23, 2004 | Snyders |
6830585 | December 14, 2004 | Artof et al. |
6830638 | December 14, 2004 | Boylan et al. |
6855126 | February 15, 2005 | Flinchbaugh |
6858039 | February 22, 2005 | McCarthy |
6884250 | April 26, 2005 | Monassevitch et al. |
6884257 | April 26, 2005 | Cox |
6893459 | May 17, 2005 | Macoviak |
6893460 | May 17, 2005 | Spenser et al. |
6908482 | June 21, 2005 | McCarthy et al. |
6918917 | July 19, 2005 | Nguyen et al. |
6926715 | August 9, 2005 | Hauck et al. |
6926730 | August 9, 2005 | Nguyen et al. |
6951571 | October 4, 2005 | Srivastava |
6960217 | November 1, 2005 | Bolduc |
6964684 | November 15, 2005 | Ortiz et al. |
6964686 | November 15, 2005 | Gordon |
6974476 | December 13, 2005 | McGuckin et al. |
6976995 | December 20, 2005 | Mathis et al. |
6986775 | January 17, 2006 | Morales et al. |
6989028 | January 24, 2006 | Lashinski et al. |
6997951 | February 14, 2006 | Solem et al. |
7004176 | February 28, 2006 | Lau |
7011669 | March 14, 2006 | Kimblad |
7011681 | March 14, 2006 | Vesely |
7011682 | March 14, 2006 | Lashinski et al. |
7018406 | March 28, 2006 | Seguin et al. |
7037334 | May 2, 2006 | Hlavka et al. |
7041132 | May 9, 2006 | Quijano et al. |
7074236 | July 11, 2006 | Rabkin et al. |
7077850 | July 18, 2006 | Kortenbach |
7077861 | July 18, 2006 | Spence |
7077862 | July 18, 2006 | Vidlund et al. |
7087064 | August 8, 2006 | Hyde |
7101395 | September 5, 2006 | Tremulis et al. |
7101396 | September 5, 2006 | Artof et al. |
7112207 | September 26, 2006 | Allen et al. |
7118595 | October 10, 2006 | Ryan et al. |
7125421 | October 24, 2006 | Tremulis et al. |
7137184 | November 21, 2006 | Schreck |
7150737 | December 19, 2006 | Purdy et al. |
7159593 | January 9, 2007 | McCarthy et al. |
7166127 | January 23, 2007 | Spence et al. |
7169187 | January 30, 2007 | Datta et al. |
7172625 | February 6, 2007 | Shu et al. |
7175656 | February 13, 2007 | Khairkhahan |
7175660 | February 13, 2007 | Cartledge et al. |
7186262 | March 6, 2007 | Saadat |
7186264 | March 6, 2007 | Liddicoat et al. |
7189199 | March 13, 2007 | McCarthy et al. |
7192443 | March 20, 2007 | Solem et al. |
7198646 | April 3, 2007 | Figulla et al. |
7201772 | April 10, 2007 | Schwammenthal |
7220277 | May 22, 2007 | Arru et al. |
7226467 | June 5, 2007 | Lucatero et al. |
7226477 | June 5, 2007 | Cox |
7226647 | June 5, 2007 | Kasperchik et al. |
7229452 | June 12, 2007 | Kayan |
7238191 | July 3, 2007 | Bachmann |
7261686 | August 28, 2007 | Couvillon, Jr. |
7288097 | October 30, 2007 | Seguin |
7288111 | October 30, 2007 | Holloway et al. |
7294148 | November 13, 2007 | McCarthy |
7297150 | November 20, 2007 | Cartledge et al. |
7311728 | December 25, 2007 | Solem et al. |
7311729 | December 25, 2007 | Mathis et al. |
7314485 | January 1, 2008 | Mathis |
7316710 | January 8, 2008 | Cheng et al. |
7316716 | January 8, 2008 | Egan |
7329279 | February 12, 2008 | Haug et al. |
7329280 | February 12, 2008 | Bolling et al. |
7335213 | February 26, 2008 | Hyde et al. |
7351256 | April 1, 2008 | Hojeibane et al. |
7361190 | April 22, 2008 | Shoulian et al. |
7364588 | April 29, 2008 | Mathis et al. |
7374571 | May 20, 2008 | Pease et al. |
7374573 | May 20, 2008 | Gabbay |
7377938 | May 27, 2008 | Sarac et al. |
7377941 | May 27, 2008 | Rhee et al. |
7381218 | June 3, 2008 | Schreck |
7381219 | June 3, 2008 | Salahieh et al. |
7390329 | June 24, 2008 | Westra et al. |
7404824 | July 29, 2008 | Webler et al. |
7422603 | September 9, 2008 | Lane |
7429269 | September 30, 2008 | Schwammenthal |
7431692 | October 7, 2008 | Zollinger et al. |
7442204 | October 28, 2008 | Schwammenthal |
7442207 | October 28, 2008 | Rafiee |
7445630 | November 4, 2008 | Lashinski et al. |
7452376 | November 18, 2008 | Lim et al. |
7455677 | November 25, 2008 | Vargas et al. |
7455688 | November 25, 2008 | Furst et al. |
7455690 | November 25, 2008 | Cartledge et al. |
7462162 | December 9, 2008 | Phan et al. |
7481838 | January 27, 2009 | Carpentier et al. |
7485142 | February 3, 2009 | Milo |
7500989 | March 10, 2009 | Solem et al. |
7507252 | March 24, 2009 | Lashinski et al. |
7510575 | March 31, 2009 | Spenser et al. |
7510577 | March 31, 2009 | Moaddeb et al. |
7513909 | April 7, 2009 | Lane et al. |
7524331 | April 28, 2009 | Birdsall |
7527646 | May 5, 2009 | Rahdert et al. |
7527647 | May 5, 2009 | Spence |
7530995 | May 12, 2009 | Quijano et al. |
7549983 | June 23, 2009 | Roue et al. |
7556632 | July 7, 2009 | Zadno |
7556646 | July 7, 2009 | Yang et al. |
7559936 | July 14, 2009 | Levine |
7562660 | July 21, 2009 | Saadat |
7563267 | July 21, 2009 | Goldfarb et al. |
7563273 | July 21, 2009 | Goldfarb et al. |
7569062 | August 4, 2009 | Kuehn et al. |
7582111 | September 1, 2009 | Krolik et al. |
7585321 | September 8, 2009 | Cribier |
7588582 | September 15, 2009 | Starksen et al. |
7591826 | September 22, 2009 | Alferness et al. |
7597711 | October 6, 2009 | Drews et al. |
7604646 | October 20, 2009 | Goldfarb et al. |
7608091 | October 27, 2009 | Goldfarb et al. |
7608103 | October 27, 2009 | McCarthy |
7611534 | November 3, 2009 | Kapadia et al. |
7618449 | November 17, 2009 | Tremulis et al. |
7621948 | November 24, 2009 | Hermann et al. |
7625403 | December 1, 2009 | Krivoruchko |
7632302 | December 15, 2009 | Vreeman et al. |
7632303 | December 15, 2009 | Stalker et al. |
7635329 | December 22, 2009 | Goldfarb et al. |
7635386 | December 22, 2009 | Gammie |
7648528 | January 19, 2010 | Styrc |
7655015 | February 2, 2010 | Goldfarb et al. |
7666204 | February 23, 2010 | Thornton et al. |
7682319 | March 23, 2010 | Martin |
7682369 | March 23, 2010 | Seguin |
7682380 | March 23, 2010 | Thornton et al. |
7686822 | March 30, 2010 | Shayani |
7699892 | April 20, 2010 | Rafiee et al. |
7704269 | April 27, 2010 | St. Goar et al. |
7704277 | April 27, 2010 | Zakay et al. |
7708775 | May 4, 2010 | Rowe et al. |
7717952 | May 18, 2010 | Case et al. |
7717955 | May 18, 2010 | Lane et al. |
7722666 | May 25, 2010 | Lafontaine |
7731741 | June 8, 2010 | Eidenschink |
7731742 | June 8, 2010 | Schlick et al. |
7736388 | June 15, 2010 | Goldfarb et al. |
7748389 | July 6, 2010 | Salahieh et al. |
7753922 | July 13, 2010 | Starksen |
7753924 | July 13, 2010 | Starksen et al. |
7753949 | July 13, 2010 | Lamphere et al. |
7758595 | July 20, 2010 | Allen et al. |
7758632 | July 20, 2010 | Hojeibane et al. |
7758640 | July 20, 2010 | Vesely |
7771467 | August 10, 2010 | Svensson |
7771469 | August 10, 2010 | Liddicoat |
7776080 | August 17, 2010 | Bei et al. |
7776083 | August 17, 2010 | Vesely |
7780726 | August 24, 2010 | Seguin |
7785341 | August 31, 2010 | Forster et al. |
7799069 | September 21, 2010 | Bailey et al. |
7803181 | September 28, 2010 | Furst et al. |
7811296 | October 12, 2010 | Goldfarb et al. |
7811316 | October 12, 2010 | Kalmann et al. |
7824442 | November 2, 2010 | Salahieh et al. |
7837645 | November 23, 2010 | Bessler et al. |
7837727 | November 23, 2010 | Goetz et al. |
7842081 | November 30, 2010 | Yadin |
7850725 | December 14, 2010 | Vardi et al. |
7871368 | January 18, 2011 | Zollinger et al. |
7871432 | January 18, 2011 | Bergin |
7871433 | January 18, 2011 | Lattouf |
7871436 | January 18, 2011 | Ryan et al. |
7887583 | February 15, 2011 | Macoviak |
7892281 | February 22, 2011 | Seguin et al. |
7896915 | March 1, 2011 | Guyenot et al. |
7914544 | March 29, 2011 | Nguyen et al. |
7914569 | March 29, 2011 | Nguyen et al. |
7927370 | April 19, 2011 | Webler et al. |
7927371 | April 19, 2011 | Navia et al. |
7942927 | May 17, 2011 | Kaye et al. |
7947072 | May 24, 2011 | Yang et al. |
7947075 | May 24, 2011 | Goetz et al. |
7951195 | May 31, 2011 | Antonsson et al. |
7955375 | June 7, 2011 | Agnew |
7955377 | June 7, 2011 | Melsheimer |
7955384 | June 7, 2011 | Rafiee et al. |
7959666 | June 14, 2011 | Salahieh et al. |
7959672 | June 14, 2011 | Salahieh et al. |
7967833 | June 28, 2011 | Sterman et al. |
7967857 | June 28, 2011 | Lane |
7981151 | July 19, 2011 | Rowe |
7981153 | July 19, 2011 | Fogarty et al. |
7988725 | August 2, 2011 | Gross et al. |
7992567 | August 9, 2011 | Hirotsuka et al. |
7993368 | August 9, 2011 | Gambale et al. |
7993393 | August 9, 2011 | Carpentier et al. |
7993397 | August 9, 2011 | Lashinski |
8002825 | August 23, 2011 | Letac et al. |
8002826 | August 23, 2011 | Seguin |
8012201 | September 6, 2011 | Lashinski et al. |
8016877 | September 13, 2011 | Seguin et al. |
8016882 | September 13, 2011 | Macoviak |
8021420 | September 20, 2011 | Dolan |
8021421 | September 20, 2011 | Fogarty et al. |
8025695 | September 27, 2011 | Fogarty et al. |
8029518 | October 4, 2011 | Goldfarb et al. |
8029557 | October 4, 2011 | Sobrino-Serrano et al. |
8029564 | October 4, 2011 | Johnson et al. |
8034103 | October 11, 2011 | Burriesci |
8034104 | October 11, 2011 | Carpentier et al. |
8038720 | October 18, 2011 | Wallace et al. |
8043360 | October 25, 2011 | McNamara et al. |
8048138 | November 1, 2011 | Sulivan et al. |
8048140 | November 1, 2011 | Purdy |
8048153 | November 1, 2011 | Salahieh et al. |
8052592 | November 8, 2011 | Goldfarb et al. |
8052741 | November 8, 2011 | Bruszewski et al. |
8052749 | November 8, 2011 | Salahieh et al. |
8057493 | November 15, 2011 | Goldfarb et al. |
8057532 | November 15, 2011 | Hoffman |
8057540 | November 15, 2011 | Letac et al. |
8062355 | November 22, 2011 | Figulla et al. |
8062359 | November 22, 2011 | Marquez et al. |
8070708 | December 6, 2011 | Rottenberg et al. |
8070800 | December 6, 2011 | Lock et al. |
8070802 | December 6, 2011 | Lamphere et al. |
8070804 | December 6, 2011 | Hyde |
8070805 | December 6, 2011 | Vidlund |
8075611 | December 13, 2011 | Milwee et al. |
8075616 | December 13, 2011 | Solem |
8080054 | December 20, 2011 | Rowe |
8083793 | December 27, 2011 | Lane et al. |
D652927 | January 24, 2012 | Braido et al. |
D653341 | January 31, 2012 | Braido et al. |
8092518 | January 10, 2012 | Schreck |
8092520 | January 10, 2012 | Quadri |
8092521 | January 10, 2012 | Figulla et al. |
8100964 | January 24, 2012 | Spence |
8105377 | January 31, 2012 | Liddicoat |
8109996 | February 7, 2012 | Stacchino et al. |
8118866 | February 21, 2012 | Herrmann et al. |
8123800 | February 28, 2012 | McCarthy |
8123801 | February 28, 2012 | Milo |
8323334 | December 4, 2012 | Deem et al. |
8133270 | March 13, 2012 | Kheradvar et al. |
8136218 | March 20, 2012 | Millwee et al. |
8137398 | March 20, 2012 | Tuval et al. |
8142492 | March 27, 2012 | Forster et al. |
8142493 | March 27, 2012 | Spence et al. |
8142494 | March 27, 2012 | Rahdert et al. |
8142495 | March 27, 2012 | Hasenkam et al. |
8142496 | March 27, 2012 | Berreklouw |
8142497 | March 27, 2012 | Friedman |
8147504 | April 3, 2012 | Ino et al. |
8147542 | April 3, 2012 | Maisano et al. |
8152844 | April 10, 2012 | Rao |
8157852 | April 17, 2012 | Bloom et al. |
8157853 | April 17, 2012 | Laske et al. |
8157860 | April 17, 2012 | McNamara et al. |
8163008 | April 24, 2012 | Wilson et al. |
8163013 | April 24, 2012 | Machold et al. |
8163014 | April 24, 2012 | Lane et al. |
D660433 | May 22, 2012 | Braido et al. |
D660967 | May 29, 2012 | Braido et al. |
8167894 | May 1, 2012 | Miles et al. |
8167932 | May 1, 2012 | Bourang et al. |
8167935 | May 1, 2012 | McGuckin, Jr. et al. |
8172896 | May 8, 2012 | McNamara et al. |
8172898 | May 8, 2012 | Alferness et al. |
8177836 | May 15, 2012 | Lee et al. |
8182528 | May 22, 2012 | Salahieh et al. |
8187299 | May 29, 2012 | Goldfarb et al. |
8187324 | May 29, 2012 | Webler et al. |
8202315 | June 19, 2012 | Hlavka et al. |
8206439 | June 26, 2012 | Gomez-Duran |
8211169 | July 3, 2012 | Lane et al. |
8216256 | July 10, 2012 | Raschdorf, Jr. et al. |
8216301 | July 10, 2012 | Bonhoeffer et al. |
8221492 | July 17, 2012 | Case et al. |
8221493 | July 17, 2012 | Boyle et al. |
8226710 | July 24, 2012 | Nguyen et al. |
8226711 | July 24, 2012 | Mortier et al. |
8231670 | July 31, 2012 | Salahieh et al. |
8231671 | July 31, 2012 | Kim |
8236045 | August 7, 2012 | Benichou et al. |
8236049 | August 7, 2012 | Rowe et al. |
8241351 | August 14, 2012 | Cabiri |
8252042 | August 28, 2012 | McNamara et al. |
8252050 | August 28, 2012 | Maisano et al. |
8252051 | August 28, 2012 | Chau et al. |
8252052 | August 28, 2012 | Salahieh et al. |
8257390 | September 4, 2012 | Carley et al. |
8262725 | September 11, 2012 | Subramanian |
8267988 | September 18, 2012 | Hamer et al. |
8277501 | October 2, 2012 | Chalekian et al. |
8277502 | October 2, 2012 | Miller et al. |
8287584 | October 16, 2012 | Salahieh et al. |
8287591 | October 16, 2012 | Keidar et al. |
8298280 | October 30, 2012 | Yadin et al. |
8303608 | November 6, 2012 | Goldfarb et al. |
8303653 | November 6, 2012 | Bonhoeffer et al. |
8308798 | November 13, 2012 | Pintor et al. |
8317853 | November 27, 2012 | Agnew |
8317855 | November 27, 2012 | Gregorich et al. |
8323335 | December 4, 2012 | Rowe et al. |
8328868 | December 11, 2012 | Paul et al. |
8333777 | December 18, 2012 | Schaller et al. |
8337541 | December 25, 2012 | Quadri et al. |
8343173 | January 1, 2013 | Starksen et al. |
8343174 | January 1, 2013 | Goldfarb et al. |
8343213 | January 1, 2013 | Salahieh et al. |
8348999 | January 8, 2013 | Kheradvar et al. |
8349002 | January 8, 2013 | Milo |
8353956 | January 15, 2013 | Miller et al. |
8357195 | January 22, 2013 | Kuehn |
8361144 | January 29, 2013 | Fish et al. |
8366767 | February 5, 2013 | Zhang |
8372140 | February 12, 2013 | Hoffman et al. |
8377119 | February 19, 2013 | Drews et al. |
8382829 | February 26, 2013 | Call et al. |
8388680 | March 5, 2013 | Starksen et al. |
8393517 | March 12, 2013 | Milo |
8398708 | March 19, 2013 | Meiri et al. |
8403981 | March 26, 2013 | Forster et al. |
8403983 | March 26, 2013 | Quadri et al. |
8408214 | April 2, 2013 | Spenser |
8414644 | April 9, 2013 | Quadri et al. |
8425593 | April 23, 2013 | Braido et al. |
8430926 | April 30, 2013 | Kirson |
8430934 | April 30, 2013 | Das |
8444689 | May 21, 2013 | Zhang |
8449599 | May 28, 2013 | Chau et al. |
8449625 | May 28, 2013 | Campbell et al. |
8454686 | June 4, 2013 | Alkhatib |
8460365 | June 11, 2013 | Haverkost et al. |
8460370 | June 11, 2013 | Zakay et al. |
8460371 | June 11, 2013 | Hlavka et al. |
8474460 | July 2, 2013 | Barrett et al. |
8475491 | July 2, 2013 | Milo |
8480732 | July 9, 2013 | Subramanian |
8500800 | August 6, 2013 | Maisano et al. |
8500821 | August 6, 2013 | Sobrino-Serrano et al. |
8512400 | August 20, 2013 | Tran et al. |
8518107 | August 27, 2013 | Tsukashima et al. |
8523881 | September 3, 2013 | Cabiri et al. |
8523940 | September 3, 2013 | Richardson et al. |
8529431 | September 10, 2013 | Baker et al. |
8539662 | September 24, 2013 | Stacchino et al. |
8540767 | September 24, 2013 | Zhang |
8545544 | October 1, 2013 | Spenser et al. |
8545553 | October 1, 2013 | Zipory et al. |
8551160 | October 8, 2013 | Figulla et al. |
8551161 | October 8, 2013 | Dolan |
8562672 | October 22, 2013 | Bonhoeffer et al. |
8568475 | October 29, 2013 | Nguyen et al. |
8579964 | November 12, 2013 | Lane et al. |
8579965 | November 12, 2013 | Bonhoeffer et al. |
8585755 | November 19, 2013 | Chau et al. |
8585756 | November 19, 2013 | Bonhoeffer et al. |
8591460 | November 26, 2013 | Wilson et al. |
8591570 | November 26, 2013 | Revuelta et al. |
8591576 | November 26, 2013 | Hasenkam et al. |
8608797 | December 17, 2013 | Gross et al. |
8623075 | January 7, 2014 | Murray et al. |
8623080 | January 7, 2014 | Fogarty et al. |
8628569 | January 14, 2014 | Benichou et al. |
8628570 | January 14, 2014 | Seguin |
8628571 | January 14, 2014 | Hacohen et al. |
8641727 | February 4, 2014 | Starksen et al. |
8652202 | February 18, 2014 | Alon et al. |
8652203 | February 18, 2014 | Quadri et al. |
8652204 | February 18, 2014 | Quill et al. |
8657872 | February 25, 2014 | Seguin |
8663322 | March 4, 2014 | Keranen |
8673020 | March 18, 2014 | Sobrino-Serrano et al. |
8679174 | March 25, 2014 | Ottma et al. |
8685086 | April 1, 2014 | Navia et al. |
8690939 | April 8, 2014 | Miller et al. |
8696742 | April 15, 2014 | Pintor et al. |
8715342 | May 6, 2014 | Zipory et al. |
8728097 | May 20, 2014 | Sugimoto et al. |
8728155 | May 20, 2014 | Montorfano et al. |
8734467 | May 27, 2014 | Miller et al. |
8734507 | May 27, 2014 | Keranen |
8740920 | June 3, 2014 | Goldfarb et al. |
8747460 | June 10, 2014 | Tuval et al. |
8771345 | July 8, 2014 | Tuval et al. |
8778021 | July 15, 2014 | Cartledge |
8784472 | July 22, 2014 | Eidenschink |
8784479 | July 22, 2014 | Antonsson et al. |
8784481 | July 22, 2014 | Alkhatib et al. |
8790367 | July 29, 2014 | Nguyen et al. |
8790394 | July 29, 2014 | Miller et al. |
8795298 | August 5, 2014 | Hernlund et al. |
8795355 | August 5, 2014 | Alkhatib |
8795356 | August 5, 2014 | Quadri et al. |
8795357 | August 5, 2014 | Yohanan et al. |
8801776 | August 12, 2014 | House et al. |
8808366 | August 19, 2014 | Braido et al. |
8808368 | August 19, 2014 | Maisano et al. |
8808371 | August 19, 2014 | Cartledge |
8840663 | September 23, 2014 | Salahieh et al. |
8840664 | September 23, 2014 | Karapetian et al. |
8845717 | September 30, 2014 | Khairkhahan et al. |
8845722 | September 30, 2014 | Gabbay |
8845723 | September 30, 2014 | Spence et al. |
8852261 | October 7, 2014 | White |
8852272 | October 7, 2014 | Gross et al. |
8858623 | October 14, 2014 | Miller et al. |
8864822 | October 21, 2014 | Spence et al. |
8870948 | October 28, 2014 | Erzberger et al. |
8870949 | October 28, 2014 | Rowe |
8870950 | October 28, 2014 | Hacohen |
8876800 | November 4, 2014 | Behan |
8888843 | November 18, 2014 | Khairkhahan et al. |
8894702 | November 25, 2014 | Quadri et al. |
8900294 | December 2, 2014 | Paniagua et al. |
8900295 | December 2, 2014 | Migliazza et al. |
8906083 | December 9, 2014 | Obermiller et al. |
8911455 | December 16, 2014 | Quadri et al. |
8911461 | December 16, 2014 | Traynor et al. |
8911489 | December 16, 2014 | Ben-Muvhar |
8911493 | December 16, 2014 | Rowe et al. |
8911494 | December 16, 2014 | Hammer et al. |
8926695 | January 6, 2015 | Gross et al. |
8926696 | January 6, 2015 | Cabiri et al. |
8926697 | January 6, 2015 | Gross et al. |
8932343 | January 13, 2015 | Alkhatib et al. |
8932348 | January 13, 2015 | Solem et al. |
8940042 | January 27, 2015 | Miller et al. |
8940044 | January 27, 2015 | Hammer et al. |
8945177 | February 3, 2015 | Dell et al. |
8945211 | February 3, 2015 | Sugimoto |
8951285 | February 10, 2015 | Sugimoto et al. |
8951286 | February 10, 2015 | Sugimoto et al. |
8961595 | February 24, 2015 | Alkhatib |
8979922 | March 17, 2015 | Jayasinghe et al. |
8986370 | March 24, 2015 | Annest |
8986373 | March 24, 2015 | Chau et al. |
8986375 | March 24, 2015 | Garde et al. |
8992599 | March 31, 2015 | Thubrikar et al. |
8992604 | March 31, 2015 | Gross et al. |
8992608 | March 31, 2015 | Haug et al. |
8998982 | April 7, 2015 | Richter et al. |
9005273 | April 14, 2015 | Salahieh et al. |
9011468 | April 21, 2015 | Ketai et al. |
9011520 | April 21, 2015 | Miller et al. |
9011527 | April 21, 2015 | Li et al. |
9011530 | April 21, 2015 | Reich et al. |
9017399 | April 28, 2015 | Gross et al. |
D730520 | May 26, 2015 | Braido et al. |
D730521 | May 26, 2015 | Braido et al. |
9023100 | May 5, 2015 | Quadri et al. |
9034032 | May 19, 2015 | McLean et al. |
9034033 | May 19, 2015 | McLean et al. |
9039757 | May 26, 2015 | McLean et al. |
D732666 | June 23, 2015 | Nguyen et al. |
9050188 | June 9, 2015 | Schweich et al. |
9060858 | June 23, 2015 | Thornton et al. |
9072603 | July 7, 2015 | Tuval et al. |
9084676 | July 21, 2015 | Chau et al. |
9095434 | August 4, 2015 | Rowe |
9119719 | September 1, 2015 | Zipory et al. |
9125632 | September 8, 2015 | Loulmet et al. |
9125738 | September 8, 2015 | Figulla et al. |
9125740 | September 8, 2015 | Morriss et al. |
9132006 | September 15, 2015 | Spenser et al. |
9132009 | September 15, 2015 | Hacohen et al. |
9138312 | September 22, 2015 | Tuval et al. |
9155619 | October 13, 2015 | Liu et al. |
9173646 | November 3, 2015 | Fabro |
9173659 | November 3, 2015 | Bodewadt et al. |
9173738 | November 3, 2015 | Murray et al. |
9180005 | November 10, 2015 | Lashinski et al. |
9192472 | November 24, 2015 | Gross et al. |
9220594 | December 29, 2015 | Braido et al. |
9226820 | January 5, 2016 | Braido et al. |
9226825 | January 5, 2016 | Starksen et al. |
9226839 | January 5, 2016 | Kariniemi et al. |
9232995 | January 12, 2016 | Kovalsky et al. |
9241790 | January 26, 2016 | Lane et al. |
9241791 | January 26, 2016 | Braido et al. |
9241792 | January 26, 2016 | Benichou et al. |
9241794 | January 26, 2016 | Braido et al. |
9248014 | February 2, 2016 | Lane et al. |
9265608 | February 23, 2016 | Miller et al. |
9277994 | March 8, 2016 | Miller et al. |
9289290 | March 22, 2016 | Alkhatib et al. |
9289291 | March 22, 2016 | Gorman et al. |
9295550 | March 29, 2016 | Nguyen et al. |
9295551 | March 29, 2016 | Straubinger et al. |
9295552 | March 29, 2016 | McLean et al. |
9301836 | April 5, 2016 | Buchbinder et al. |
9308087 | April 12, 2016 | Lane et al. |
9320591 | April 26, 2016 | Bolduc |
D755384 | May 3, 2016 | Pesce et al. |
9326852 | May 3, 2016 | Spenser |
9326876 | May 3, 2016 | Acosta et al. |
9345573 | May 24, 2016 | Nyuli et al. |
9351830 | May 31, 2016 | Gross et al. |
9387078 | July 12, 2016 | Gross et al. |
9393110 | July 19, 2016 | Levi et al. |
9421098 | August 23, 2016 | Gifford et al. |
9427303 | August 30, 2016 | Liddy et al. |
9427316 | August 30, 2016 | Schweich, Jr. et al. |
9439757 | September 13, 2016 | Wallace et al. |
9463102 | October 11, 2016 | Kelly |
9474599 | October 25, 2016 | Keränen |
9474638 | October 25, 2016 | Robinson et al. |
9480559 | November 1, 2016 | Vidlund et al. |
9492273 | November 15, 2016 | Wallace et al. |
9498314 | November 22, 2016 | Behan |
9498332 | November 22, 2016 | Hacohen et al. |
9510947 | December 6, 2016 | Straubinger et al. |
9532870 | January 3, 2017 | Cooper et al. |
9554897 | January 31, 2017 | Lane et al. |
9554899 | January 31, 2017 | Granada et al. |
9561103 | February 7, 2017 | Granada et al. |
9566152 | February 14, 2017 | Schweich et al. |
9597182 | March 21, 2017 | Straubinger et al. |
9629716 | April 25, 2017 | Seguin |
9662203 | May 30, 2017 | Sheahan et al. |
9681952 | June 20, 2017 | Hacohen et al. |
9717591 | August 1, 2017 | Chau et al. |
9743932 | August 29, 2017 | Amplatz et al. |
9763657 | September 19, 2017 | Hacohen et al. |
9763817 | September 19, 2017 | Roeder |
9770256 | September 26, 2017 | Cohen et al. |
D800908 | October 24, 2017 | Hariton et al. |
9788941 | October 17, 2017 | Hacohen |
9895226 | February 20, 2018 | Harari et al. |
9974651 | May 22, 2018 | Hariton et al. |
9987132 | June 5, 2018 | Hariton et al. |
9993360 | June 12, 2018 | Shalev et al. |
10010414 | July 3, 2018 | Cooper et al. |
10045845 | August 14, 2018 | Hacohen et al. |
10076415 | September 18, 2018 | Metchik et al. |
10098732 | October 16, 2018 | Hariton et al. |
10105222 | October 23, 2018 | Metchik et al. |
10111751 | October 30, 2018 | Metchik et al. |
10123873 | November 13, 2018 | Metchik et al. |
10130475 | November 20, 2018 | Metchik et al. |
10136993 | November 27, 2018 | Metchik et al. |
10143552 | December 4, 2018 | Wallace et al. |
10149761 | December 11, 2018 | Granada et al. |
10154903 | December 18, 2018 | Albitov et al. |
10154906 | December 18, 2018 | Granada et al. |
10159570 | December 25, 2018 | Metchik et al. |
10182908 | January 22, 2019 | Tubishevitz et al. |
10206668 | February 19, 2019 | Mcgoldrick et al. |
10226341 | March 12, 2019 | Gross et al. |
10231831 | March 19, 2019 | Hacohen |
10231837 | March 19, 2019 | Metchik et al. |
10238493 | March 26, 2019 | Metchik et al. |
10245143 | April 2, 2019 | Gross et al. |
10245144 | April 2, 2019 | Metchik et al. |
10258471 | April 16, 2019 | Lutter et al. |
10292816 | May 21, 2019 | Raanani et al. |
10299927 | May 28, 2019 | McLean et al. |
10321995 | June 18, 2019 | Christianson et al. |
10322020 | June 18, 2019 | Lam et al. |
10327895 | June 25, 2019 | Lozonschi et al. |
10335278 | July 2, 2019 | McLean et al. |
10376361 | August 13, 2019 | Gross et al. |
10390952 | August 27, 2019 | Hariton et al. |
10426614 | October 1, 2019 | Hariton et al. |
10449047 | October 22, 2019 | Hariton et al. |
10456256 | October 29, 2019 | Braido et al. |
10492908 | December 3, 2019 | Hammer et al. |
10507108 | December 17, 2019 | Delgado et al. |
10507109 | December 17, 2019 | Metchik et al. |
10512456 | December 24, 2019 | Hacohen et al. |
10517719 | December 31, 2019 | Miller et al. |
10524792 | January 7, 2020 | Hernandez et al. |
10524910 | January 7, 2020 | Hammer et al. |
10531866 | January 14, 2020 | Hariton et al. |
10531872 | January 14, 2020 | Hacohen et al. |
10537426 | January 21, 2020 | Iamberger et al. |
10548726 | February 4, 2020 | Hacohen et al. |
10548731 | February 4, 2020 | Lashinski et al. |
10575948 | March 3, 2020 | Iamberger et al. |
10595992 | March 24, 2020 | Chambers |
10595997 | March 24, 2020 | Metchik et al. |
10610358 | April 7, 2020 | Vidlund et al. |
10610359 | April 7, 2020 | Hacohen |
10631871 | April 28, 2020 | Goldfarb et al. |
10631982 | April 28, 2020 | Hammer et al. |
10646342 | May 12, 2020 | Marr et al. |
10660751 | May 26, 2020 | Hacohen |
10667908 | June 2, 2020 | Hariton et al. |
10667912 | June 2, 2020 | Dixon et al. |
10682227 | June 16, 2020 | Hariton et al. |
10695177 | June 30, 2020 | Hariton et al. |
10702385 | July 7, 2020 | Hacohen et al. |
10736742 | August 11, 2020 | Hariton et al. |
10758342 | September 1, 2020 | Chau et al. |
10779939 | September 22, 2020 | Hariton et al. |
10813760 | October 27, 2020 | Metchik et al. |
10820998 | November 3, 2020 | Marr et al. |
10842627 | November 24, 2020 | Delgado et al. |
10856972 | December 8, 2020 | Hariton et al. |
10856975 | December 8, 2020 | Hariton et al. |
10856978 | December 8, 2020 | Straubinger et al. |
10874514 | December 29, 2020 | Dixon et al. |
10888422 | January 12, 2021 | Hariton et al. |
10888425 | January 12, 2021 | Delgado et al. |
10888644 | January 12, 2021 | Ratz et al. |
10905552 | February 2, 2021 | Dixon et al. |
10905554 | February 2, 2021 | Cao |
10918481 | February 16, 2021 | Hariton et al. |
10918483 | February 16, 2021 | Metchik et al. |
10925732 | February 23, 2021 | Delgado et al. |
10945843 | March 16, 2021 | Delgado et al. |
10945844 | March 16, 2021 | McCann et al. |
10952850 | March 23, 2021 | Hariton et al. |
10959846 | March 30, 2021 | Marr et al. |
10993809 | May 4, 2021 | McCann et al. |
11065114 | July 20, 2021 | Raanani et al. |
11083582 | August 10, 2021 | McCann et al. |
11147672 | October 19, 2021 | McCann et al. |
11179240 | November 23, 2021 | Delgado et al. |
11291545 | April 5, 2022 | Hacohen |
11291546 | April 5, 2022 | Gross et al. |
11291547 | April 5, 2022 | Gross et al. |
11304806 | April 19, 2022 | Hariton et al. |
11389297 | July 19, 2022 | Franklin et al. |
20010002445 | May 31, 2001 | Vesely |
20010005787 | June 28, 2001 | Oz et al. |
20010021872 | September 13, 2001 | Bailey et al. |
20010021874 | September 13, 2001 | Carpentier et al. |
20010044656 | November 22, 2001 | Williamson et al. |
20010056295 | December 27, 2001 | Solem |
20020013571 | January 31, 2002 | Goldfarb et al. |
20020022862 | February 21, 2002 | Grafton et al. |
20020029080 | March 7, 2002 | Mortier et al. |
20020032481 | March 14, 2002 | Gabbay |
20020042621 | April 11, 2002 | Liddicoat et al. |
20020082525 | June 27, 2002 | Oslund et al. |
20020087048 | July 4, 2002 | Brock et al. |
20020099436 | July 25, 2002 | Thornton et al. |
20020103532 | August 1, 2002 | Langberg et al. |
20020151916 | October 17, 2002 | Muramatsu et al. |
20020151961 | October 17, 2002 | Lashinski et al. |
20020151970 | October 17, 2002 | Garrison et al. |
20020169358 | November 14, 2002 | Mortier et al. |
20020173841 | November 21, 2002 | Ortiz et al. |
20020177894 | November 28, 2002 | Acosta et al. |
20020177904 | November 28, 2002 | Huxel et al. |
20020198586 | December 26, 2002 | Inoue |
20030009236 | January 9, 2003 | Godin |
20030018358 | January 23, 2003 | Saadat |
20030036791 | February 20, 2003 | Philipp et al. |
20030050693 | March 13, 2003 | Quijano et al. |
20030050694 | March 13, 2003 | Yang et al. |
20030060846 | March 27, 2003 | Egnelov et al. |
20030060875 | March 27, 2003 | Wittens |
20030069635 | April 10, 2003 | Cartledge |
20030074052 | April 17, 2003 | Besselink |
20030078465 | April 24, 2003 | Pai et al. |
20030078653 | April 24, 2003 | Vesely et al. |
20030083742 | May 1, 2003 | Spence et al. |
20030100943 | May 29, 2003 | Bolduc |
20030105519 | June 5, 2003 | Fasol et al. |
20030114901 | June 19, 2003 | Loeb et al. |
20030130731 | July 10, 2003 | Vidlund et al. |
20030158578 | August 21, 2003 | Pantages et al. |
20030167062 | September 4, 2003 | Gambale et al. |
20030171760 | September 11, 2003 | Gambale |
20030191528 | October 9, 2003 | Quijano et al. |
20030199974 | October 23, 2003 | Lee et al. |
20030204195 | October 30, 2003 | Keane et al. |
20030229350 | December 11, 2003 | Kay |
20030229395 | December 11, 2003 | Cox |
20030233142 | December 18, 2003 | Morales et al. |
20040010272 | January 15, 2004 | Manetakis et al. |
20040019377 | January 29, 2004 | Taylor et al. |
20040024451 | February 5, 2004 | Johnson et al. |
20040030382 | February 12, 2004 | St. Goar et al. |
20040039414 | February 26, 2004 | Carley et al. |
20040039436 | February 26, 2004 | Spenser et al. |
20040039442 | February 26, 2004 | St. Goar et al. |
20040049207 | March 11, 2004 | Goldfarb et al. |
20040059413 | March 25, 2004 | Argento |
20040092962 | May 13, 2004 | Thornton et al. |
20040093060 | May 13, 2004 | Seguin et al. |
20040122448 | June 24, 2004 | Levine |
20040122503 | June 24, 2004 | Campbell et al. |
20040122514 | June 24, 2004 | Fogarty et al. |
20040127982 | July 1, 2004 | Machold et al. |
20040127983 | July 1, 2004 | Mortier et al. |
20040133220 | July 8, 2004 | Lashinski et al. |
20040133267 | July 8, 2004 | Lane |
20040133274 | July 8, 2004 | Webler et al. |
20040133374 | July 8, 2004 | Kattan |
20040138744 | July 15, 2004 | Lashinski et al. |
20040138745 | July 15, 2004 | Macoviak et al. |
20040143315 | July 22, 2004 | Bruun et al. |
20040148019 | July 29, 2004 | Vidlund et al. |
20040148020 | July 29, 2004 | Vidlund et al. |
20040148021 | July 29, 2004 | Cartledge et al. |
20040153146 | August 5, 2004 | Lashinski et al. |
20040172046 | September 2, 2004 | Hlavka et al. |
20040176788 | September 9, 2004 | Opolski |
20040176839 | September 9, 2004 | Huynh et al. |
20040181287 | September 16, 2004 | Gellman |
20040186558 | September 23, 2004 | Pavenik et al. |
20040186565 | September 23, 2004 | Schreck |
20040186566 | September 23, 2004 | Hindrichs et al. |
20040210244 | October 21, 2004 | Vargas et al. |
20040210304 | October 21, 2004 | Seguin et al. |
20040220593 | November 4, 2004 | Greenhalgh |
20040225354 | November 11, 2004 | Allen et al. |
20040236354 | November 25, 2004 | Seguin |
20040236419 | November 25, 2004 | Milo |
20040249433 | December 9, 2004 | Freitag |
20040249453 | December 9, 2004 | Cartledge et al. |
20040260317 | December 23, 2004 | Bloom et al. |
20040260389 | December 23, 2004 | Case et al. |
20040260393 | December 23, 2004 | Rahdert et al. |
20040260394 | December 23, 2004 | Douk et al. |
20040267358 | December 30, 2004 | Reitan |
20050004668 | January 6, 2005 | Aklog et al. |
20050010287 | January 13, 2005 | Macoviak et al. |
20050010787 | January 13, 2005 | Tarbouriech |
20050016560 | January 27, 2005 | Voughlohn |
20050021056 | January 27, 2005 | St. Goar et al. |
20050027305 | February 3, 2005 | Shiu et al. |
20050027348 | February 3, 2005 | Case et al. |
20050038494 | February 17, 2005 | Eidenschink |
20050055038 | March 10, 2005 | Kelleher et al. |
20050055086 | March 10, 2005 | Stobie |
20050055087 | March 10, 2005 | Starksen |
20050060030 | March 17, 2005 | Lashinski et al. |
20050065601 | March 24, 2005 | Lee et al. |
20050070999 | March 31, 2005 | Spence |
20050075726 | April 7, 2005 | Svanidze et al. |
20050075727 | April 7, 2005 | Wheatley |
20050075731 | April 7, 2005 | Artof et al. |
20050080430 | April 14, 2005 | Wright et al. |
20050080474 | April 14, 2005 | Andreas et al. |
20050085900 | April 21, 2005 | Case et al. |
20050085903 | April 21, 2005 | Lau |
20050090827 | April 28, 2005 | Gedebou |
20050096740 | May 5, 2005 | Langberg et al. |
20050107871 | May 19, 2005 | Realyvasquez et al. |
20050119734 | June 2, 2005 | Spence et al. |
20050125002 | June 9, 2005 | Baran et al. |
20050125011 | June 9, 2005 | Spence et al. |
20050131533 | June 16, 2005 | Alfieri et al. |
20050137686 | June 23, 2005 | Salahieh et al. |
20050137688 | June 23, 2005 | Salahieh et al. |
20050137689 | June 23, 2005 | Salahieh et al. |
20050137690 | June 23, 2005 | Salahieh et al. |
20050137691 | June 23, 2005 | Salahieh et al. |
20050137692 | June 23, 2005 | Haug et al. |
20050137693 | June 23, 2005 | Haug et al. |
20050137695 | June 23, 2005 | Salahieh et al. |
20050137697 | June 23, 2005 | Salahieh et al. |
20050137699 | June 23, 2005 | Salahieh et al. |
20050143809 | June 30, 2005 | Salahieh et al. |
20050149160 | July 7, 2005 | McFerran |
20050154443 | July 14, 2005 | Linder et al. |
20050159728 | July 21, 2005 | Armour et al. |
20050171601 | August 4, 2005 | Cosgrove et al. |
20050177180 | August 11, 2005 | Kaganov et al. |
20050177228 | August 11, 2005 | Solem et al. |
20050182483 | August 18, 2005 | Osborne et al. |
20050182486 | August 18, 2005 | Gabbay |
20050187613 | August 25, 2005 | Bolduc et al. |
20050192596 | September 1, 2005 | Jugenheimer et al. |
20050197695 | September 8, 2005 | Stacchino et al. |
20050197696 | September 8, 2005 | Gomez Duran |
20050203549 | September 15, 2005 | Realyvasquez |
20050203606 | September 15, 2005 | VanCamp |
20050203618 | September 15, 2005 | Sharkawy et al. |
20050216039 | September 29, 2005 | Lederman |
20050216079 | September 29, 2005 | MaCoviak |
20050222665 | October 6, 2005 | Aranyi |
20050222678 | October 6, 2005 | Lashinski et al. |
20050234508 | October 20, 2005 | Cummins et al. |
20050240200 | October 27, 2005 | Bergheim |
20050251251 | November 10, 2005 | Cribier |
20050256532 | November 17, 2005 | Nayak et al. |
20050256566 | November 17, 2005 | Gabbay |
20050267478 | December 1, 2005 | Corradi et al. |
20050267573 | December 1, 2005 | Macoviak et al. |
20050273138 | December 8, 2005 | To et al. |
20050288776 | December 29, 2005 | Shaoulian et al. |
20050288778 | December 29, 2005 | Shaoulian et al. |
20050288781 | December 29, 2005 | Moaddeb et al. |
20060004439 | January 5, 2006 | Spenser et al. |
20060004442 | January 5, 2006 | Spenser et al. |
20060004443 | January 5, 2006 | Liddicoat et al. |
20060004469 | January 5, 2006 | Sokel |
20060015171 | January 19, 2006 | Armstrong |
20060020275 | January 26, 2006 | Goldfarb et al. |
20060020326 | January 26, 2006 | Bolduc et al. |
20060020327 | January 26, 2006 | Lashinski et al. |
20060020333 | January 26, 2006 | Lashinski et al. |
20060020336 | January 26, 2006 | Liddicoat |
20060025787 | February 2, 2006 | Morales et al. |
20060025855 | February 2, 2006 | Lashinski et al. |
20060025858 | February 2, 2006 | Alameddine |
20060030885 | February 9, 2006 | Hyde |
20060041189 | February 23, 2006 | Vancaillie |
20060041319 | February 23, 2006 | Taylor et al. |
20060052867 | March 9, 2006 | Revuelta et al. |
20060052868 | March 9, 2006 | Mortier |
20060058871 | March 16, 2006 | Zakay et al. |
20060069429 | March 30, 2006 | Spence et al. |
20060074486 | April 6, 2006 | Liddicoat et al. |
20060085012 | April 20, 2006 | Dolan |
20060089627 | April 27, 2006 | Burnett et al. |
20060095009 | May 4, 2006 | Lampropoulos et al. |
20060106423 | May 18, 2006 | Weisel et al. |
20060111773 | May 25, 2006 | Rittgers et al. |
20060116750 | June 1, 2006 | Herbert et al. |
20060116757 | June 1, 2006 | Lashinski et al. |
20060122692 | June 8, 2006 | Gilad et al. |
20060129166 | June 15, 2006 | Lavelle |
20060135964 | June 22, 2006 | Vesley |
20060149280 | July 6, 2006 | Harvine et al. |
20060149368 | July 6, 2006 | Spence |
20060155357 | July 13, 2006 | Melsheimer |
20060161250 | July 20, 2006 | Shaw |
20060161265 | July 20, 2006 | Levine et al. |
20060047297 | March 2, 2006 | Case |
20060178700 | August 10, 2006 | Quinn |
20060178740 | August 10, 2006 | Stacchino et al. |
20060184203 | August 17, 2006 | Martin et al. |
20060184240 | August 17, 2006 | Jimenez et al. |
20060184242 | August 17, 2006 | Lichtenstein |
20060190036 | August 24, 2006 | Wendel et al. |
20060190038 | August 24, 2006 | Carley et al. |
20060195134 | August 31, 2006 | Crittenden |
20060195183 | August 31, 2006 | Navia et al. |
20060195184 | August 31, 2006 | Lane et al. |
20060201519 | September 14, 2006 | Frazier et al. |
20060212111 | September 21, 2006 | Case et al. |
20060216404 | September 28, 2006 | Seyler et al. |
20060229708 | October 12, 2006 | Powell et al. |
20060241622 | October 26, 2006 | Zergiebel |
20060241656 | October 26, 2006 | Starksen et al. |
20060241745 | October 26, 2006 | Solem |
20060241748 | October 26, 2006 | Lee et al. |
20060247680 | November 2, 2006 | Amplatz et al. |
20060247763 | November 2, 2006 | Slater |
20060253191 | November 9, 2006 | Salahieh et al. |
20060259135 | November 16, 2006 | Navia et al. |
20060259136 | November 16, 2006 | Nguyen et al. |
20060259137 | November 16, 2006 | Artof et al. |
20060271166 | November 30, 2006 | Thill et al. |
20060271171 | November 30, 2006 | McQuinn et al. |
20060271175 | November 30, 2006 | Woolfson |
20060282150 | December 14, 2006 | Olson et al. |
20060282161 | December 14, 2006 | Huyn et al. |
20060287661 | December 21, 2006 | Bolduc et al. |
20060287716 | December 21, 2006 | Banbury et al. |
20060287719 | December 21, 2006 | Rowe et al. |
20070001627 | January 4, 2007 | Lin et al. |
20070008018 | January 11, 2007 | Nagashima et al. |
20070016286 | January 18, 2007 | Herrmann et al. |
20070016287 | January 18, 2007 | Cartledge et al. |
20070016288 | January 18, 2007 | Gurskis et al. |
20070021781 | January 25, 2007 | Jervis et al. |
20070027528 | February 1, 2007 | Agnew |
20070027533 | February 1, 2007 | Douk |
20070027536 | February 1, 2007 | Mihaljevic et al. |
20070027549 | February 1, 2007 | Godin |
20070038221 | February 15, 2007 | Fine et al. |
20070038293 | February 15, 2007 | St. Goar et al. |
20070038295 | February 15, 2007 | Case et al. |
20070043435 | February 22, 2007 | Seguin et al. |
20070049942 | March 1, 2007 | Hindrichs et al. |
20070049970 | March 1, 2007 | Belef et al. |
20070051377 | March 8, 2007 | Douk et al. |
20070055206 | March 8, 2007 | To et al. |
20070055340 | March 8, 2007 | Pryor |
20070056346 | March 15, 2007 | Spenser et al. |
20070061010 | March 15, 2007 | Hauser et al. |
20070066863 | March 22, 2007 | Rafiee et al. |
20070078297 | April 5, 2007 | Rafiee et al. |
20070078510 | April 5, 2007 | Ryan |
20070080188 | April 12, 2007 | Spence et al. |
20070083168 | April 12, 2007 | Whiting et al. |
20070106328 | May 10, 2007 | Wardle et al. |
20070112359 | May 17, 2007 | Kimura et al. |
20070112422 | May 17, 2007 | Dehdashtian |
20070112425 | May 17, 2007 | Schaller et al. |
20070118151 | May 24, 2007 | Davidson |
20070118154 | May 24, 2007 | Crabtree |
20070118213 | May 24, 2007 | Loulmet |
20070118215 | May 24, 2007 | Moaddeb |
20070142907 | June 21, 2007 | Moaddeb et al. |
20070162103 | July 12, 2007 | Case et al. |
20070162107 | July 12, 2007 | Haug et al. |
20070162111 | July 12, 2007 | Fukamachi et al. |
20070173932 | July 26, 2007 | Cali et al. |
20070197858 | August 23, 2007 | Goldfarb et al. |
20070198077 | August 23, 2007 | Cully et al. |
20070198082 | August 23, 2007 | Kapadia et al. |
20070198097 | August 23, 2007 | Zegdi |
20070208550 | September 6, 2007 | Cao et al. |
20070213582 | September 13, 2007 | Zollinger et al. |
20070213810 | September 13, 2007 | Newhauser et al. |
20070213813 | September 13, 2007 | Von Segesser et al. |
20070219558 | September 20, 2007 | Deutsch |
20070219630 | September 20, 2007 | Chu |
20070225759 | September 27, 2007 | Thommen et al. |
20070225760 | September 27, 2007 | Moszner et al. |
20070233186 | October 4, 2007 | Meng |
20070233237 | October 4, 2007 | Krivoruchko |
20070233239 | October 4, 2007 | Navia et al. |
20070239208 | October 11, 2007 | Crawford |
20070239272 | October 11, 2007 | Navia et al. |
20070239273 | October 11, 2007 | Allen |
20070244546 | October 18, 2007 | Francis |
20070244555 | October 18, 2007 | Rafiee et al. |
20070244556 | October 18, 2007 | Rafiee et al. |
20070244557 | October 18, 2007 | Rafiee et al. |
20070250160 | October 25, 2007 | Rafiee |
20070255397 | November 1, 2007 | Ryan et al. |
20070255400 | November 1, 2007 | Parravicini et al. |
20070270755 | November 22, 2007 | Von Oepen et al. |
20070270943 | November 22, 2007 | Solem et al. |
20070276437 | November 29, 2007 | Call et al. |
20070282375 | December 6, 2007 | Hindrichs et al. |
20070282429 | December 6, 2007 | Hauser et al. |
20070295172 | December 27, 2007 | Swartz |
20070299424 | December 27, 2007 | Cumming et al. |
20080004688 | January 3, 2008 | Spenser et al. |
20080004697 | January 3, 2008 | Lichtenstein et al. |
20080027483 | January 31, 2008 | Cartledge et al. |
20080027555 | January 31, 2008 | Hawkins |
20080035160 | February 14, 2008 | Woodson et al. |
20080039935 | February 14, 2008 | Buch |
20080051703 | February 28, 2008 | Thornton et al. |
20080058595 | March 6, 2008 | Snoke et al. |
20080065011 | March 13, 2008 | Marchand et al. |
20080065204 | March 13, 2008 | Mackoviak et al. |
20080071361 | March 20, 2008 | Tuval et al. |
20080071363 | March 20, 2008 | Tuval et al. |
20080071366 | March 20, 2008 | Tuval et al. |
20080071369 | March 20, 2008 | Tuval et al. |
20080077235 | March 27, 2008 | Kirson |
20080082083 | April 3, 2008 | Forde et al. |
20080082159 | April 3, 2008 | Tseng et al. |
20080082166 | April 3, 2008 | Styrc et al. |
20080086138 | April 10, 2008 | Stone et al. |
20080086164 | April 10, 2008 | Rowe et al. |
20080086203 | April 10, 2008 | Roberts |
20080086204 | April 10, 2008 | Rankin |
20080091257 | April 17, 2008 | Andreas et al. |
20080091261 | April 17, 2008 | Long et al. |
20080097523 | April 24, 2008 | Bolduc et al. |
20080097595 | April 24, 2008 | Gabbay |
20080132989 | June 5, 2008 | Snow et al. |
20080140003 | June 12, 2008 | Bei et al. |
20080140116 | June 12, 2008 | Bonutti |
20080147182 | June 19, 2008 | Righini et al. |
20080161910 | July 3, 2008 | Revuelta et al. |
20080167705 | July 10, 2008 | Agnew |
20080167714 | July 10, 2008 | St. Goar et al. |
20080188929 | August 7, 2008 | Schreck |
20080195126 | August 14, 2008 | Solem |
20080195200 | August 14, 2008 | Vidlund et al. |
20080200980 | August 21, 2008 | Robin et al. |
20080208265 | August 28, 2008 | Frazier et al. |
20080208328 | August 28, 2008 | Antocci et al. |
20080208330 | August 28, 2008 | Keranen |
20080208332 | August 28, 2008 | Lamphere et al. |
20080221672 | September 11, 2008 | Lamphere et al. |
20080234814 | September 25, 2008 | Salahieh et al. |
20080243245 | October 2, 2008 | Thambar et al. |
20080255580 | October 16, 2008 | Hoffman et al. |
20080262609 | October 23, 2008 | Gross et al. |
20080269879 | October 30, 2008 | Sathe et al. |
20080275300 | November 6, 2008 | Rothe et al. |
20080275469 | November 6, 2008 | Fanton et al. |
20080275551 | November 6, 2008 | Alfieri |
20080281411 | November 13, 2008 | Berreklouw |
20080288044 | November 20, 2008 | Osborne |
20080288062 | November 20, 2008 | Andrieu et al. |
20080294234 | November 27, 2008 | Hartley et al. |
20080300629 | December 4, 2008 | Surti |
20090005863 | January 1, 2009 | Goetz et al. |
20090036966 | February 5, 2009 | O'Connor et al. |
20090043153 | February 12, 2009 | Zollinger et al. |
20090043381 | February 12, 2009 | Macoviak et al. |
20090054969 | February 26, 2009 | Salahieh et al. |
20090062866 | March 5, 2009 | Jackson |
20090076586 | March 19, 2009 | Hauser et al. |
20090076600 | March 19, 2009 | Quinn |
20090082844 | March 26, 2009 | Zacharias et al. |
20090088836 | April 2, 2009 | Bishop et al. |
20090088837 | April 2, 2009 | Gillinov et al. |
20090099554 | April 16, 2009 | Forster et al. |
20090099650 | April 16, 2009 | Bolduc et al. |
20090105794 | April 23, 2009 | Ziarno |
20090105816 | April 23, 2009 | Olsen et al. |
20090112159 | April 30, 2009 | Slattery et al. |
20090125098 | May 14, 2009 | Chuter |
20090125102 | May 14, 2009 | Cartledge |
20090149872 | June 11, 2009 | Gross et al. |
20090157175 | June 18, 2009 | Benichou |
20090163934 | June 25, 2009 | Raschdorf, Jr. et al. |
20090177274 | July 9, 2009 | Scorsin et al. |
20090171363 | July 2, 2009 | Chocron |
20090171439 | July 2, 2009 | Niss1 |
20090177266 | July 9, 2009 | Powell et al. |
20090177277 | July 9, 2009 | Milo |
20090177278 | July 9, 2009 | Spence |
20090210052 | August 20, 2009 | Forster et al. |
20090222081 | September 3, 2009 | Linder et al. |
20090240320 | September 24, 2009 | Tuval et al. |
20090241656 | October 1, 2009 | Jacquemin |
20090248143 | October 1, 2009 | Laham |
20090248148 | October 1, 2009 | Shaolian et al. |
20090254103 | October 8, 2009 | Deustch |
20090259306 | October 15, 2009 | Rowe |
20090259307 | October 15, 2009 | Gross et al. |
20090264859 | October 22, 2009 | Mas |
20090264994 | October 22, 2009 | Saadat |
20090264995 | October 22, 2009 | Subramanian |
20090276040 | November 5, 2009 | Rowe et al. |
20090281619 | November 12, 2009 | Le et al. |
20090287299 | November 19, 2009 | Tabor et al. |
20090287304 | November 19, 2009 | Dahlgren et al. |
20090299409 | December 3, 2009 | Coe et al. |
20090299449 | December 3, 2009 | Styrc |
20090306768 | December 10, 2009 | Quardi |
20090319037 | December 24, 2009 | Rowe et al. |
20090326648 | December 31, 2009 | Machold et al. |
20100001038 | January 7, 2010 | Levin et al. |
20100010538 | January 14, 2010 | Juravic et al. |
20100022823 | January 28, 2010 | Goldfarb et al. |
20100023117 | January 28, 2010 | Yoganathan et al. |
20100023118 | January 28, 2010 | Medlock et al. |
20100023120 | January 28, 2010 | Holecek et al. |
20100030014 | February 4, 2010 | Ferrazzi |
20100036479 | February 11, 2010 | Hill et al. |
20100036484 | February 11, 2010 | Hariton et al. |
20100042147 | February 18, 2010 | Janovsky et al. |
20100049313 | February 25, 2010 | Alon et al. |
20100063542 | March 11, 2010 | Van der Burg et al. |
20100063550 | March 11, 2010 | Felix et al. |
20100063586 | March 11, 2010 | Hasenkam et al. |
20100069852 | March 18, 2010 | Kelley |
20100076499 | March 25, 2010 | McNamara et al. |
20100076548 | March 25, 2010 | Konno |
20100082094 | April 1, 2010 | Quadri et al. |
20100094248 | April 15, 2010 | Nguyen et al. |
20100100167 | April 22, 2010 | Bortlein et al. |
20100114180 | May 6, 2010 | Rock |
20100114299 | May 6, 2010 | Ben-Muvhar et al. |
20100121349 | May 13, 2010 | Meier |
20100130992 | May 27, 2010 | Machold et al. |
20100131054 | May 27, 2010 | Tuval et al. |
20100137979 | June 3, 2010 | Tuval et al. |
20100152845 | June 17, 2010 | Bloom et al. |
20100160958 | June 24, 2010 | Clark |
20100161036 | June 24, 2010 | Pintor et al. |
20100161041 | June 24, 2010 | Maisano et al. |
20100161042 | June 24, 2010 | Maisano et al. |
20100161043 | June 24, 2010 | Maisano et al. |
20100161047 | June 24, 2010 | Cabiri |
20100168845 | July 1, 2010 | Wright |
20100174358 | July 8, 2010 | Rabkin et al. |
20100174363 | July 8, 2010 | Castro |
20100179574 | July 15, 2010 | Longoria et al. |
20100179643 | July 15, 2010 | Shalev |
20100179648 | July 15, 2010 | Richter et al. |
20100179649 | July 15, 2010 | Richter et al. |
20100185277 | July 22, 2010 | Braido et al. |
20100198347 | August 5, 2010 | Zakay et al. |
20100217382 | August 26, 2010 | Chau et al. |
20100222810 | September 2, 2010 | DeBeer et al. |
20100228285 | September 9, 2010 | Miles et al. |
20100234935 | September 16, 2010 | Bashiri et al. |
20100234940 | September 16, 2010 | Dolan |
20100249908 | September 30, 2010 | Chau et al. |
20100249915 | September 30, 2010 | Zhang |
20100249917 | September 30, 2010 | Zhang |
20100249920 | September 30, 2010 | Bolling et al. |
20100256737 | October 7, 2010 | Pollock et al. |
20100262232 | October 14, 2010 | Annest |
20100262233 | October 14, 2010 | He |
20100280603 | November 4, 2010 | Maisano et al. |
20100280604 | November 4, 2010 | Zipory et al. |
20100280605 | November 4, 2010 | Hammer et al. |
20100280606 | November 4, 2010 | Naor |
20100286628 | November 11, 2010 | Gross |
20100286767 | November 11, 2010 | Zipory et al. |
20100305475 | December 2, 2010 | Hinchliffe et al. |
20100312333 | December 9, 2010 | Navia et al. |
20100324595 | December 23, 2010 | Linder et al. |
20100331971 | December 30, 2010 | Keränen et al. |
20110004210 | January 6, 2011 | Johnson et al. |
20110004227 | January 6, 2011 | Goldfarb et al. |
20110004296 | January 6, 2011 | Lutter et al. |
20110004298 | January 6, 2011 | Lee et al. |
20110004299 | January 6, 2011 | Navia et al. |
20110011917 | January 20, 2011 | Loulmet |
20110015729 | January 20, 2011 | Jimenez et al. |
20110015731 | January 20, 2011 | Carpentier et al. |
20110015739 | January 20, 2011 | Cheung et al. |
20110021985 | January 27, 2011 | Spargias |
20110022165 | January 27, 2011 | Oba et al. |
20110178597 | July 21, 2011 | Navia et al. |
20110026208 | February 3, 2011 | Otsuro et al. |
20110029066 | February 3, 2011 | Gilad et al. |
20110029067 | February 3, 2011 | Mcguckin, Jr. et al. |
20110029072 | February 3, 2011 | Gabbay |
20110035000 | February 10, 2011 | Nieminen et al. |
20110040374 | February 17, 2011 | Goetz et al. |
20110040375 | February 17, 2011 | Letac et al. |
20110046662 | February 24, 2011 | Moszner et al. |
20110054466 | March 3, 2011 | Rothstein et al. |
20110054596 | March 3, 2011 | Taylor |
20110054598 | March 3, 2011 | Johnson |
20110066231 | March 17, 2011 | Cartledge et al. |
20110066233 | March 17, 2011 | Thornton et al. |
20110067770 | March 24, 2011 | Pederson et al. |
20110071626 | March 24, 2011 | Wright et al. |
20110077730 | March 31, 2011 | Fentster |
20110082538 | April 7, 2011 | Dahlgren et al. |
20110087146 | April 14, 2011 | Ryan et al. |
20110087322 | April 14, 2011 | Letac et al. |
20110093002 | April 21, 2011 | Rucker et al. |
20110093063 | April 21, 2011 | Schreck |
20110098525 | April 28, 2011 | Kermode et al. |
20110106245 | May 5, 2011 | Miller et al. |
20110106247 | May 5, 2011 | Miller et al. |
20110112625 | May 12, 2011 | Ben-Muvhar et al. |
20110112632 | May 12, 2011 | Chau et al. |
20110113768 | May 19, 2011 | Bauer et al. |
20110118830 | May 19, 2011 | Liddicoat et al. |
20110118832 | May 19, 2011 | Punjabi |
20110125257 | May 26, 2011 | Seguin et al. |
20110125258 | May 26, 2011 | Centola |
20110137326 | June 9, 2011 | Bachman |
20110137397 | June 9, 2011 | Chau et al. |
20110137409 | June 9, 2011 | Yang et al. |
20110137410 | June 9, 2011 | Hacohen |
20110144703 | June 16, 2011 | Krause et al. |
20110144742 | June 16, 2011 | Madrid et al. |
20110166636 | July 7, 2011 | Rowe |
20110166649 | July 7, 2011 | Gross et al. |
20110172784 | July 14, 2011 | Richter |
20110184510 | July 28, 2011 | Maisano et al. |
20110190877 | August 4, 2011 | Lane et al. |
20110190879 | August 4, 2011 | Bobo et al. |
20110202076 | August 18, 2011 | Richter |
20110202130 | August 18, 2011 | Cartledge et al. |
20110208283 | August 25, 2011 | Rust |
20110208293 | August 25, 2011 | Tabor |
20110208298 | August 25, 2011 | Tuval et al. |
20110213459 | September 1, 2011 | Garrison et al. |
20110213461 | September 1, 2011 | Seguin et al. |
20110218619 | September 8, 2011 | Benichou et al. |
20110218620 | September 8, 2011 | Meiri et al. |
20110224785 | September 15, 2011 | Hacohen |
20110230941 | September 22, 2011 | Markus |
20110230961 | September 22, 2011 | Langer et al. |
20110238088 | September 29, 2011 | Bodluc et al. |
20110238094 | September 29, 2011 | Thomas et al. |
20110238159 | September 29, 2011 | Guyenot et al. |
20110245911 | October 6, 2011 | Quill et al. |
20110245917 | October 6, 2011 | Savage et al. |
20110251675 | October 13, 2011 | Dwork |
20110251676 | October 13, 2011 | Sweeney et al. |
20110251678 | October 13, 2011 | Eidenschink et al. |
20110251679 | October 13, 2011 | Weimeyer et al. |
20110251680 | October 13, 2011 | Tran et al. |
20110251682 | October 13, 2011 | Murray, III et al. |
20110251683 | October 13, 2011 | Tabor |
20110257433 | October 20, 2011 | Walker |
20110257633 | October 20, 2011 | Cartledge et al. |
20110257721 | October 20, 2011 | Tabor |
20110257728 | October 20, 2011 | Kuehn |
20110257729 | October 20, 2011 | Spenser et al. |
20110257736 | October 20, 2011 | Marquez et al. |
20110257737 | October 20, 2011 | Fogarty et al. |
20110264191 | October 27, 2011 | Rothstein |
20110264196 | October 27, 2011 | Savage et al. |
20110264198 | October 27, 2011 | Murray, III et al. |
20110264199 | October 27, 2011 | Tran et al. |
20110264200 | October 27, 2011 | Tran et al. |
20110264201 | October 27, 2011 | Yeung |
20110264202 | October 27, 2011 | Murray, III et al. |
20110264203 | October 27, 2011 | Dwork et al. |
20110264206 | October 27, 2011 | Tabor |
20110264208 | October 27, 2011 | Duffy |
20110270276 | November 3, 2011 | Rothstein et al. |
20110271967 | November 10, 2011 | Mortier et al. |
20110276062 | November 10, 2011 | Bolduc |
20110282361 | November 17, 2011 | Miller et al. |
20110282438 | November 17, 2011 | Drews et al. |
20110282439 | November 17, 2011 | Thill et al. |
20110282440 | November 17, 2011 | Cao |
20110283514 | November 24, 2011 | Fogarty et al. |
20110288435 | November 24, 2011 | Christy et al. |
20110288632 | November 24, 2011 | White |
20110288634 | November 24, 2011 | Tuval et al. |
20110288635 | November 24, 2011 | Miller et al. |
20110295354 | December 1, 2011 | Bueche et al. |
20110295363 | December 1, 2011 | Girard et al. |
20110301498 | December 8, 2011 | Maenhout et al. |
20110301688 | December 8, 2011 | Dolan |
20110301698 | December 8, 2011 | Miller et al. |
20110301701 | December 8, 2011 | Padala et al. |
20110301702 | December 8, 2011 | Rust et al. |
20110306916 | December 15, 2011 | Nitzan et al. |
20110307049 | December 15, 2011 | Kao |
20110313452 | December 22, 2011 | Carley et al. |
20110313515 | December 22, 2011 | Quadri et al. |
20110319989 | December 29, 2011 | Lane et al. |
20110319991 | December 29, 2011 | Hariton et al. |
20120010694 | January 12, 2012 | Lutter et al. |
20120016468 | January 19, 2012 | Robin et al. |
20120022557 | January 26, 2012 | Cabiri et al. |
20120022629 | January 26, 2012 | Perera et al. |
20120022633 | January 26, 2012 | Olson et al. |
20120022637 | January 26, 2012 | Ben-Movhar et al. |
20120022639 | January 26, 2012 | Hacohen et al. |
20120022640 | January 26, 2012 | Gross et al. |
20120022644 | January 26, 2012 | Reich et al. |
20120035703 | February 9, 2012 | Lutter et al. |
20120035712 | February 9, 2012 | Maisano et al. |
20120035713 | February 9, 2012 | Lutter et al. |
20120035722 | February 9, 2012 | Tuval et al. |
20120041547 | February 16, 2012 | Duffy et al. |
20120041551 | February 16, 2012 | Spenser et al. |
20120046738 | February 23, 2012 | Lau et al. |
20120046742 | February 23, 2012 | Tuval et al. |
20120053676 | March 1, 2012 | Ku et al. |
20120053680 | March 1, 2012 | Bolling et al. |
20120053682 | March 1, 2012 | Kovalsky et al. |
20120053688 | March 1, 2012 | Fogarty et al. |
20120059337 | March 8, 2012 | Eilat |
20120059454 | March 8, 2012 | Millwee et al. |
20120059458 | March 8, 2012 | Buchbinder et al. |
20120065464 | March 15, 2012 | Ellis et al. |
20120078237 | March 29, 2012 | Wang et al. |
20120078353 | March 29, 2012 | Quadri et al. |
20120078355 | March 29, 2012 | Zipory et al. |
20120078357 | March 29, 2012 | Conklin |
20120078359 | March 29, 2012 | Li et al. |
20120083832 | April 5, 2012 | Delaloye et al. |
20120083839 | April 5, 2012 | Letac et al. |
20120083879 | April 5, 2012 | Eberhardt et al. |
20120089022 | April 12, 2012 | House et al. |
20120089223 | April 12, 2012 | Nguyen et al. |
20120095552 | April 19, 2012 | Spence et al. |
20120101570 | April 26, 2012 | Tuval et al. |
20120101571 | April 26, 2012 | Thambar et al. |
20120101572 | April 26, 2012 | Kovalsky et al. |
20120109155 | May 3, 2012 | Robinson et al. |
20120123511 | May 17, 2012 | Brown |
20120123529 | May 17, 2012 | Levi et al. |
20120123530 | May 17, 2012 | Carpentier et al. |
20120130473 | May 24, 2012 | Norris et al. |
20120130474 | May 24, 2012 | Buckley |
20120130475 | May 24, 2012 | Shaw |
20120136434 | May 31, 2012 | Carpentier et al. |
20120136436 | May 31, 2012 | Cabiri et al. |
20120143323 | June 7, 2012 | Hasenkam et al. |
20120150218 | June 14, 2012 | Sandgren et al. |
20120150290 | June 14, 2012 | Gabbay |
20120158021 | June 21, 2012 | Morrill |
20120165915 | June 28, 2012 | Melsheimer et al. |
20120165930 | June 28, 2012 | Gifford, III et al. |
20120179086 | July 12, 2012 | Shank et al. |
20120179244 | July 12, 2012 | Schankereli et al. |
20120191182 | July 26, 2012 | Hauser et al. |
20120197292 | August 2, 2012 | Chin-Chen et al. |
20120197388 | August 2, 2012 | Khairkhahan et al. |
20120215303 | August 23, 2012 | Quadri et al. |
20120239142 | September 20, 2012 | Liu et al. |
20120245604 | September 27, 2012 | Tegzes |
20120271198 | October 25, 2012 | Whittaker et al. |
20120277845 | November 1, 2012 | Bowe |
20120283757 | November 8, 2012 | Miller et al. |
20120283824 | November 8, 2012 | Lutter et al. |
20120290062 | November 15, 2012 | McNamara et al. |
20120296349 | November 22, 2012 | Smith et al. |
20120296360 | November 22, 2012 | Norris et al. |
20120296417 | November 22, 2012 | Hill et al. |
20120296418 | November 22, 2012 | Bonyuet et al. |
20120296419 | November 22, 2012 | Richardson |
20120300063 | November 29, 2012 | Majkrzak et al. |
20120123531 | May 17, 2012 | Tsukashima et al. |
20120310328 | December 6, 2012 | Olson et al. |
20120310330 | December 6, 2012 | Buchbinder et al. |
20120323313 | December 20, 2012 | Seguin |
20120323316 | December 20, 2012 | Chau et al. |
20120330408 | December 27, 2012 | Hillukka et al. |
20120330410 | December 27, 2012 | Hammer et al. |
20120330411 | December 27, 2012 | Gross et al. |
20130006347 | January 3, 2013 | McHugo |
20130018450 | January 17, 2013 | Hunt |
20130018458 | January 17, 2013 | Yohanan et al. |
20130023758 | January 24, 2013 | Fabro |
20130030519 | January 31, 2013 | Tran et al. |
20130030522 | January 31, 2013 | Rowe et al. |
20130035759 | February 7, 2013 | Gross et al. |
20130041204 | February 14, 2013 | Heilman et al. |
20130041451 | February 14, 2013 | Patterson et al. |
20130046373 | February 21, 2013 | Cartledge et al. |
20130066341 | March 14, 2013 | Ketai et al. |
20130066342 | March 14, 2013 | Dell et al. |
20130079872 | March 28, 2013 | Gallagher |
20130079873 | March 28, 2013 | Migliazza et al. |
20130085529 | April 4, 2013 | Housman |
20130090724 | April 11, 2013 | Subramanian et al. |
20130096673 | April 18, 2013 | Hill et al. |
20130116776 | May 9, 2013 | Gross et al. |
20130116779 | May 9, 2013 | Weber |
20130116780 | May 9, 2013 | Miller et al. |
20130123896 | May 16, 2013 | Bloss et al. |
20130123900 | May 16, 2013 | Eblacas et al. |
20130123910 | May 16, 2013 | Cartledge et al. |
20130131791 | May 23, 2013 | Hlavka et al. |
20130131792 | May 23, 2013 | Miller et al. |
20130150945 | June 13, 2013 | Crawford et al. |
20130150956 | June 13, 2013 | Yohanan et al. |
20130158647 | June 20, 2013 | Norris et al. |
20130166017 | June 27, 2013 | Cartledge et al. |
20130166022 | June 27, 2013 | Conklin |
20130172978 | July 4, 2013 | Vidlund et al. |
20130172992 | July 4, 2013 | Gross et al. |
20130178930 | July 11, 2013 | Straubinger et al. |
20130190857 | July 25, 2013 | Mitra et al. |
20130190861 | July 25, 2013 | Chau et al. |
20130190863 | July 25, 2013 | Call et al. |
20130190866 | July 25, 2013 | Zipory et al. |
20130197632 | August 1, 2013 | Kovach et al. |
20130204361 | August 8, 2013 | Adams et al. |
20130211501 | August 15, 2013 | Buckley et al. |
20130211508 | August 15, 2013 | Lane et al. |
20130226289 | August 29, 2013 | Shaolian et al. |
20130226290 | August 29, 2013 | Yellin et al. |
20130231735 | September 5, 2013 | Deem et al. |
20130245742 | September 19, 2013 | Norris |
20130253643 | September 26, 2013 | Rolando et al. |
20130261737 | October 3, 2013 | Costello |
20130261738 | October 3, 2013 | Clague et al. |
20130268069 | October 10, 2013 | Zakai et al. |
20130274870 | October 17, 2013 | Lombardi et al. |
20130282059 | October 24, 2013 | Ketai et al. |
20130289711 | October 31, 2013 | Liddy et al. |
20130289718 | October 31, 2013 | Tsukashima et al. |
20130289740 | October 31, 2013 | Liddy et al. |
20130297013 | November 7, 2013 | Klima et al. |
20130304093 | November 14, 2013 | Serina et al. |
20130304197 | November 14, 2013 | Buchbinder et al. |
20130304200 | November 14, 2013 | McLean et al. |
20130310928 | November 21, 2013 | Morriss et al. |
20130325114 | December 5, 2013 | McLean et al. |
20130325118 | December 5, 2013 | Cartledge |
20130331929 | December 12, 2013 | Mitra et al. |
20140000112 | January 2, 2014 | Braido et al. |
20140005767 | January 2, 2014 | Glazier et al. |
20140005778 | January 2, 2014 | Buchbinder et al. |
20140018911 | January 16, 2014 | Zhou et al. |
20140018914 | January 16, 2014 | Zipory et al. |
20140018915 | January 16, 2014 | Biadillah et al. |
20140031928 | January 30, 2014 | Murphy et al. |
20140046430 | February 13, 2014 | Shaw |
20140052237 | February 20, 2014 | Lane et al. |
20140067050 | March 6, 2014 | Costello et al. |
20140067054 | March 6, 2014 | Chau et al. |
20140081376 | March 20, 2014 | Burkart et al. |
20140088368 | March 27, 2014 | Park |
20140094826 | April 3, 2014 | Sutherland et al. |
20140094903 | April 3, 2014 | Miller et al. |
20140094906 | April 3, 2014 | Spence et al. |
20140099726 | April 10, 2014 | Heller |
20140106951 | April 17, 2014 | Brandon |
20140120287 | May 1, 2014 | Jacoby et al. |
20140121749 | May 1, 2014 | Roeder |
20140121763 | May 1, 2014 | Duffy et al. |
20140135799 | May 15, 2014 | Henderson |
20140135894 | May 15, 2014 | Norris et al. |
20140135895 | May 15, 2014 | Andress et al. |
20140142619 | May 22, 2014 | Serina et al. |
20140142681 | May 22, 2014 | Norris |
20140142688 | May 22, 2014 | Duffy et al. |
20140142695 | May 22, 2014 | Gross et al. |
20140148849 | May 29, 2014 | Serina et al. |
20140148891 | May 29, 2014 | Johnson |
20140148898 | May 29, 2014 | Gross et al. |
20140155783 | June 5, 2014 | Starksen et al. |
20140163670 | June 12, 2014 | Alon et al. |
20140163690 | June 12, 2014 | White |
20140172069 | June 19, 2014 | Roeder et al. |
20140172077 | June 19, 2014 | Bruchman et al. |
20140172082 | June 19, 2014 | Bruchman et al. |
20140188108 | July 3, 2014 | Goodine et al. |
20140188140 | July 3, 2014 | Meier et al. |
20140188210 | July 3, 2014 | Beard et al. |
20140188215 | July 3, 2014 | Hlavka et al. |
20140188221 | July 3, 2014 | Chung et al. |
20140194970 | July 10, 2014 | Chobotov |
20140194976 | July 10, 2014 | Starksen et al. |
20140194981 | July 10, 2014 | Menk et al. |
20140194983 | July 10, 2014 | Kovalsky et al. |
20140207231 | July 24, 2014 | Hacohen et al. |
20140214157 | July 31, 2014 | Börtlein et al. |
20140214159 | July 31, 2014 | Vidlund et al. |
20140222136 | August 7, 2014 | Geist et al. |
20140222137 | August 7, 2014 | Miller et al. |
20140222142 | August 7, 2014 | Kovalsky et al. |
20140236287 | August 21, 2014 | Clague et al. |
20140236289 | August 21, 2014 | Alkhatib |
20140243859 | August 28, 2014 | Robinson |
20140243894 | August 28, 2014 | Groothuis et al. |
20140243963 | August 28, 2014 | Sheps et al. |
20140249622 | September 4, 2014 | Carmi et al. |
20140257461 | September 11, 2014 | Robinson et al. |
20140257467 | September 11, 2014 | Lane et al. |
20140257475 | September 11, 2014 | Gross et al. |
20140257476 | September 11, 2014 | Montorfano et al. |
20140275757 | September 18, 2014 | Goodwin et al. |
20140276648 | September 18, 2014 | Hammer et al. |
20140277358 | September 18, 2014 | Slazas |
20140277409 | September 18, 2014 | Börtlein et al. |
20140277411 | September 18, 2014 | Börtlein et al. |
20140277412 | September 18, 2014 | Börtlein et al. |
20140277418 | September 18, 2014 | Miller |
20140277422 | September 18, 2014 | Ratz et al. |
20140277427 | September 18, 2014 | Ratz et al. |
20140296962 | October 2, 2014 | Cartledge et al. |
20140296969 | October 2, 2014 | Tegels et al. |
20140303649 | October 9, 2014 | Nguyen et al. |
20140303720 | October 9, 2014 | Sugimoto et al. |
20140309661 | October 16, 2014 | Sheps et al. |
20140309730 | October 16, 2014 | Alon et al. |
20140324164 | October 30, 2014 | Gross et al. |
20140329225 | November 6, 2014 | Morin |
20140331475 | November 13, 2014 | Duffy et al. |
20140336744 | November 13, 2014 | Tani et al. |
20140343668 | November 20, 2014 | Zipory et al. |
20140343670 | November 20, 2014 | Bakis et al. |
20140350662 | November 27, 2014 | Vaturi |
20140350670 | November 27, 2014 | Keränen |
20140358222 | December 4, 2014 | Gorman, III et al. |
20140358224 | December 4, 2014 | Tegels et al. |
20140378331 | December 25, 2014 | Morin |
20140379006 | December 25, 2014 | Sutherland et al. |
20140379065 | December 25, 2014 | Johnson et al. |
20140379074 | December 25, 2014 | Spence et al. |
20140379076 | December 25, 2014 | Vidlund et al. |
20150012087 | January 8, 2015 | Miller et al. |
20150018940 | January 15, 2015 | Quill et al. |
20150018944 | January 15, 2015 | O'Connor et al. |
20150032205 | January 29, 2015 | Matheny |
20150045880 | February 12, 2015 | Hacohen |
20150045881 | February 12, 2015 | Lim |
20150051697 | February 19, 2015 | Spence et al. |
20150081014 | March 19, 2015 | Gross et al. |
20150094802 | April 2, 2015 | Buchbinder et al. |
20150105855 | April 16, 2015 | Cabiri et al. |
20150119970 | April 30, 2015 | Nakayama et al. |
20150127097 | May 7, 2015 | Neumann et al. |
20150142100 | May 21, 2015 | Morriss et al. |
20150142103 | May 21, 2015 | Vidlund |
20150148894 | May 28, 2015 | Damm et al. |
20150157457 | June 11, 2015 | Hacohen |
20150157458 | June 11, 2015 | Thambar et al. |
20150164640 | June 18, 2015 | McLean et al. |
20150173896 | June 25, 2015 | Richter et al. |
20150173897 | June 25, 2015 | Raanani et al. |
20150182336 | July 2, 2015 | Zipory et al. |
20150196390 | July 16, 2015 | Ma et al. |
20150196393 | July 16, 2015 | Vidlund et al. |
20150216661 | August 6, 2015 | Hacohen et al. |
20150230924 | August 20, 2015 | Miller et al. |
20150238313 | August 27, 2015 | Spence et al. |
20150245934 | September 3, 2015 | Lombardi et al. |
20150250588 | September 10, 2015 | Yang et al. |
20150272730 | October 1, 2015 | Melnick et al. |
20150272731 | October 1, 2015 | Racchini et al. |
20150272734 | October 1, 2015 | Sheps et al. |
20150282964 | October 8, 2015 | Beard et al. |
20150305903 | October 29, 2015 | Kitaoka |
20150320556 | November 12, 2015 | Levi et al. |
20150327994 | November 19, 2015 | Morriss et al. |
20150328000 | November 19, 2015 | Ratz et al. |
20150335429 | November 26, 2015 | Morriss et al. |
20150342736 | December 3, 2015 | Rabito et al. |
20150351903 | December 10, 2015 | Morriss et al. |
20150351904 | December 10, 2015 | Cooper et al. |
20150351906 | December 10, 2015 | Hammer et al. |
20150359629 | December 17, 2015 | Ganesan et al. |
20160030169 | February 4, 2016 | Shahriari |
20160030171 | February 4, 2016 | Quijano et al. |
20160089482 | March 31, 2016 | Siegenthaler |
20160095700 | April 7, 2016 | Righini |
20160100939 | April 14, 2016 | Armstrong et al. |
20160106539 | April 21, 2016 | Buchbinder et al. |
20160113766 | April 28, 2016 | Ganesan et al. |
20160113768 | April 28, 2016 | Ganesan et al. |
20160125160 | May 5, 2016 | Heneghan et al. |
20160175095 | June 23, 2016 | Dienno et al. |
20160200773 | July 14, 2016 | Morin |
20160213473 | July 28, 2016 | Hacohen et al. |
20160220367 | August 4, 2016 | Barrett |
20160228247 | August 11, 2016 | Maimon et al. |
20160242902 | August 25, 2016 | Morriss et al. |
20160245802 | August 25, 2016 | Morin et al. |
20160258939 | September 8, 2016 | Morin et al. |
20160266089 | September 15, 2016 | Morin et al. |
20160270911 | September 22, 2016 | Ganesan et al. |
20160296330 | October 13, 2016 | Hacohen |
20160310268 | October 27, 2016 | Oba et al. |
20160310274 | October 27, 2016 | Gross et al. |
20160317301 | November 3, 2016 | Quadri et al. |
20160317305 | November 3, 2016 | Pelled et al. |
20160324633 | November 10, 2016 | Gross et al. |
20160324635 | November 10, 2016 | Vidlund et al. |
20160324640 | November 10, 2016 | Gifford et al. |
20160331526 | November 17, 2016 | Schweich et al. |
20160331527 | November 17, 2016 | Vidlund et al. |
20160338706 | November 24, 2016 | Rowe |
20160367360 | December 22, 2016 | Cartledge et al. |
20160367368 | December 22, 2016 | Vidlund et al. |
20160374801 | December 29, 2016 | Jimenez et al. |
20160374802 | December 29, 2016 | Levi et al. |
20170042678 | February 16, 2017 | Ganesan et al. |
20170049435 | February 23, 2017 | Sauer et al. |
20170056166 | March 2, 2017 | Ratz et al. |
20170056171 | March 2, 2017 | Cooper et al. |
20170065407 | March 9, 2017 | Hacohen et al. |
20170065411 | March 9, 2017 | Grundeman et al. |
20170074855 | March 16, 2017 | Morin et al. |
20170100236 | April 13, 2017 | Robertson et al. |
20170128205 | May 11, 2017 | Tamir et al. |
20170135816 | May 18, 2017 | Lashinski et al. |
20170189174 | July 6, 2017 | Braido et al. |
20170196688 | July 13, 2017 | Christianson et al. |
20170196692 | July 13, 2017 | Kirk et al. |
20170209264 | July 27, 2017 | Chau et al. |
20170216026 | August 3, 2017 | Quill et al. |
20170224323 | August 10, 2017 | Rowe et al. |
20170231757 | August 17, 2017 | Gassler |
20170231759 | August 17, 2017 | Geist et al. |
20170231760 | August 17, 2017 | Lane et al. |
20170231766 | August 17, 2017 | Hariton et al. |
20170234850 | August 17, 2017 | Morin |
20170239048 | August 24, 2017 | Goldfarb et al. |
20170252159 | September 7, 2017 | Hacohen et al. |
20170266003 | September 21, 2017 | Hammer et al. |
20170333183 | November 23, 2017 | Backus |
20170333187 | November 23, 2017 | Hariton et al. |
20170349940 | December 7, 2017 | Morin et al. |
20170360426 | December 21, 2017 | Hacohen et al. |
20170367823 | December 28, 2017 | Hariton et al. |
20180000580 | January 4, 2018 | Wallace et al. |
20180014930 | January 18, 2018 | Hariton et al. |
20180014932 | January 18, 2018 | Hammer et al. |
20180021129 | January 25, 2018 | Peterson et al. |
20180023114 | January 25, 2018 | Morin et al. |
20180023115 | January 25, 2018 | Morin et al. |
20180028215 | February 1, 2018 | Cohen |
20180028311 | February 1, 2018 | Hacohen |
20180049873 | February 22, 2018 | Manash et al. |
20180055628 | March 1, 2018 | Patel et al. |
20180055630 | March 1, 2018 | Patel et al. |
20180098850 | April 12, 2018 | Rafiee et al. |
20180116790 | May 3, 2018 | Ratz et al. |
20180116843 | May 3, 2018 | Schreck et al. |
20180125644 | May 10, 2018 | Conklin |
20180132999 | May 17, 2018 | Perouse |
20180147059 | May 31, 2018 | Hammer et al. |
20180153687 | June 7, 2018 | Hariton et al. |
20180153689 | June 7, 2018 | Maimon et al. |
20180153696 | June 7, 2018 | Albitov et al. |
20180161159 | June 14, 2018 | Lee et al. |
20180177593 | June 28, 2018 | Hariton et al. |
20180177594 | June 28, 2018 | Patel et al. |
20180185148 | July 5, 2018 | Hariton et al. |
20180206983 | July 26, 2018 | Noe et al. |
20180214263 | August 2, 2018 | Rolando et al. |
20180243086 | August 30, 2018 | Barbarino et al. |
20180250126 | September 6, 2018 | O'connor et al. |
20180250147 | September 6, 2018 | Syed |
20180271654 | September 27, 2018 | Hariton et al. |
20180280136 | October 4, 2018 | Hariton et al. |
20180296333 | October 18, 2018 | Dixon et al. |
20180296336 | October 18, 2018 | Cooper et al. |
20180296341 | October 18, 2018 | Noe et al. |
20180325671 | November 15, 2018 | Abunassar et al. |
20180344457 | December 6, 2018 | Gross et al. |
20180344490 | December 6, 2018 | Fox et al. |
20180353294 | December 13, 2018 | Calomeni et al. |
20180360457 | December 20, 2018 | Ellis et al. |
20190000613 | January 3, 2019 | Delgado et al. |
20190015200 | January 17, 2019 | Delgado et al. |
20190021852 | January 24, 2019 | Delgado et al. |
20190021857 | January 24, 2019 | Hacohen et al. |
20190038404 | February 7, 2019 | Iamberger et al. |
20190038405 | February 7, 2019 | Iamberger et al. |
20190053896 | February 21, 2019 | Adamek-Bowers et al. |
20190060060 | February 28, 2019 | Chau et al. |
20190060068 | February 28, 2019 | Cope et al. |
20190060070 | February 28, 2019 | Groothuis et al. |
20190069997 | March 7, 2019 | Ratz et al. |
20190069998 | March 7, 2019 | Hacohen |
20190083248 | March 21, 2019 | Hariton et al. |
20190083249 | March 21, 2019 | Hariton et al. |
20190083261 | March 21, 2019 | Perszyk et al. |
20190105153 | April 11, 2019 | Barash et al. |
20190117391 | April 25, 2019 | Humair |
20190167423 | June 6, 2019 | Hariton et al. |
20190175339 | June 13, 2019 | Vidlund |
20190175342 | June 13, 2019 | Hariton et al. |
20190183639 | June 20, 2019 | Moore |
20190192295 | June 27, 2019 | Spence et al. |
20190216602 | July 18, 2019 | Lozonschi |
20190231525 | August 1, 2019 | Hariton et al. |
20190240010 | August 8, 2019 | Hacohen |
20190336280 | November 7, 2019 | Naor |
20190350701 | November 21, 2019 | Adamek-Bowers et al. |
20190365530 | December 5, 2019 | Hoang et al. |
20190388218 | December 26, 2019 | Vidlund et al. |
20190388220 | December 26, 2019 | Vidlund et al. |
20200000449 | January 2, 2020 | Goldfarb et al. |
20200000579 | January 2, 2020 | Manash et al. |
20200000580 | January 2, 2020 | Hacohen |
20200015964 | January 16, 2020 | Noe et al. |
20200030098 | January 30, 2020 | Delgado et al. |
20200038181 | February 6, 2020 | Hariton et al. |
20200046496 | February 13, 2020 | Hammer et al. |
20200054335 | February 20, 2020 | Hernandez et al. |
20200060818 | February 27, 2020 | Geist et al. |
20200113677 | April 16, 2020 | McCann et al. |
20200113689 | April 16, 2020 | McCann et al. |
20200113692 | April 16, 2020 | McCann et al. |
20200138567 | May 7, 2020 | Marr et al. |
20200146824 | May 14, 2020 | Hammer et al. |
20200163760 | May 28, 2020 | Hariton et al. |
20200163761 | May 28, 2020 | Hariton et al. |
20200205969 | July 2, 2020 | Hacohen |
20200214832 | July 9, 2020 | Metchik et al. |
20200237512 | July 30, 2020 | McCann et al. |
20200246136 | August 6, 2020 | Marr et al. |
20200246140 | August 6, 2020 | Hariton et al. |
20200253600 | August 13, 2020 | Darabian |
20200261094 | August 20, 2020 | Goldfarb et al. |
20200306037 | October 1, 2020 | Siegel et al. |
20200315786 | October 8, 2020 | Metchik et al. |
20200337842 | October 29, 2020 | Metchik et al. |
20200360139 | November 19, 2020 | Hammer et al. |
20200390548 | December 17, 2020 | Hariton et al. |
20210093449 | April 1, 2021 | Hariton et al. |
20210106419 | April 15, 2021 | Abunassar |
20210113331 | April 22, 2021 | Quadri et al. |
20210137680 | May 13, 2021 | Kizuka et al. |
20210259835 | August 26, 2021 | Tyler, II et al. |
20220000612 | January 6, 2022 | Hacohen |
2822801 | August 2006 | CA |
2671966 | June 2008 | CA |
101653365 | February 2010 | CN |
103974674 | August 2014 | CN |
103997990 | August 2014 | CN |
105324091 | February 2016 | CN |
0170262 | February 1986 | EP |
06/14342 | September 1994 | EP |
10/06905 | June 2000 | EP |
0954257 | August 2000 | EP |
1258437 | November 2002 | EP |
1264582 | December 2002 | EP |
0871417 | October 2003 | EP |
1266641 | October 2004 | EP |
1034753 | February 2005 | EP |
1258232 | January 2006 | EP |
1637092 | March 2006 | EP |
1990014 | November 2008 | EP |
1562522 | December 2008 | EP |
1420723 | January 2009 | EP |
1903991 | September 2009 | EP |
1418865 | October 2009 | EP |
2119399 | November 2009 | EP |
1531762 | April 2010 | EP |
1450733 | February 2011 | EP |
2446915 | May 2012 | EP |
2088965 | November 2012 | EP |
1768630 | January 2015 | EP |
1861045 | March 2015 | EP |
1465555 | May 2015 | EP |
2349124 | October 2018 | EP |
2739214 | October 2018 | EP |
3417813 | December 2018 | EP |
3583922 | December 2019 | EP |
3270825 | April 2020 | EP |
2485795 | September 2020 | EP |
223448 | December 2012 | IL |
S53152790 | December 1978 | JP |
20010046894 | June 2001 | KR |
2011/144351 | November 2011 | OA |
92/05093 | April 1992 | WO |
93/10714 | June 1993 | WO |
96/39963 | December 1996 | WO |
96/40344 | December 1996 | WO |
97/01369 | January 1997 | WO |
98/46149 | October 1998 | WO |
1998/043557 | October 1998 | WO |
1999/030647 | June 1999 | WO |
00/22981 | April 2000 | WO |
2000-047139 | August 2000 | WO |
01/26586 | April 2001 | WO |
01/56457 | August 2001 | WO |
2001-062189 | August 2001 | WO |
01/82832 | November 2001 | WO |
02/085250 | October 2002 | WO |
02/085251 | October 2002 | WO |
02/085252 | October 2002 | WO |
2003/020179 | March 2003 | WO |
2003/028558 | April 2003 | WO |
03/047467 | June 2003 | WO |
2003/049647 | June 2003 | WO |
2003/105667 | December 2003 | WO |
2004/028399 | April 2004 | WO |
04/103434 | December 2004 | WO |
2004/108191 | December 2004 | WO |
05/021063 | March 2005 | WO |
05/046488 | May 2005 | WO |
2005/062931 | July 2005 | WO |
2005/107650 | November 2005 | WO |
2006/007389 | January 2006 | WO |
2006/007401 | January 2006 | WO |
06/012013 | February 2006 | WO |
06/012038 | February 2006 | WO |
06/054930 | May 2006 | WO |
2006/065212 | June 2006 | WO |
2006/070372 | July 2006 | WO |
06/086434 | August 2006 | WO |
2006/089236 | August 2006 | WO |
2006/091163 | August 2006 | WO |
06/097931 | September 2006 | WO |
06/105084 | October 2006 | WO |
06/116558 | November 2006 | WO |
2006/128193 | November 2006 | WO |
07/011799 | January 2007 | WO |
2007/030063 | March 2007 | WO |
2007/047488 | April 2007 | WO |
2007/059252 | May 2007 | WO |
07/121314 | October 2007 | WO |
07/136783 | November 2007 | WO |
07/136981 | November 2007 | WO |
08/013915 | January 2008 | WO |
2008/014144 | January 2008 | WO |
2008/029296 | March 2008 | WO |
2008/031103 | March 2008 | WO |
2008/058940 | May 2008 | WO |
08/068756 | June 2008 | WO |
2008/070797 | June 2008 | WO |
2008/103722 | August 2008 | WO |
2009/026563 | February 2009 | WO |
09/033469 | March 2009 | WO |
09/053497 | April 2009 | WO |
2009/080801 | July 2009 | WO |
2009/091509 | July 2009 | WO |
2009/160631 | October 2009 | WO |
10/004546 | January 2010 | WO |
2010/000454 | January 2010 | WO |
2010/006627 | January 2010 | WO |
2010/006905 | January 2010 | WO |
2010/027485 | March 2010 | WO |
2010/037141 | April 2010 | WO |
2010/044851 | April 2010 | WO |
2010/045297 | April 2010 | WO |
2010/057262 | May 2010 | WO |
2010/073246 | July 2010 | WO |
2010/081033 | July 2010 | WO |
2010/085649 | July 2010 | WO |
2010/121076 | October 2010 | WO |
2010/128502 | November 2010 | WO |
2010/128503 | November 2010 | WO |
2010/150178 | December 2010 | WO |
2011/025972 | March 2011 | WO |
2011/051942 | May 2011 | WO |
2011/067770 | June 2011 | WO |
2011/069048 | June 2011 | WO |
2011/089401 | July 2011 | WO |
2011/089601 | July 2011 | WO |
2011/106137 | September 2011 | WO |
2011/111047 | September 2011 | WO |
01/87190 | November 2011 | WO |
2011/137531 | November 2011 | WO |
2011-143263 | November 2011 | WO |
2011/148374 | December 2011 | WO |
2011/154942 | December 2011 | WO |
2012/011108 | January 2012 | WO |
2012/014201 | February 2012 | WO |
2012/024428 | February 2012 | WO |
2012/036740 | March 2012 | WO |
2012/048035 | April 2012 | WO |
2012/068541 | May 2012 | WO |
2012/127309 | September 2012 | WO |
2012/176195 | December 2012 | WO |
2012/177942 | December 2012 | WO |
2013/021374 | February 2013 | WO |
2013/021375 | February 2013 | WO |
2013/021384 | February 2013 | WO |
2013/059747 | April 2013 | WO |
2013/069019 | May 2013 | WO |
2013/072496 | May 2013 | WO |
2013/078497 | June 2013 | WO |
2013/088327 | June 2013 | WO |
2013/114214 | August 2013 | WO |
2013/128436 | September 2013 | WO |
2013/175468 | November 2013 | WO |
2014/022124 | February 2014 | WO |
2014/064694 | May 2014 | WO |
2014/064695 | May 2014 | WO |
2014/076696 | May 2014 | WO |
2014/087402 | June 2014 | WO |
2014/115149 | July 2014 | WO |
2014/121280 | August 2014 | WO |
2014/144937 | September 2014 | WO |
2014/145338 | September 2014 | WO |
2014/164364 | October 2014 | WO |
2014/194178 | December 2014 | WO |
2014/195786 | December 2014 | WO |
2015/059699 | April 2015 | WO |
2015/173794 | November 2015 | WO |
2016/016899 | February 2016 | WO |
2016/093877 | June 2016 | WO |
2016/125160 | August 2016 | WO |
2017/223486 | December 2017 | WO |
2018/025260 | February 2018 | WO |
2018/025263 | February 2018 | WO |
2018/029680 | February 2018 | WO |
2018/039631 | March 2018 | WO |
2018/106837 | June 2018 | WO |
2018/112429 | June 2018 | WO |
2018/118717 | June 2018 | WO |
2018/131042 | July 2018 | WO |
2018/131043 | July 2018 | WO |
2019/026059 | February 2019 | WO |
2019/027507 | February 2019 | WO |
2019/030753 | February 2019 | WO |
2019/077595 | April 2019 | WO |
2019/116369 | June 2019 | WO |
2019/138400 | July 2019 | WO |
2019/195860 | October 2019 | WO |
2019/202579 | October 2019 | WO |
2020/058972 | March 2020 | WO |
2020/167677 | August 2020 | WO |
2021/156866 | August 2021 | WO |
2021/186424 | September 2021 | WO |
- An Office Action dated Nov. 25, 2021, which issued during the prosecution of European Patent Application No. 18826823.9.
- IPR2021-01051 Institution decision dated Dec. 10, 2021.
- Notice of Allowance dated Dec. 7, 2021, which issued during the prosecution of U.S. Appl. No. 17/394,807.
- Notice of Allowance dated Dec. 6, 2021, which issued during the prosecution of U.S. Appl. No. 16/738,516.
- Notice of Allowance dated Dec. 29, 2021, which issued during the prosecution of U.S. Appl. No. 17/210,183.
- IPR2021-00383 Petitioners' Reply to Patent Owner's Response dated Jan. 5, 2022.
- IPR2021-00383 Petitioners' Opposition to Patent Owner's Contingent Motion to Amend dated Jan. 5, 2022.
- An Office Action dated Sep. 22, 2021, which issued during the prosecution of European Patent Application No. 20714289.4.
- Summary of Examination Notice dated Jan. 6, 2022, which issued during the prosecution of Chinese Patent Application No. 201880064313.X.
- An Office Action dated Jan. 12, 2022, which issued during the prosecution of U.S. Appl. No. 17/101,787.
- Poirier, Nancy C., et al. “A novel repair for patients with atrioventricular septal defect requiring reoperation for left atrioventricular valve regurgitation.” European journal of cardio-thoracic surgery 18.1 (2000): 54-61.
- An Office Action dated Mar. 29, 2021, which issued during the prosecution of U.S. Appl. No. 16/738,516.
- Ando, Tomo, et al. “Iatrogenic ventricular septal defect following transcatheter aortic valve replacement: a systematic review.” Heart, Lung and Circulation 25.10 (2016): 968-974.
- Urena, Marina, et al. “Transseptal transcatheter mitral valve replacement using balloon-expandable transcatheter heart valves: a step-by-step approach.” JACC: Cardiovascular Interventions 10.19 (2017): 1905-1919.
- An English summary of an Official Action dated Mar. 29, 2021, which issued during the prosecution of Chinese Patent Application No. 201780061210.3.
- An International Search Report and a Written Opinion both dated Jan. 28, 2020, which issued during the prosecution of Applicant's PCT/IL2019/051031.
- An International Preliminary Report on Patentability dated Mar. 9, 2021, which issued during the prosecution of Applicant's PCT/IL2019/051031.
- An Office Action dated May 4, 2021, which issued during the prosecution of U.S. Appl. No. 16/636,204.
- Notice of Allowance dated May 17, 2021, which issued during the prosecution of U.S. Appl. No. 16/138,129.
- Notice of Allowance dated Jun. 4, 2021, which issued during the prosecution of U.S. Appl. No. 16/802,353.
- An Office Action dated May 12, 2021, which issued during the prosecution of Canadian Patent Application No. 2,973,940.
- Petition for Inter Partes Review of U.S. Pat. No. 10,702,385—dated Jun. 4, 2021.
- Declaration of Ivan Vesely, Ph.D. In Support of Petition for Inter Partes Review of U.S. Pat. No. 10,702,385—dated Jun. 4, 2021.
- An Office Action dated Sep. 9, 2021, which issued during the prosecution of U.S. Appl. No. 16/768,909.
- An Office Action dated Sep. 15, 2021, which issued during the prosecution of U.S. Appl. No. 16/135,599.
- An Office Action dated Oct. 14. 2021, which issued during the prosecution of U.S. Appl. No. 16/680,739.
- An Office Action dated Oct. 21, 2021, which issued during the prosecution of U.S. Appl. No. 17/335,845.
- European Search Report dated Oct. 11, 2021 which issued during the prosecution of Applicant's European App No. 21176010.3.
- Fann, James I., et al. “Beating heart catheter-based edge-to-edge mitral valve procedure in a porcine model: efficacy and healing response.” Circulation 110.8 (2004): 988-993.
- Feldman, Ted, et al. “Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort.” Journal of the American College of Cardiology 54.8 (2009): 686-694.
- IPR2021-00383 Patent Owner's Contingent Motion To Amend Under 37 C.F.R. §42.121 dated Oct. 13, 2021.
- IPR2021-00383 Patent Owner's Response Pursuant To 37 C.F.R. § 42.120 dated Oct. 13, 2021.
- IPR2021-00383 Second Declaration of Dr. Michael Sacks dated Oct. 13, 2021.
- An Office Action dated Oct. 21, 2021, which issued during the prosecution of U.S. Appl. No. 17/306,231.
- Maisano, Francesco, et al. “The evolution from surgery to percutaneous mitral valve interventions: the role of the edge-to-edge technique.” Journal of the American College of Cardiology 58.21 (2011): 2174-2182.
- IPR2021-00383 Deposition of DR. Ivan Vesely, dated Sep. 22, 2021.
- Cardiovalve Exhibit 2009—Percutaneous Mitral Leaflet Repair: MitraClip® Therapy for Mitral Regurgitation (2012).
- Feldman, Ted, et al. “Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial.” Journal of the American College of Cardiologv 46.11 (2005): 2134-2140.
- An Office Action summarized English translation and Search Report dated Oct. 8, 2021, which issued during the prosecution of Chinese Patent Application No. 201780061210.3.
- An Office Action dated Nov. 4, 2021, which issued during the prosecution of U.S. Appl. No. 17/366,711.
- An Office Action summarized English translation and Search Report dated Aug. 12, 2021, which issued during the prosecution of Chinese Patent Application No. 201880058940.2.
- IPR2021-00383 Decision Final Written Decision dated Jul. 18, 2022.
- IPR2021-01051 Preliminary Guidance Patent Owner's Motion To Amend dated Jun. 24, 2022.
- Ex Parte Quayle dated May 2, 2022, which issued during the prosecution of U.S. Appl. No. 16/879,952.
- An International Search Report and a Written Opinion both dated May 3, 2022, which issued during the prosecution of Applicant's PCT/IL2021/051433.
- An Office Action together with an English Summary dated May 7, 2022 which issued during the prosecution of Chinese Patent Application No. 201880058940.2.
- Notice of Allowance dated May 4, 2022, which issued during the prosecution of U.S. Appl. No. 16/680,739.
- An Office Action dated Jun. 28, 2022, which issued during the prosecution of U.S. Appl. No. 16/135,969.
- An Office Action dated Jul. 8, 2022, which issued during the prosecution of U.S. Appl. No. 16/144,054.
- An Office Action dated Jan. 26, 2022, which issued during the prosecution of U.S. Appl. No. 16/888,210.
- Notice of Allowance dated Jan. 31, 2022, which issued during the prosecution of U.S. Appl. No. 17/479,418.
- An Office Action dated Mar. 18, 2022, which issued during the prosecution of U.S. Appl. No. 16/746,489.
- Notice of Allowance dated Mar. 22, 2022, which issued during the prosecution of U.S. Appl. No. 17/366,711.
- Notice of Allowance dated Mar. 4, 2022, which issued during the prosecution of U.S. Appl. No. 16/768,909.
- An Office Action dated Dec. 9, 2021, which issued during the prosecution of U.S. Appl. No. 16/135,969.
- An Office Action dated Jan. 24, 2022, which issued during the prosecution of U.S. Appl. No. 16/135,466.
- An Office Action dated Apr. 11, 2022, which issued during the prosecution of U.S. Appl. No. 17/473,472.
- IPR2021-00383 Preliminary Guidance dated Jan. 31, 2022.
- European Search Report dated Jun 10, 2021 which issued during the prosecution of Applicant's European App No. 21157988.3.
- An Invitation to pay additional fees dated May 19, 2021, which issued during the prosecution of Applicant's PCT/IL2021/050132.
- An International Search Report and a Written Opinion both dated Jul. 12, 2021, which issued during the prosecution of Applicant's PCT/IL2021/050132.
- IPR2021-00383 Petitioners' Authorized Reply to Patent Owner's Preliminary Response dated May 27, 2021.
- Exhibit 1014—Transcript of proceedings held May 20, 2021 (Edwards Lifesciences vs. Cardiovalve)
- Exhibit 1015—Facilitate, Meriam-Webster.com, https://www.merriamwebster.com/dictionary/facilitate (visited May 26, 2021).
- Patent Owner's Authorized Surreply to Petitioner's Reply to Patent Owner's Preliminary Response dated Jun. 4, 2021(Edwards Lifesciences vs. Cardiovalve).
- An Office Action dated Aug. 18, 2021, which issued during the prosecution of U.S. Appl. No 17/210,183.
- Institution decision dated Jul. 20, 2021(Edwards Lifesciences vs. Cardiovalve)
- An Office Action dated Jul. 27, 2022, which issued during the prosecution of U.S. Appl. No. 16/881,350.
- An Office Action dated Sep. 21, 2022, which issued during the prosecution of U.S. Appl. No. 16/776,581.
- An Office Action dated Jul. 20, 2022, which issued during the prosecution of U.S. Appl. No. 17/101,787.
- An Office Action dated Sep. 16, 2022, which issued during the prosecution of U.S. Appl. No. 16/135,466.
- An Office Action dated Aug. 1, 2022, which issued during the prosecution of European Patent Application No. 18826823.9.
- European Search Report dated Sep. 6, 2022 which issued during the prosecution of Applicant's European App No. 22161862.2.
- IPR2021-01051 Petitioners' Reply To Preliminary Guidance dated Aug. 2, 2022.
- IPR2021-01051 Patent Owner's Sur-Reply To Petitioners' Reply To Preliminary Guidance dated Aug. 23, 2022.
- An Office Action dated Aug. 5, 2022, which issued during the prosecution of U.S. Appl. No. 16/760,147.
- An Office Action dated Sep. 8, 2022, which issued during the prosecution of U.S. Appl. No. 16/896,858.
- An Office Action dated Nov. 23, 2012, which issued during the prosecution of U.S. Appl. No. 13/033,852.
- An Office Action dated Dec. 31, 2012, which issued during the prosecution of U.S. Appl. No. 13/044,694.
- An Office Action dated Feb. 6, 2013, which issued during the prosecution of U.S. Appl. No. 13/412,814.
- Langer F et al., “RING plus STRING: Papillary muscle repositioning as an adjunctive repair technique for ischemic mitral regurgitation,” J Thorac Cardiovasc Surg 133:247-9, Jan. 2007.
- Langer F et al., “RING+STRING: Successful repair technique for ischemic mitral regurgitation with severe leaflet tethering,” Circulation 120[suppl 1]: S85-S91, Sep. 2009.
- “Transcatheter Valve-in-Valve Implantation for Failed Bioprosthetic Heart Valves”, J Webb et al., Circulation. Apr. 2010; 121: 1848-1857.
- Jansen, J., Willeke, S., Reul, H. and Rum, G. (1992), Detachable Shape-Memory Sewing Ring for Heart Valves. Artificial Organs, 16:294-297. 1992 (an abstract).
- Alexander S. Geha, et al., Replacement of degenerated mitral and aortic bioprostheses without explanation Ann Thorac Surg. Jun. 2001; 72:1509-1514.
- An International Search Report and a Written Opinion both dated Oct. 13, 2011 which issued during the prosecution of Applicant's PCT/IL11/00231.
- An Office Action dated Jul. 1, 2016, which issued during the prosecution of U.S. Appl. No. 14/161,921.
- An International Search Report and a Written Opinion both dated Dec. 5, 2011, which issued during the prosecution of Applicant's PCT/IL11/00582.
- An Office Action dated May 29, 2012, which issued during the prosecution of U.S. Appl. No. 12/840,463.
- U.S. Appl. No. 61/555,160, filed Nov. 3, 2011.
- U.S. Appl. No. 61/525,281, filed Aug. 19, 2011.
- U.S. Appl. No. 61/537,276, filed Sep. 21, 2011.
- U.S. Appl. No. 61/515,372, filed Aug. 5, 2011.
- U.S. Appl. No. 61/492,449, filed Jun. 2, 2011.
- U.S. Appl. No. 61/588,892, filed Jan. 20, 2012.
- An International Search Report and a Written Opinion both dated Feb. 6, 2013, which issued during the prosecution of Applicant's PCT/IL12/00292.
- An International Search Report and a Written Opinion both dated Feb. 6, 2013, which issued during the prosecution of Applicant's PCT/IL12/00293.
- An Office Action dated Nov. 28, 2012, which issued during the prosecution of U.S. Appl. No. 12/961,721.
- An Office Action dated Feb. 15, 2013, which issued during the prosecution of U.S. Appl. No. 12/840,463.
- An Office Action dated Feb. 10, 2014, which issued during the prosecution of U.S. Appl. No. 13/031,852.
- An Office Action dated Sep. 19, 2014, which issued during the prosecution of U.S. Appl. No. 13/044,694.
- An International Search Report and a Written Opinion both dated Sep. 4, 2014 which issued during the prosecution of Applicant's PCT/IL2014/050087.
- Invitation to Pay Additional Fees dated Jun. 12, 2014 PCT/IL2014/050087.
- An Office Action dated Jun. 17, 2014, which issued during the prosecution of U.S. Appl. No. 12/961,721.
- An Office Action dated Jul. 3, 2014, which issued during the prosecution of U.S. Appl. No. 13/033,852.
- An Office Action dated May 23, 2014, which issued during the prosecution of U.S. Appl. No. 13/411,814.
- Dominique Himbert; Mitral Regurgitation and Stenosis from Bioprosthesis and Annuloplasty Failure: Transcatheter approaches and outcomes, 24 pages Oct. 28, 2013.
- An International Search Report and a Written Opinion both dated Mar. 17, 2014 which issued during the prosecution of Applicant's PCT/IL2013/050937.
- An International Preliminary Report on patentabilty dated Dec. 2, 2013, which issued during the prosecution of Applicant's PCT/IL11/00582.
- An Office Action dated Sep. 12, 2013, which issued during the prosecution of U.S. Appl. No. 13/411,814.
- An Office Action dated Aug. 2, 2013, which issued during the prosecution of U.S. Appl. No. 13/031,852.
- An International Preliminary Report on patentabilty dated Sep. 11, 2012, which issued during the prosecution of Applicant's PCT/IL2011/000231.
- An Office Action dated Jul. 2, 2014, which issued during the prosecution of U.S. Appl. No. 13/811,308.
- An Office Action dated Jan. 20, 2016, which issued during the prosecution of U.S. Appl. No. 14/161,921.
- An Office Action dated Jul. 23, 2013, which issued during the prosecution of U.S. Appl. No. 12/961,721.
- An Office Action dated Jul. 18, 2013, which issued during the prosecution of U.S. Appl. No. 13/ 044,694.
- An Office Action dated Nov. 8, 2013, which issued during the prosecution of U.S. Appl. No. 12/840,463.
- An Office Action dated Jun. 4, 2014, which issued during the prosecution of U.S. Appl. No. 12/840,463.
- An Office Action dated Aug. 13, 2012, which issued during the prosecution of U.S. Appl. No. 13/044,694.
- An Office Action dated Jul. 2, 2012, which issued during the prosecution of U.S. Appl. No. 13/033,852.
- An Office Action dated Feb. 3, 2014, which issued during the prosecution of U.S. Appl. No. 13/811,308.
- An International Preliminary Report on patentabilty dated Feb. 11, 2014, which issued during the prosecution of Applicant's PCT/IL12/00292.
- An International Preliminary Report on patentabilty dated Feb. 11, 2014, which issued during the prosecution of Applicant's PCT/IL12/00293.
- A Notice of Allowance dated Aug. 15, 2014, which issued during the prosecution of U.S. Appl. No. 13/411,814.
- An Office Action dated Aug. 14, 2012, which issued during the prosecution of U.S. Appl. No. 12/961,721.
- U.S. Appl. No. 61/283,819, filed Dec. 8, 2009.
- Notice of Allowance dated Apr. 8, 2016, which issued during the prosecution of U.S. Appl. No. 14/237,258.
- U.S. Appl. No. 61/756,034, filed Jan. 24, 2013.
- U.S. Appl. No. 61/756,049, filed Jan. 24, 2013.
- An International Preliminary Report on Patentability dated Jan. 31, 2017, which issued during the prosecution of Applicant's PCT/IL2015/050792.
- U.S. Appl. No. 62/372,861, filed Aug. 10, 2016.
- Notice of Allowance dated Aug. 13, 2018, which issued during the prosecution of U.S. Appl. No. 15/995,597.
- Notice of Allowance dated Apr. 20, 2018, which issued during the prosecution of U.S. Appl. No. 15/878,206.
- An Office Action dated Dec. 10, 2015, which issued during the prosecution of U.S. Appl. No. 14/237,258.
- An International Preliminary Report on Patentability dated Jul. 28, 2015, which issued during the prosecution of Applicant's PCT/IL2014/050087.
- An Office Action dated Nov. 27, 2015, which issued during the prosecution of U.S. Appl. No. 14/626,267.
- An Office Action dated Jan. 21, 2016, which issued during the prosecution of U.S. Appl. No. 14/237,264.
- An Office Action dated Jan. 30, 2015, which issued during the prosecution of UK Patent Application No. 1413474.6.
- An International Search Report and a Written Opinion both dated May 30, 2016, which issued during the prosecution of Applicant's PCT/IL2016/050125.
- An Office Action dated Sep. 26, 2016, which issued during the prosecution of U.S. Appl. No. 14/761,004.
- An Office Action dated Jan. 18, 2017, which issued during the prosecution of U.S. Appl. No. 14/626,267.
- An Office Action dated Feb. 7, 2017, which issued during the prosecution of U.S. Appl. No. 14/689,608.
- An Office Action dated Feb. 8, 2017, which issued during the prosecution of UK Patent Application No. 1613219.3.
- An Office Action together dated Feb. 10, 2017, which issued during the prosecution of European Patent Application No. 12821522.5.
- An International Search Report and a Written Opinion both dated Oct. 27, 2015, which issued during the prosecution of Applicant's PCT/IL2015/050792.
- European Search Report dated Feb. 18, 2015: which issued during the prosecution of Applicant's European App No. 12821522.5.
- Saturn Project—a novel solution for transcatheter heart valve replacement specifically designed to address clinical therapeutic needs on mitral valve: Dec. 2016.
- Righini presentation EuroPCR May 2015 (Saturn)—(downloaded from: https://www.pcronline.com/Cases-resourcesimages/Resources/Course-videos-slides/2015/Cardiovascularinnovation-pipeline-Mitral-and-tricuspid-valve-interventions).
- An Advisory Action dated Apr. 2, 2018, which issued during the prosecution of U.S. Appl. No. 14/763,004.
- An Office Action dated Jul. 26, 2018, which issued during the prosecution of U.S. Appl. No. 15/872,501.
- An Office Action dated May 4, 2018, which issued during the prosecution of U.S. Appl. No. 15/872,501.
- An Office Action dated Apr. 20, 2018, which issued during the prosecution of U.S. Appl. No. 15/886,517.
- An Office Action dated Aug. 9, 2018, which issued during the prosecution of U.S. Appl. No. 15/899,858.
- An Office Action dated Aug. 9, 2018, which issued during the prosecution of U.S. Appl. No. 15/902,403.
- An Office Action dated Jun. 28, 2018, which issued during the prosecution of US Design U.S. Appl. No. 29/635,658.
- An Office Action dated Jun. 28, 2018, which issued during the prosecution of US Design U.S. Appl. No. 29/635,661.
- Georg Lutter, MD, et al; “Percutaneous Valve Replacement: Current State and Future Prospects”, The Annals of Thoracic Surgery ; vol. 78, pp. 2199-2206; Dec. 2004.
- An Office Action dated Jun. 6, 2018, which issued during the prosecution of UK Patent Application No. 1720803.4.
- An International Search Report and a Written Opinion both dated Jun. 20, 2018, which issued during the prosecution of Applicant's PCT/IL2018/050024.
- An Office Action dated Jun. 18, 2018, which issued during the prosecution of UK Patent Appl. No. 1800399.6.
- An Office Action dated Oct. 23, 2017, which issued during the prosecution of U.S. Appl. No. 14/763,004.
- An Office Action dated Dec. 7, 2017, which issued during the prosecution of U.S. Appl. No. 15/213,791.
- Interview Summary dated Feb. 8, 2018, which issued during the prosecution of U.S. Appl. No. 15/211,791.
- An Office Action dated Feb. 7, 2018, which issued during the prosecution of U.S. Appl. No. 15/197,069.
- An International Search Report and a Written Opinion both dated Nov. 24, 2017, which issued during the prosecution of Applicant's PCT/IL2017/050873.
- An Office Action dated Jan. 5, 2018, which issued during the prosecution of U.S. Appl. No. 15/541,783.
- An Office Action dated Feb. 2, 2018, which issued during the prosecution of U.S. Appl. No. 15/329,920.
- An Invitation to pay additional fees dated Jan. 2, 2018, which issued during the prosecution of Applicant's PCT/IL2017/050849.
- An Invitation to pay additional fees dated Sep. 29, 2017, which issued during the prosecution of Applicant's PCT/IL2017/050873.
- European Search Report dated Jun. 29, 2017, which issued during the prosecution of Applicant's European App No. 11809374.9.
- An Invitation to pay additional fees dated Oct. 11, 2018, which issued during the prosecution of Applicant's PCT/IL2018/050725.
- An Office Action dated Dec. 4, 2018, which issued during the prosecution of U.S. Appl. No. 16/045,059.
- An Office Action together with the English translation dated Nov. 5, 2018 which issued during the prosecution of Chinese Patent Application No. 201680008328.5.
- Notice of Allowance dated Sep. 25, 2018, which issued during the prosecution of U.S. Appl. No. 15/188,507.
- European Search Report dated Sep. 26, 2018 which issued during the prosecution of Applicant's European App No. 18186784.7.
- An Office Action dated Jun. 30, 2015, which issued during the prosecution of U.S. Appl. No. 14/522,987.
- Notice of Allowance dated Dec. 13, 2013, which issued during the prosecution of U.S. Appl. No. 13/675,119.
- An International Preliminary Report on Patentability dated Aug. 8, 2017, which issued during the prosecution of Applicant's PCT/IL2016/050125.
- An Office Action dated Jan. 17, 2018, which issued during the prosecution of U.S. Appl. No. 14/763,004.
- An Office Action dated Mar. 25, 2015, which issued during the prosecution of U.S. Appl. No. 12/840,463.
- An Office Action dated Feb. 25, 2016, which issued during the prosecution of U.S. Appl. No. 14/522,987.
- An Office Action dated Apr. 13, 2016, which issued during the prosecution of U.S. Appl. No. 14/626,267.
- An Office Action dated Aug. 28, 2015, which issued during the prosecution of U.S. Appl. No. 14/237,264.
- Maisano (2015) TCR presentation re Cardiovalve.
- Notice of Allowance dated Sep. 29, 2016, which issued during the prosecution of U.S. Appl. No. 14/442,541.
- Notice of Allowance dated May 10, 2016, which issued during the prosecution of U.S. Appl. No. 14/237,258.
- Notice of Allowance dated May 20, 2016, which issued during the prosecution of U.S. Appl. No. 14/237,258.
- An International Preliminary Report on Patentability dated May 19, 2015, which issued during the prosecution of Applicant's PCT/IL2013/050937.
- Dusan Pavcnik, MD, PhD2, et al; “Development and Initial Experimental Evaluation of a Prosthetic Aortic Valve for Transcatheter Placement”, Cardiovascular Radiology. Radiology Apr. 1992, vol. 183, pp. 151-154.
- Notice of Allowance dated Oct. 16, 2013, which issued during the prosecution of U.S. Appl. No. 13/675,119.
- Notice of Allowance dated Feb. 11, 2015, which issued during the prosecution of U.S. Appl. No. 13/033,852.
- Notice of Allowance dated May 5, 2015, which issued during the prosecution of U.S. Appl. No. 12/840,463.
- Notice of Allowance dated Mar. 10, 2015, which issued during the prosecution of U.S. Appl. No. 13/811,308.
- Notice of Allowance dated Jul. 1, 2016, which issued during the prosecution of U.S. Appl. No. 14/442,541.
- An Office Action dated Mar. 25, 2019, which issued during the prosecution of European Patent Application No. 14710060.6.
- An International Search Report and a Written Opinion both dated Nov. 9, 2018, which issued during the prosecution of Applicant's PCT/IL2018/050869.
- An International Search Report and a Written Opinion both dated Dec. 5, 2018, which issued during the prosecution of Applicant's PCT/IL2018/050725.
- An International Search Report and a Written Opinion both dated Apr. 25, 2019, which issued during the prosecution of Applicant's PCT/IL2019/050142.
- An International Preliminary Report on Patentability dated Feb. 12, 2019, which issued during the prosecution of Applicant's PCT/IL2017/050873.
- An Office Action dated Sep. 13, 2019, which issued during the prosecution of U.S. Appl. No. 16/460,313.
- An Office Action dated Nov. 26, 2019, which issued during the prosecution of U.S. Appl. No. 16/532,945.
- An Office Action dated Aug. 16, 2019, which issued during the prosecution of U.S. Appl. No. 15/668,659.
- An Office Action dated Nov. 1, 2019, which issued during the prosecution of U.S. Appl. No. 15/872,501.
- An Office Action dated Jun. 14, 2019, which issued during the prosecution of U.S. Appl. No. 15/703,385.
- An Office Action dated Oct. 4, 2019, which issued during the prosecution of U.S. Appl. No. 16/183,140.
- An Office Action dated Jun. 13, 2019, which issued during the prosecution of U.S. Appl. No. 16/388,038.
- An International Preliminary Report on Patentability dated Feb. 4, 2020, which issued during the prosecution of Applicant's PCT/IL2018/050725.
- An International Search Report and a Written Opinion both dated Jan. 25, 2019, which issued during the prosecution of Applicant's PCT/IL2018/051122.
- An International Search Report and a Written Opinion both dated May 13, 2019, which issued during the prosecution of Applicant's PCT/IL2018/051350.
- An International Preliminary Report on Patentability dated Feb. 5, 2019, which issued during the prosecution of Applicant's PCT/IL2017/050849.
- An Office Action dated Oct. 25, 2018, which issued during the prosecution of U.S. Appl. No. 14/763,004.
- An Office Action dated Mar. 4, 2019, which issued during the prosecution of U.S. Appl. No. 14/763,004.
- An Office Action dated Jan. 9, 2019, which issued during the prosecution of U.S. Appl. No. 15/329,920.
- An Office Action dated Jan. 30, 2019, which issued during the prosecution of U.S. Appl. No. 15/872,501.
- An Office Action dated Feb. 5, 2019, which issued during the prosecution of U.S. Appl. No. 15/899,858.
- An Office Action dated May 23, 2019, which issued during the prosecution of U.S. Appl. No. 15/668,659.
- An Office Action dated May 1, 2019, which issued during the prosecution of U.S. Appl. No. 15/691,032.
- An Office Action dated Aug. 1, 2019, which issued during the prosecution of U.S. Appl. No. 15/668,559.
- An Office Action dated Jun. 19, 2019, which issued during the prosecution of U.S. Appl. No. 15/682,789.
- Notice of Allowance dated Jan. 13, 2020, which issued during the prosecution of U.S. Appl. No. 15/956,956.
- An Office Action dated Jun. 25, 2019, which issued during the prosecution of U.S. Appl. No. 15/329,920.
- An Office Action dated May 16, 2019, which issued during the prosecution of U.S. Appl. No. 15/433,547.
- U.S. Appl. No. 62/560,384, filed Sep. 19, 2017.
- U.S. Appl. No. 62/112,343, filed Feb. 5, 2015.
- An International Preliminary Report on Patentability dated Feb. 11, 2020, which issued during the prosecution of Applicant's PCT/IL2018/050869.
- An International Preliminary Report on Patentability dated Oct. 20, 2020, which issued during the prosecution of Applicant's PCT/IL2019/050142.
- An Office Action dated Jan. 6, 2020, which issued during the prosecution of U.S. Appl. No. 16/660,231.
- An Office Action dated Dec. 31, 2019, which issued during the prosecution of U.S. Appl. No. 16/183,140.
- Notice of Allowance dated Apr. 24, 2019, which issued during the prosecution of U.S. Appl. No. 16/045,059.
- An Office Action dated Jan. 14, 2020, which issued during the prosecution of U.S. Appl. No. 16/284,331.
- European Search Report dated Mar. 5, 2020 which issued during the prosecution of Applicant's European App No. 17752184.6.
- European Search Report dated Mar. 4, 2020 which issued during the prosecution of Applicant's European App No. 16706913.7.
- Notice of Allowance dated Mar. 12, 2020, which issued during the prosecution of U.S. Appl. No. 16/460,313.
- An Office Action dated Jan. 9, 2020, which issued during the prosecution of U.S. Appl. No. 15/600,190.
- An Office Action dated Jan. 3, 2020, which issued during the prosecution of U.S. Appl. No. 16/678,355.
- An Office Action dated Feb. 6, 2020, which issued during the prosecution of U.S. Appl. No. 15/668,659.
- Notice of Allowance dated Nov. 26, 2019, which issued during the prosecution of U.S. Appl. No. 16/532,945.
- Notice of Allowance dated Aug. 19, 2020, which issued during the prosecution of U.S. Appl. No. 16/637,166.
- Notice of Allowance dated Jul. 27, 2020, which issued during the prosecution of U.S. Appl. No. 16/637,166.
- Notice of Allowance dated Jun. 23, 2020, which issued during the prosecution of U.S. Appl. No. 16/637,166.
- Notice of Allowance dated May 7, 2020, which issued during the prosecution of U.S. Appl. No. 16/637,166.
- Sündermann, Simon H., et al. “Feasibility of the Engager™ aortic transcatheter valve system using a flexible over-the-wire design.” European Journal of Cardio-Thoracic Surgery 42.4 (2012): e48-e52.
- An Office Action summarized English translation and Search Report dated Jul. 3, 2020, which issued during the prosecution of Chinese Patent Application No. 201780061210.3.
- Serruys, P. W., Piazza, N., Cribier, A., Webb, J., Laborde, J. C., & de Jaegere, P. (Eds.). (2009). Transcatheter aortic valve implantation: tips and tricks to avoid failure. CRC Press.—Screenshots from Google Books downloaded from: https://books.google.co.il/books?id=FLzLBQAAQBAJ&lpg=PA198&ots=soqWrDH-y_&dq=%20%22Edwards%20SAPIEN%22&lr&pg=PA20#y=onepage&q=%22Edwards%20SAPIEN%22&f=false ; Downloaded on Jun. 18, 2020.
- An International Search Report and a Written Opinion both dated Jun. 24, 2020, which issued during the prosecution of Applicant's PCT/IL2019/051398.
- An Office Action dated Jul. 14, 2020, which issued during the prosecution of U.S. Appl. No. 16/324,339.
- Notice of Allowance dated Aug. 28, 2020, which issued during the prosecution of U.S. Appl. No. 16/324,339.
- Notice of Allowance dated Jul. 29, 2020, which issued during the prosecution of U.S. Appl. No. 16/132,937.
- An Office Action dated Jul. 29, 2020, which issued during the prosecution of U.S. Appl. No. 16/269,328.
- Notice of Allowance dated Aug. 26, 2020, which issued during the prosecution of U.S. Appl. No. 16/269,328.
- An Office Action dated Aug. 7, 2020, which issued during the prosecution of U.S. Appl. No. 15/668,659.
- Tchetche, D. and Nicolas M. Van Mieghem: “New-generation TAVI devices: description and specifications” EuroIntervention, 2014, No. 10:U90-U100.
- An Office Action dated Aug. 23, 2019, which issued during the prosecution of U.S. Appl. No. 15/600,190.
- Symetis S.A.: “ACURATE neo™ Aortic Bioprosthesis for Implantation using the ACURATE neo™ TA Transapical Delivery System in Patients with Severe Aortic Stenosis,” Clinical Investigation Plan, Protocol No. 2015-01, Vs. No. 2, 2015:1-76, Thomas Walther.
- Notice of Allowance dated Sep. 10, 2020, which issued during the prosecution of U.S. Appl. No. 15/600,190.
- Notice of Allowance dated Sep. 10, 2020, which issued during the prosecution of U.S. Appl. No. 16/324,339.
- Notice of Allowance dated Oct. 19, 2020, which issued during the prosecution of U.S. Appl. No. 16/324,339.
- Notice of Allowance dated Sep. 21, 2020, which issued during the prosecution of U.S. Appl. No. 16/269,328.
- Notice of Allowance dated Oct. 28, 2020, which issued during the prosecution of U.S. Appl. No. 16/269,328.
- Notice of Allowance dated Jan. 16, 2020, which issued during the prosecution of U.S. Appl. No. 15/872,501.
- An Office Action dated May 11, 2020, which issued during the prosecution of U.S. Appl. No. 16/811,732.
- An Office Action dated Sep. 24, 2020, which issued during the prosecution of U.S. Appl. No. 16/811,732.
- Notice of Allowance dated Mar. 29, 2017, which issued during the prosecution of U.S. Appl. No. 14/161,921.
- Agarwal et al. International Cardiology Perspective Functional Tricuspid Regurgitation, Circ Cardiovasc Interv 2009;2;2;565-573 (2009).
- Alfieri et al., “An effective technique to correct anterior mitral leafet prolapse,” J Card 14(6):468-470. (1999).
- Alfieri et al., “The double orifice technique in mitral valve repair: a simple solution for complex problems,” Journal of Thoracic Cardiovascular Surgery 122:674-681 (2001).
- Alfieri, “The edge-to-edge repair of the mitral valve,” [Abstract] 6th Annual NewEra Cardiac Care: Innovation & Technology, Heart Surgery Forum pp. 103. (2000).
- Alfieri et al. “Novel Suture Device for Beating-Heart Mitral Leaflet Approximation”, Ann Thorac Surg. 2002, 74:1488-1493.
- Alfieri et al., “The edge to edge technique,” The European Association for Cardio-Thoracic Surgery 14th Annual Meeting Oct. 7-11, Book of Procees. (2000).
- Amplatzer Cardiac Plug brochure (English pages), AGA Medical Corporation (Plymouth, MN) (copyright 2008-2010, downloaded Jan. 11, 2011).
- AMPLATZER® Cribriform Occluder. A patient guide to Percutaneous, Transcatheter, Atrial Septal Defect Closuer, AGA Medical Corporation, Apr. 2008.
- AMPLATZER® Septal Occluder. A patient guide to the Non-Surgical Closuer of the Atrial Septal Defect Using the AMPLATZER Septal Occluder System, AGA Medical Corporation, Apr. 2008.
- Brennan, Jennifer, 510(k) Summary of safety and effectiveness, Jan. 2008.
- Dictionary.com definition of “lock”, Jul. 29, 2013.
- Dang NC et al. “Simplified Placement of Multiple Artificial Mitral Valve Chords,” The Heart Surgery Forum #2005-1005. 8 (3) (2005).
- Maisano, The double-orifice technique as a standardized approach to treat mitral . . . , European Journal of Cardio-thoracic Surgery 17 (2000) 201-205.
- “Two dimensional real-time ultrasonic imaging of the heart and great vessels”, Mayo Clin Proc. vol. 53:271-303, 1978.
- Odell JA et al., “Early Results o4yf a Simplified Method of Mitral Valve Annuloplasty,” Circulation 92: 150-154 (1995).
- O'Reilly S et al., “Heart valve surgery pushes the envelope,” Medtech Insight 8(3): 73, 99-108 (2006).
- Swain CP et al., “An endoscopically deliverable tissue-transfixing device for securing biosensors in the gastrointestinal tract,” Gastrointestinal Endoscopy 40(6): 730-734 (1994).
- An Invitation to pay additional fees dated Jan. 31, 2014, which issued during the prosecution of Applicant's PCT/IL2013/050860.
- U.S. Appl. No. 62/030,715, filed Jul. 30, 2014.
- U.S. Appl. No. 62/139,854, filed Mar. 30, 2015.
- U.S. Appl. No. 61/312,412, filed Mar. 10, 2010.
- An Invitation to pay additional fees dated Jan. 31, 2014, which issued during the prosecution of Applicant's PCT/IL2013/050861.
- An International Preliminary Report on Patentability dated Dec. 23, 2013, which issued during the prosecution of Applicant's PCT/IL2012/000250.
- An International Preliminary Report on Patentability dated Sep. 18, 2007, which issued during the prosecution of Applicant's PCT/IL2006/000342.
- An International Preliminary Report on Patentability dated Jun. 5, 2012, which issued during the prosecution of Applicant's PCT/IL2010/001024.
- An International Preliminary Report on Patentability dated Apr. 28, 2015, which issued during the prosecution of Applicant's PCT/IL2013/050861.
- An International Preliminary Report on Patentability dated Apr. 26, 2016, which issued during the prosecution of Applicant's PCT/IL2014/050914.
- An International Preliminary Report on Patentability dated Jun. 10, 2009, which issued during the prosecution of Applicant's PCT/IL07/01503.
- An International Preliminary Report on Patentability dated Dec. 18, 2010, which issued during the prosecution of Applicant's PCT/IL09/00593.
- An International Preliminary Report on Patentability dated Jun. 29, 2011, which issued during the prosecution of Applicant's PCT/IL2009/001209.
- Notice of Allowance dated Aug. 18, 2017, which issued during the prosecution of U.S. Appl. No. 14/689,608.
- Notice of Allowance dated Jul. 6, 2017, which issued during the prosecution of U.S. Appl. No. 14/682,608.
- Notice of Allowance dated May 22, 2017, which issued during the prosecution of U.S. Appl. No. 14/689,608.
- An Office Action dated Apr. 21, 2017, which issued during the prosecution of U.S. Appl. No. 15/213,791.
- An Office Action dated Sep. 29, 2017, which issued during the prosecution of U.S. Appl. No. 15/191,069.
- An International Preliminary Report on Patentability dated Nov. 9, 2011, which issued during the prosecution of Applicant's PCT/IL2010/000357.
- An International Preliminary Report on Patentability dated Nov. 9, 2011 which issued during the prosecution of Applicant's PCT/IL2010/000358.
- An International Preliminary Report on Patentability dated Nov. 27, 2012, which issued during the prosecution of Applicant's PCT/IL2011/000404.
- An International Preliminary Report on Patentability dated Feb. 4, 2014, which issued during the prosecution of Applicant's PCT/IL2011/000446.
- An International Preliminary Report on Patentability dated Jan. 29, 2013, which issued during the prosecution of Applicant's PCT/IL2011/000600.
- An International Preliminary Report on Patentability dated Dec. 23, 2014, which issued during the prosecution of Applicant's PCT/IL2012/050451.
- A Notice of Allowance dated Jul. 30, 2015, which issued during the prosecution of U.S. Appl. No. 13/319,007.
- An Office Action dated Sep. 29, 2014, which issued during the prosecution of U.S. Appl. No. 13/504,370.
- An Office Action dated Jan. 13, 2015, which issued during the prosecution of U.S. Appl. No. 13/707,013.
- An Office Action dated Mar. 23, 2015, which issued during the prosecution of U.S. Appl. No. 13/707,013.
- Notice of Allowance dated Mar. 25, 2015, which issued during the prosecution of U.S. Appl. No. 13/749,153.
- An Office Action dated Oct. 3, 2014, which issued during the prosecution of U.S. Appl. No. 13/749,153.
- Notice of Allowance dated May 22, 2015, which issued during the prosecution of U.S. Appl. No. 13/749,153.
- Notice of Allowance dated Aug. 3, 2015, which issued during the prosecution of U.S. Appl. No. 13/749,153.
- An Office Action dated Dec. 19, 2013, which issued during the prosecution of U.S. Appl. No. 14/027,934.
- An Office Action dated Jun. 11, 2014, which issued during the prosecution of U.S. Appl. No. 14/027,934.
- An Office Action dated Aug. 22, 2014, which issued during the prosecution of U.S. Appl. No. 14/027,934.
- An Office Action dated Apr. 2, 2015, which issued during the prosecution of U.S. Appl. No. 14/027,934.
- An Office Action dated Jan. 5, 2016, which issued during the prosecution of U.S. Appl. No. 14/027,934.
- An Office Action dated Jan. 5, 2016, which issued during the prosecution of U.S. Appl. No. 14/084,426.
- An Office Action dated Mar. 16, 2015, which issued during the prosecution of U.S. Appl. No. 14/084,426.
- An Office Action dated Jan. 6, 2016, which issued during the prosecution of U.S. Appl. No. 14/128,756.
- An Office Action dated May 11, 2016, which issued during the prosecution of U.S. Appl. No. 14/128,756.
- Notice of Allowance dated Oct. 20, 2015, which issued during the prosecution of U.S. Appl. No. 12/996,954.
- Notice of Allowance dated Feb. 19, 2014, which issued during the prosecution of U.S. Appl. No. 12/795,192.
- An Office Action dated Jul. 20, 2012, which issued during the prosecution of U.S. Appl. No. 12/843,412.
- An Office Action dated Mar. 27, 2013, which issued during the prosecution of U.S. Appl. No. 12/841,412.
- A Restriction Requirement dated May 1, 2012, which issued during the prosecution of U.S. Appl. No. 12/843,412.
- A Notice of Allowance dated May 2, 2013, which issued during the prosecution U.S. Appl. No. 17/824,412.
- A Restriction Requirement dated Nov. 19, 2012, which issued during the prosecution of U.S. Appl. No. 12/926,673.
- An Office Action dated Feb. 12, 2013, which issued during the prosecution of U.S. Appl. No. 12/926,673.
- An Office Action dated Oct. 22, 2013, which issued during the prosecution of U.S. Appl. No. 12/926,673.
- A Notice of Allowance dated Jan. 7, 2014, which issued during the prosecution of U.S. Appl. No. 12/926,673.
- An Office Action dated Oct. 9, 2013, which issued during the prosecution of U.S. Appl. No. 12/996,954.
- An Office Action dated Mar. 24, 2015, which issued during the prosecution of U.S. Appl. No. 12/996,954.
- An Office Action dated Oct. 5, 2012, which issued during the prosecution of U.S. Appl. No. 12/996,954.
- Notice of Allowance dated Jul. 7, 2015, which issued during the prosecution of U.S. Appl. No. 12/996,954.
- An Office Action dated Nov. 16, 2018, which issued during the prosecution of U.S. Appl. No. 16/042,028.
- An International Search Report with Written Opinion both dated Feb. 2, 2012, which issued during the prosecution of Applicant's PCT/IL2011/000600.
- An International Search Report together with Written Opinion both dated Mar. 30, 2011, which issued during the prosecution of Applicant's PCT/IL2010/001024.
- An International Search Report and A Written Opinion both dated Feb. 10, 2011, which issued during the prosecution of Applicant's PCT/IL10/00890.
- An Office Action dated May 28, 2015, which issued during the prosecution of U.S. Appl. No. 14/128,756.
- An Office Action dated Sep. 6, 2018, which issued during the prosecution of U.S. Appl. No. 15/994,022.
- An Office Action dated Sep. 7, 2018, which issued during the prosecution of U.S. Appl. No. 15/995,725.
- An Office Action dated Nov. 26, 2018, which issued during the prosecution of U.S. Appl. No. 16/040,831.
- An Office Action dated Jul. 11, 2018, which issued during the prosecution of U.S. Appl. No. 15/978,494.
- An Office Action dated Nov. 23, 2018, which issued during the prosecution of U.S. Appl. No. 16/041,208.
- An Office Action dated Jun. 15, 2018, which issued during the prosecution of U.S. Appl. No. 15/970,314.
- An Office Action dated Oct. 12, 2018, which issued during the prosecution of U.S. Appl. No. 15/970,314.
- An Office Action dated Jul. 26, 2018, which issued during the prosecution of U.S. Appl. No. 15/979,686.
- An Office Action dated Sep. 10, 2018, which issued during the prosecution of U.S. Appl. No. 16/008,618.
- An International Preliminary Report on Patentability dated Apr. 28, 2015, which issued during the prosecution of Applicant's PCT/IL2013/050860.
- An Office Action dated Apr. 22, 2019, which issued during the prosecution of U.S. Appl. No. 15/668,559.
- Notice of Allowance dated Aug. 30, 2019, which issued during the prosecution of U.S. Appl. No. 15/682,789.
- Notice of Allowance dated Mar. 29, 2019, which issued during the prosecution of U.S. Appl. No. 15/541,783.
- Dieter RS, “Percutaneous valve repair: Update on mitral regurgitation and endovascular approaches to the mitral valve,” Applications in Imaging, Cardiac Interventions, Supported by an educational grant from Amersham Health pp. 11-14 (2003).
- An Advisory Action dated Dec. 13, 2013, which issued during the prosecution of U.S. Appl. No. 12/961,721.
- An Office Action dated August 7, 2015, which issued during the prosecution of U.S. Appl. No. 14/128,756.
- An Office Action dated May 19, 2011, which issued during the prosecution of U.S. Appl. No. 12/706,868.
- An Office Action dated Sep. 1, 2011, which issued during the prosecution of U.S. Appl. No. 12/706,868.
- An Office Action dated May 30, 2012, which issued during the prosecution of U.S. Appl. No. 12/706,868.
- A Notice of Allowance dated Sep. 18, 2012, which issued during the prosecution of U.S. Appl. No. 12/706,868.
- Restriction Requirement dated May 5, 2011, which issued during the prosecution of U.S. Appl. No. 12/706,868.
- A Restriction Requirement dated Mar. 30, 2012, which issued during the prosecution of U.S. Appl. No. 12/785,717.
- An Office Action dated Oct. 5, 2020, which issued during the prosecution of Canadian Patent Application No. 2,973,940.
- An Office Action dated Nov. 30, 2020, which issued during the prosecution of U.S. Appl. No. 16/138,129.
- An Office Action summarized English translation and Search Report dated Nov. 25, 2020, which issued during the prosecution of Chinese Patent Application No. 201910449820.1.
- Notice of Allowance dated Nov. 19, 2020, which issued during the prosecution of U.S. Appl. No. 16/318,025.
- An Office Action dated Aug. 2, 2011, which issued during the prosecution of U.S. Appl. No. 12/435,291.
- Notice of Allowance dated Dec. 7, 2011, which issued during the prosecution of U.S. Appl. No. 12/435,291.
- An Office Action dated Apr. 6, 2010, which issued during the prosecution of Applicant's U.S. Appl. No. 12/484,512.
- An Office Action dated Oct. 6, 2010, which issued during the prosecution of Applicant's U.S. Appl. No. 12/484,512.
- Notice of Allowance dated Apr. 20, 2011, which issued during the prosecution of U.S. Appl. No. 12/484,512.
- Notice of Allowance dated Mar. 23, 2011, which issued during the prosecution of U.S. Appl. No. 12/484,512.
- An Office Action dated Jan. 27, 2012, which issued during the prosecution of U.S. Appl. No. 12/548,991.
- An Office Action dated Aug. 6, 2012, which issued during the prosecution of U.S. Appl. No. 12/548,991.
- An Advisory Action dated Sep. 6, 2012 which issued during the prosecution of U.S. Appl. No. 12/548,991.
- Notice of Allowance dated Jun. 23, 2014, which issued during the prosecution of U.S. Appl. No. 12/548,991.
- A Restriction Requirement dated Nov. 14, 2011 which issued during the prosecution of U.S. Appl. No. 12/548,991.
- Amendment, Terminal Disclaimer and Extension dated Jun. 27, 2012, which issued during the prosecution of U.S. Appl. No. 12/548,991.
- A Restriction Requirement dated Jul. 5, 2012, which issued during the prosecution of U.S. Appl. No. 12/563,930.
- An Office Action dated Apr. 2, 2013, which issued during the prosecution of U.S. Appl. No. 12/785,717.
- An Office Action dated Dec. 27, 2013, which issued during the prosecution of U.S. Appl. No. 12/785,717.
- An Office Action dated Nov. 5, 2012, which issued during the prosecution of U.S. Appl. No. 12/795,026.
- An Office Action dated May 10, 2012, which issued during the prosecution of U.S. Appl. No. 12/795,026.
- Notice of Allowance dated Nov. 13, 2014, which issued during the prosecution of U.S. Appl. No. 12/795,026.
- Notice of Allowance dated Dec. 24, 2014, which issued during the prosecution of U.S. Appl. No. 12/795,026.
- A Restriction Requirement dated Jan. 6, 2012, which issued during the prosecution of U.S. Appl. No. 12/795,026.
- A Restriction Requirement dated Sep. 14, 2012, which issued during the prosecution of U.S. Appl. No. 12/795,192.
- An Office Action dated Aug. 15, 2013, which issued during the prosecution of U.S. Appl. No. 12/795,192.
- An Office Action dated Jan. 17, 2013, which issued during the prosecution of U.S. Appl. No. 12/795,192.
- Notice of Allowance dated Nov. 19, 2013, which issued during the prosecution of U.S. Appl. No. 12/795,192.
- A Notice of Allowance dated Jun. 26, 2012, which issued during the prosecution of U.S. Appl. No. 12/608,316.
- An Office Action dated Nov. 14, 2011, which issued during the prosecution of U.S. Appl. No. 12/608,316.
- A Restriction Requirement dated Apr. 1, 2011, which issued during the prosecution of U.S. Appl. No. 12/608,316.
- An Office Action dated Jul. 6, 2012, which issued during the prosecution of U.S. Appl. No. 12/692,061.
- An Office Action dated Jan. 23, 2012, which issued during the prosecution of U.S. Appl. No. 12/692,061.
- An Office Action dated Mar. 9, 2012, which issued during the prosecution of U.S. Appl. No. 12/689,635.
- An Office Action dated Nov. 30, 2012, which issued during the prosecution of U.S. Appl. No. 12/689,635.
- A Notice of Allowance dated May 22, 2013, which issued during the prosecution of U.S. Appl. No. 12/689,635.
- Restriction Requirement dated Nov. 14, 2011, which issued during the prosecution of U.S. Appl. No. 12/689,635.
- An Office Action dated May 6, 2013, which issued during the prosecution of U.S. Appl. No. 12/689,693.
- An Office Action dated Feb. 3, 2014, which issued during the prosecution of U.S. Appl. No. 12/689,693.
- Notice of Allowance dated Jun. 11, 2014, which issued during the prosecution of U.S. Appl. No. 12/689,693.
- A Restriction Requirement dated Sep. 17, 2012, which issued during the prosecution of U.S. Appl. No. 12/689,693.
- A Notice of Allowance dated Sep. 3, 2014, which issued during the prosecution of U.S. Appl. No. 12/689,693.
- European Search Report dated Jul. 8, 2016, which issued during the prosecution of Applicant's European App No. 13849843.1.
- A Supplementary European Search Report dated Dec. 4, 2012, which issued during the prosecution of European Patent Application No. EP 09834225.6.
- A Supplementary European Search Report dated Mar. 28, 2013, which issued during the prosecution of European Patent Application No. EP 1077 2091.4.
- Search Report in European Patent Application 10772090.6 dated Jan. 17, 2014.
- Supplementary European Search Report dated Oct. 23, 2014 which issued during the prosecution of Applicant's European App No. 10826224.7.
- Notice of Allowance dated May 6, 2016, which issued during the prosecution of U.S. Appl. No. 14/667,090.
- Notice of Allowance dated Apr. 12, 2016, which issued during the prosecution of U.S. Appl. No. 14/667,090.
- An Office Action dated Jun. 7, 2013 which issued during the prosecution of U.S. Appl. No. 13/141,606.
- An Office Action dated Jun. 13, 2014, which issued during the prosecution of U.S. Appl. No. 13/141,606.
- Notice of Allowance dated Sep. 29, 2014, which issued during the prosecution of U.S. Appl. No. 13/141,606.
- An Office Action dated Feb. 4, 2013 which issued during the prosecution of U.S. Appl. No. 13/141,606.
- An English translation of an Office Action dated Apr. 23, 2014 which issued during the prosecution of Chinese Patent Application No. 201080059948.4.
- Communication dated Jul. 25, 2014, issued by the State Intellectual Property Office of the P.R. of China in counterpart Application No. 200980157331.3.
- An International Search Report and a Written Opinion both dated Jan. 25, 2016, which issued during the prosecution of Applicant's PCT/IL2015/051027.
- An International Search Report dated May 19, 2011, which issued during the prosecution of Applicant's PCT/IL2011/00064.
- An International Search Report and a Written Opinion both dated Feb. 22, 2013, which issued during the prosecution of Applicant's PCT/IL201/050451.
- An International Search Report & Written Opinion both dated Mar. 21, 2014, which issued during the prosecution of Applicant's PCT/IL13/50992.
- An International Search Report and Written Opinion both dated Apr. 9, 2014, which issued during the prosecution of Applicant's PCT/IL13/50860.
- An International Search Report and a Written Opinion both dated Apr. 15, 2014, which issued during the prosecution of Applicant's PCT/IL2013/050861.
- An International Search Report & Written Opinion both dated May 12, 2015, which issued during the prosecution of Applicant's PCT/IL2014/050914.
- An International Search Report and a Written Opinion both dated May 30, 2007, which issued during the prosecution of Applicant's PCT/IL2006/000342.
- An International Search Report and a Written Opinion both dated Jun. 10, 2010, which issued during the prosecution of Applicant's PCT/IL09/01209.
- An International Search Report and a Written Opinion both dated Aug. 17, 2010, which issued during the prosecution of Applicant's PCT/IL10/00357.
- An International Search Report & Written Opinion both dated Sep. 8, 2009, which issued during the prosecution of Applicant's PCT/IL09/00593.
- An International Search Report and a Written Opinion both dated Sep. 12, 2008, which issued during the prosecution of Applicant's PCT/IL07/01503.
- An International Search Report and Written Opinion dated Nov. 8, 2010, which issued during the prosecution of Applicant's PCT/IL2010/000358.
- An International Search Report and a Written Opinion both dated Nov. 23, 2011, which issued during the prosecution of Applicant's PCT/IL2011/000446.
- Supplementary European Search Report dated Sep. 25, 2015, which issued during the prosecution of Applicant's European App No. 09794095.1.
- A Supplementary European Search Report dated Feb. 1, 2011, which issued during the prosecution of European Patent Application No. EP 07849540.
- An English translation of an Office Action dated Dec. 12, 2013 which issued during the prosecution of Chinese Patent Application No. 200980157331.3.
- Communication regarding amended claims filed dated Dec. 27, 2012, regarding European App No. 11792047.0.
- An Office Action dated Mar. 23, 2015, which issued during the prosecution of European Patent Application No. EP 09834225.6.
- An English translation of an Office Action dated Jul. 17, 2015 which issued during the prosecution of Chinese Patent Application No. 201080059948.4
- An English translation of an Office Action dated Dec. 16, 2015 which issued during the prosecution of Chinese Patent Application No. 201080059948.4.
- Communication from the European Patent Office dated Jun. 11, 2015, which issued during the prosecution of European Patent Application No. 11811934.
- A communication from the European Patent Office dated Sep. 28, 2011 which issued during the prosecution of European Application No. 09834225.6.
- A communication from the European Patent Office dated Oct. 19, 2012 which issued during the prosecution of European Application No. 11792047.0.
- An Office Action dated Oct. 23, 2012: which issued during the prosecution of Japanese Patent Application No. 2009-539871.
- An English Translation of an Office Action dated Nov. 24, 2015, which issued during the prosecution of Israel Patent Application No. 223448. (the relevant part only).
- Notice of Allowance dated Nov. 17, 2015, which issued during the prosecution of U.S. Appl. No. 14/486,226.
- Notice of Allowance dated Jan. 29, 2016, which issued during the prosecution of U.S. Appl. No. 14/551,951.
- An Office Action dated Jun. 18, 2015, which issued during the prosecution of U.S. Appl. No. 14/551,951.
- An Office Action dated Jan. 4, 2016, which issued during the prosecution of U.S. Appl. No. 14/589,100.
- An Office Action dated May 4, 2016, which issued during the prosecution of U.S. Appl. No. 14/589,100.
- An International Search Report and a Written Opinion both dated Nov. 14, 2011, which issued during the prosecution of Applicant's PCT/IL2011/000404.
- An International Search Report and a Written Opinion both dated Dec. 6, 2012 which issued during the prosecution of Applicant's PCT/IL2012/000250.
- A Notice of Allowance dated Apr. 3, 2013, which issued during the prosecution of U.S. Appl. No. 12/563,930.
- An Office Action dated Aug. 24, 2012, which issued during the prosecution of U.S. Appl. No. 12/563,930.
- An Office Action dated Dec. 29, 2011, which issued during the prosecution of U.S. Appl. No. 12/563,952.
- A Restriction Requirement dated Oct. 27, 2011, which issued during the prosecution of U.S. Appl. No. 12/563,952.
- A Notice of Allowance dated May 24, 2012, which issued during the prosecution of U.S. Appl. No. 12/563,952.
- An Office Action dated Apr. 1, 2013 which issued during the prosecution of U.S. Appl. No. 13/167,2476.
- An Office Action dated Nov. 21, 2013, which issued during the prosecution of U.S. Appl. No. 13/161,476.
- An Advisory Action dated Feb. 4, 2014, which issued during the prosecution of U.S. Appl. No. 13/161,476.
- A Restriction Requirement dated Oct. 25, 2012 which issued during the prosecution of U.S. Appl. No. 13/167,444.
- An Office Action dated Jan. 17, 2013, which issued during the prosecution of U.S. Appl. No. 13/167,444.
- An Office Action dated Aug. 26, 2014 which issued during the prosecution of U.S. Appl. No. 13/167,444.
- An Office Action dated Aug. 23, 2013 which issued during the prosecution of U.S. Appl. No. 13/167,444.
- Notice of Allowance dated Nov. 12, 2015, which issued during the prosecution of U.S. Appl No. 13/319,007.
- Notice of Allowance dated Jan. 7, 2016, which issued during the prosecution of U.S. Appl. No. 13/319,007.
- An Office Action dated Oct. 2, 2013, which issued during the prosecution of U.S. Appl. No. 13/167,492.
- A Restriction Requirement dated Nov. 2, 2012, which issued during the prosecution of U.S. Appl. No. 13/161,492.
- An Office Action dated Feb. 14, 2013 which issued during the prosecution of U.S. Appl. No. 13/167,492.
- Notice of Allowance dated Nov. 7, 2014, which issued during the prosecution of U.S. Appl. No. 13/161,492.
- An Office Action dated Jun. 10, 2014, which issued during the prosecution of U.S. Appl. No. 13/161,492.
- Notice of Allowance dated Dec. 9, 2014, which issued during the prosecution of U.S. Appl. No. 13/161,476.
- Notice of Allowance dated Jan. 22, 2015, which issued during the prosecution of U.S. Appl. No. 13/167,444.
- An International Preliminary Report on Patentability dated May 1, 2012, which issued during the prosecution of Applicant's PCT/IL2010/000890.
- An International Preliminary Report on Patentability dated Jun 9, 2015, which issued during the prosecution of Applicant's PCT/IL2013/050992.
- U.S. Appl. No. 60/873,075, filed Dec. 5, 2006.
- U.S. Appl. No. 60/902,146, filed Feb. 16, 2007.
- An Office Action dated Mar. 29, 2018, which issued during the prosecution of U.S. Appl. No. 15/188,507.
- Notice of Allowance dated Sep. 17, 2014, which issued during the prosecution of U.S. Appl. No. 12/961,721.
- An Office Action dated Oct. 1, 2015, which issued during the prosecution of U.S. Appl. No. 14/141,228.
- A Restriction Requirement dated Jun. 2, 2014, which issued during the prosecution of U.S. Appl. No. 13/319,030.
- An Office Action dated Oct. 14, 2014, which issued during the prosecution of U.S. Appl. No. 13/319,030.
- An Office Action dated Jun. 18, 2015, which issued during the prosecution of U.S. Appl. No. 13/319,030.
- An Office Action dated May 3, 2016, which issued during the prosecution of U.S. Appl. No. 13/319,030.
- Notice of Allowance dated Dec. 30, 2016, which issued during the prosecution of U.S. Appl. No. 13/319,030.
- An Office Action dated Apr. 7, 2015, which issued during the prosecution of U.S. Appl. No. 13/319,007.
- An Office Action dated April 8, 2016, which issued during the prosecution of U.S. Appl. No. 14/141,228.
- An Office Action dated Oct. 5, 2015, which issued during the prosecution of U.S. Appl. No. 14/246,417.
- An Office Action dated April 7, 2016, which issued during the prosecution of U.S. Appl. No. 14/242,151.
- An Office Action dated May 23, 2016, which issued during the prosecution of U.S. Appl. No. 14/209,171.
- An Office Action dated Jul. 20, 2016, which issued during the prosecution of U.S. Appl. No. 14/246,417.
- An Office Action dated Jun, 14, 2016, which issued during the prosecution of U.S. Appl. No. 14/273,155.
- An Office Action dated Jun. 17, 2016, which issued during the prosecution of U.S. Appl. No. 14/357,040.
- An Office Action dated Mar. 24, 2015, which issued during the prosecution of U.S. Appl. No. 14/486,226.
- U.S. Appl. No. 61/001,013, filed Oct. 29, 2007.
- U.S. Appl. No. 61/132,295, filed Jun. 16, 2008.
- U.S. Appl. No. 61/265,936, filed Dec. 2, 2009.
- U.S. Appl. No. 61/283,445, filed Dec. 2, 2009.
- U.S. Appl. No. 61/207,908, filed Feb. 17, 2009.
- U.S. Appl. No. 61/733,979, filed Dec. 6, 2012.
- U.S. Appl. No. 61/717,303, filed Oct. 23, 2012.
- U.S. Appl. No. 61/820,979, filed May 8, 2013.
- U.S. Appl. No. 61/745,848, filed Dec. 6, 2012.
- U.S. Appl. No. 61/555,570, filed Nov. 4, 2011.
- U.S. Appl. No. 61/557,082, filed Nov. 8, 2011.
- U.S. Appl. No. 60/662,616, filed Mar. 17, 2005.
- U.S. Appl. No. 60/700,542, filed Jul. 18, 2005.
- U.S. Appl. No. 61/782,121, filed Mar. 14, 2013.
- European Search Report dated Jul. 15, 2016, which issued during the prosecution of Applicant's European App No. 13849947.0.
- European Search Report dated Nov. 4, 2015, which issued during the prosecution of European Patent Application No. EP 1077 2091.4.
- Search Report in European Patent Application 10826224.7 dated Nov. 16, 2015.
- Supplementary European Search Report dated Dec. 23, 2014 which issued during the prosecution of Applicant's European App No. 10834311.
- Supplementary European Search Report dated Jan. 21, 2014 which issued during the prosecution of Applicant's European App No. 11 78 6226.
- A Supplementary European Search Report dated Jan. 20, 2015, which issued during the prosecution of European Patent Application No. 12803037.6.
- Supplementary European Search Report dated Aug. 4, 2014 which issued during the prosecution of Applicant's European App No. 11 81 1934.6.
- European Search Report dated Jun. 24, 2016, which issued during the prosecution of European Patent Application No. EP 12847363.
- Supplementary European Search Report dated Apr. 29, 2015, which issued during the prosecution of Applicant's European App No. 14200202.
- An Office Action dated Dec. 16, 2013, which issued during the prosecution of U.S. Appl. No. 13/666,262.
- An Office Action dated Dec. 18, 2013, which issued during the prosecution of U.S. Appl. No. 13/666,141.
- Notice of Allowance dated Jun. 25, 2014, which issued during the prosecution of U.S. Appl. No. 13/666,262.
- A Notice of Allowance dated Feb. 2, 2015, which issued during the prosecution of U.S. Appl. No. 13/504,870.
- Notice of Allowance dated Aug. 19, 2013, which issued during the prosecution of U.S. Appl. No. 11/908,906.
- An Office Action dated Jun. 8, 2012, which issued during the prosecution of U.S. Appl. No. 11/908,906.
- An Office Action dated Dec. 21, 2012, which issued during the prosecution of U.S. Appl. No. 11/908,906.
- A Restriction Requirement dated Aug. 5, 2011, which issued during the prosecution of U.S. Appl. No. 11/908,906.
- An Office Action dated Sep. 16, 2009 which issued during the prosecution of U.S. Appl. No. 11/950,930.
- Notice of Allowance dated Sep. 12, 2014, which issued during the prosecution of U.S. Appl. No. 11/950,930.
- An Office Action dated Aug. 5, 2010 which issued during the prosecution of U.S. Appl. No. 11/950,930.
- An Office Action dated Feb. 17, 2010 which issued during the prosecution of U.S. Appl. No. 11/950,930.
- A Restriction Requirement dated Apr. 19, 2010 which issued during the prosecution of U.S. Appl. No. 12/341,960.
- An Office Action dated Sep. 28, 2011, which issued during the prosecution of U.S. Appl. No. 12/437,103.
- An Office Action dated Jun. 13, 2012, which issued during the prosecution of U.S. Appl. No. 12/437,103.
- A Restriction Requirement dated Jul. 12, 2011, which issued during the prosecution of U.S. Appl. No. 12/437,103.
- Notice of Allowance dated Mar. 6, 2014, which issued during the prosecution of U.S. Appl. No. 12/437,103.
- Notice of Allowance dated Dec. 20, 2013, which issued during the prosecution of U.S. Appl. No. 12/437,103.
- Notice of Allowance dated Apr. 27, 2012, which issued during the prosecution of U.S. Appl. No. 12/341,960.
- An Office Action dated Mar. 29, 2011, which issued during the prosecution of U.S. Appl. No. 12/341,960.
- An Office Action dated Aug. 4, 2010, which issued during the prosecution of U.S. Appl. No. 12/341,960.
- An Interview Summary dated Jul. 27, 2011, which issued during the prosecution of U.S. Appl. No. 12/341,960.
- Notice of Allowance dated Aug. 21, 2019, which issued during the prosecution of U.S. Appl. No. 15/703,385.
- Notice of Allowance dated Oct. 16, 2019, which issued during the prosecution of U.S. Appl. No. 15/703,385.
- Notice of Allowance dated Dec. 24, 2020, which issued during the prosecution of U.S. Appl. No. 15/668,659.
- Notice of Allowance dated Oct. 21, 2020, which issued during the prosecution of U.S. Appl. No. 15/668,659.
- Declaration of Ivan Vesely, Ph.D., in Support of Petition for Inter Partesreview of U.S. Pat. No. 7,563,267—dated May 29, 2019.
- U.S. Appl. No. 60/128,690, filed Apr. 9, 1999.
- U.S. Appl. No. 60/613,867, filed Sep. 27, 2004.
- An Office Action dated Dec. 24, 2020, which issued during the prosecution of U.S. Appl. No. 16/144,054.
- An Office Action dated Feb. 2, 2021, which issued during the prosecution of U.S. Appl. No. 16/811,732.
- An Office Action dated Jan. 13, 2021, which issued during the prosecution of European Patent Application No. 15751089.2.
- An Office Action together with an English summary dated Mar. 3, 2021, which issued during the prosecution of Chinese Patent Application No. 201780047391.4.
- Declaration of Dr. Ivan Vesely, Ph.D. in Support of Petition for Inter Partes Review of U.S. Pat. No. 10,226,341—dated Dec. 17, 2020.
- Petition for Inter Partes Review of U.S. Pat. No. 10,226,341 and Exhibits 1001-1013—dated Dec. 29, 2020.
- Batista, Randas JV, et al. “Partial left ventriculectomy to treat end-stage heart disease.” The Annals of thoracic surgery 64.3 (1997): 634-638.
- Beall Jr, Arthur C., et al. “Clinical experience with a dacron velour-covered teflon-disc mitral-valve prosthesis.” The Annals of thoracic surgery 5.5 (1968): 402-410.
- Kalbacher, D., et al. “1000 MitraClip™ procedures: Lessons learnt from the largest single-centre experience worldwide.” (2019): 3137-3139.
- Maisano, F., et al. “The edge-to-edge technique: a simplified method to correct mitral insufficiency.” European journal of cardio-thoracic surgery 13.3 (1998): 240-246.
- Fucci, C., et al. “Improved results with mitral valve repair using new surgical techniques.” European journal of cardio-thoracic surgery 9.11 (1995): 621-627.
- Notice of Allowance dated Nov. 19, 2019, which issued during the prosecution of U.S. Appl. No. 15/668,559.
- Mitral Valve Academic Research Consortium. “Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 1: Clinical Trial Design Principles A Consensus Document from the Mitral Valve Academic Research Consortium.” Journal of the American College of Cardiology 66.3 (2015): 278-307.
- An Office Action dated Aug. 29, 2018, which issued during the prosecution of U.S. Appl. No. 15/329,920.
- An Office Action dated May 8, 2018, which issued during the prosecution of U.S. Appl. No. 15/902,403.
- An Office Action dated May 11, 2018, which issued during the prosecution of U.S. Appl. No. 15/899,858.
- Notice of Allowance dated Oct. 5, 2018, which issued during the prosecution of U.S. Appl. No. 15/886,517.
- Notice of Allowance dated Jul. 19, 2019, which issued during the prosecution of U.S. Appl. No. 15/899,858.
- Notice of Allowance dated Nov. 16, 2020, which issued during the prosecution of U.S. Appl. No. 16/324,339.
- Notice of Allowance dated Apr. 27, 2020, which issued during the prosecution of U.S. Appl. No. 16/591,330.
- An Advisory Action dated Jan. 2, 2020, which issued during the prosecution of U.S. Appl. No. 15/668,659.
- Notice of Allowance dated Oct. 17, 2019, which issued during the prosecution of U.S. Appl. No. 15/329,920.
- An Office Action dated Dec. 31, 2019, which issued during the prosecution of U.S. Appl. No. 16/591,330.
- Notice of Allowance dated Feb. 9, 2021, which issued during the prosecution of U.S. Appl. No. 16/937,216.
- An Office Action dated Sep. 29, 2022, which issued during the prosecution of U.S. Appl. No. 17/010,886.
- An Office Action dated Sep. 29, 2022, which issued during the prosecution of U.S. Appl. No. 16/656,790.
- An Office Action dated Nov. 2, 2022, which issued during the prosecution of U.S. Appl. No. 17/004,693.
- An Office Action dated Oct. 19, 2022, which issued during the prosecution of U.S. Appl. No. 17/875,589.
- An Office Action dated Oct. 26, 2022, which issued during the prosecution of U.S. Appl. No. 16/746,489.
- An Office Action dated Mar. 3, 2023, which issued during the prosecution of European Patent Application No. 17751143.3.
- An Office Action dated Mar. 20, 2023, which issued during the prosecution of U.S. Appl. No. 17/181,722.
- European Search Report dated Mar. 20, 2023 which issued during the prosecution of Applicant's European App No. 22204764.9.
- Notice of Allowance dated Apr. 6, 2023, which issued during the prosecution of U.S. Appl. No. 16/746,489.
- An Office Action dated Apr. 14, 2023, which issued during the prosecution of U.S. Appl. No. 16/144,054.
- An Office Action dated May 15, 2023, which issued during the prosecution of U.S. Appl. No. 16/656,790.
- An Office Action dated May 16, 2023, which issued during the prosecution of U.S. Appl. No. 17/114,771.
- An Office Action dated May 17, 2023, which issued during the prosecution of U.S. Appl. No. 17/466,785.
- An Office Action dated May 25, 2023, which issued during the prosecution of U.S. Appl. No. 17/397,235.
Type: Grant
Filed: Jan 5, 2021
Date of Patent: Oct 31, 2023
Patent Publication Number: 20210145578
Assignee: CARDIOVALVE LTD. (Or Yehuda)
Inventors: Ilia Hariton (Zichron Yaackov), Boaz Harari (Ganey Tikva), Maxim Karalnik (Karmiel), Meni Iamberger (Kfar Saba)
Primary Examiner: Tuan V Nguyen
Application Number: 17/141,853
International Classification: A61F 2/24 (20060101); A61F 2/95 (20130101); A61F 2/915 (20130101);